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Physicochemical and bioactive properties of whey protein hydrolysates 
produced using gastric and pancreatic proteinases
Margaret M. Mullally
This project investigated the contribution of gastric and pancreatic enzymes to some 
physicochemical and biological activity characteristics of whey protein hydrolysates. 
Depending on the method of isolation, and particularly on the zymogen activation 
conditions, it was shown in this study that the endoproteinase and exopeptidase activities 
in pancreatic preparations can exist in different ratios. Furthermore, it has been shown that 
certain physicochemical characteristics o f whey protein hydrolysates can be altered by 
manipulation of the zymogen activation conditions of pancreatic protease preparations. 
Novel whey protein derived peptide inhibitors of angiotensin I converting enzyme (ACE), 
generated using pancreatic proteinases, have been identified in this study. Differential 
scanning calorimetry (DSC) was used to study the thermal stability o f an enriched fraction 
of [3-lactoglobulin. The susceptibility of (3-lactoglobulin to hydrolysis by gastric and 
pancreatic proteinases was related to the thermal stability o f the protein. A pilot scale 
(tangential crossflow plate and frame) ultrafiltration system was investigated with the view 
to developing a procedure for the fractionation and continuous hydrolysis of whey 
proteins.
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1 Gastric and pancreatic proteinases
Proteolytic enzyme preparations find many applications in the food industry, 
such as the baking, brewing or cheese-making industries. More specifically, 
proteolytic preparations have been extensively used in the hydrolysis o f milk 
proteins. Table 1.1 lists proteinases used in the food industry (printed in boldface), 
in addition to their source, their optimal pH range and their preferential specificity. 
More detailed information on the individual en2ymes is given by Godfrey and 
Reichelt (1983) and in a recent book concerning enzymes in food processing edited 
by Nagodawithana and Reed (1993).
The gastric enzyme pepsin and the proteolytic enzymes of the pancreas, 
trypsin, chymotrypsin, elastase, carboxypeptidase A and B are reviewed herein. Only 
pertinent aspects of the literature, which is extensive, are examined in detail. The focus 
is mainly on factors which may lead to a greater understanding of the action of crude 
proteolytic preparations (such as those used in industry) on protein hydrolysis. These 
factors include biochemical characteristics, purification, activation, autolysis, stability, 
inhibition and denaturation. Throughout this section attention has been paid to species 
differences (porcine or bovine), in the production of different proportions of 
proteinases (Marchis-Mouren, 1965), on the mechanism of action (Vithayathil et al., 
1961; Buck et al., 1962); the stability (Vestling et al., 1990) and activation of the 
enzymes (Desnuelle and Rovery, 1961), with a view to how these differences in the 
proteinase preparations could affect the production of milk protein hydrolysates with 
desired functional and/or bioactive characteristics (Thibault, 1990; Jost and Monti, 
1977).
1.1 Classification of Proteinases
Proteinases are classified according to their source (animal, plant, microbial), 
their catalytic action (endoproteinase or exopeptidase), and the nature o f the catalytic 
site. In the Enzyme Commission (EC) system for enzyme nomenclature, all 
proteinases (or peptide hydrolyases) are in subclass 3.4. This sub-class is further 
divided into the exopeptidases, 3.4.11-19 and the endo-peptidases or proteinases,
2
Table 1.1 Protease enzymes finding application in the food industry.
Type o f protease Source Common names, tradenames Typical pH 
range
Preferential specificity
Serine protease bovine / porcine pancreas Trypsin pH 7-9 Lys-, Arg-COOH
Chymotrypsin pH 8-9 Phe-, Tyr-, Trp-COOH
Bacillus licheniformis Subtilisin Carlsberg, Alcalase,
Maxatase, Optimase.
pH 6-10 Broad specificity, mainly 
hydrophobic-COOH
Bacillus amyoliquefaciens Subtilisin NOVO, subtilisin BPN' pH 6-10 ii  n  n  ii
(Bacillus subsilis) n  tf  n  il
Bacillus sp. alkalophilic Subtilisin Esperase, subtilisin Savinase t i  rr  n  n
Cysteine protease Papaya latex Papain pH 5-8 Broad specificity, mainly 
hydrophobic-COOH
Pineapple stem Bromelain pH 5-8 II II II II
Fig latex Ficin pH 5-8 I t  II II II
Aspartic protease bovine, porcine Pepsin, pepsin A pH 1-4 Mainly hydrophobic-COOH and NH2
Calf Chymosin, rennin pH 4-6 Rennet specificity on casein;
Mucor miehei Rennilase, Fromase, Marzyme, 
Morcurd
pH 4-6 mainly hydrophobic -COOH 
and NH2 on protein substrates
Mucor pusillus Emporase, Meito rennet, Noury lab pH 4-6 in general
Endothia parasitica Surecurd, Suparen pH 4-6 Also Glx-COOH
Aspergillus niger (Aspergillus Aspergillopeptidase A (pure aspartic pH 2-5 Pure aspartic protease: like
saitoi) protease), Sumyzyme AP, Proctase, 
Molsin, Pamprosin (mixed with 
carboxypeptidase)
pepsin; mixed preparations: 
broad specificity.
Rhizopus sp. Sumyzyme RP, Newlase pH 3-6 Like pepsin
Metalloprotease Bacillus thermoproteolyticus Thermolysin, Termoase pH 7-9 lie-, Leu-, Val-, Phe-NH2
B. amyloliquefaciens (B. subtilis) Neutrase pH 6-8 Leu-, Phe-NH2
(continues on next page)
(continued from  previous page)
Type o f protease Source Common names, tradenames Typical pH 
range
Preferential specificity
Mixture o f  trypsin 
chymotrypsin, elastase, 
carboxypeptidase A or B
Bovine, porcine Pancreatin pH 7-9 Very broad specificity
Mixture o f  papain, chymopapain, 
and lysozyme
Papaya fruit Papain, crude pH 5-9 Broad specificity
Mixture o f  B. amyloliquefaciens 
serine and metalloprotease
B. amyloliquefaciens Biophrase, Nagase, Rapidermase, 
Rhozyme P 53, MKC protease
pH 6-9 Broad specificity
Mixture o f aspartic protease, 
metalloprotease, serine protease 
and carboxypeptidase
Aspergillus oryzae A. oryzae protease, Takadiastase, 
Sumyzyme LP, Veron P, Panazyme, 
Prozyme, Biozyme A, Sanzyme
pH 4-8 Very broad specificity
Mixture o f  alkaline and neutral 
protease plus aminopeptidase 
and carboxypeptidase
Streptomyces griseus Pronase pH 7-9 Very broad specificity
Aspartic protease, with some 
carboxypeptidase
Pénicillium duponti P. duponti protease pH 2-5 Broad specificity
taken from Adler-Nissen (1993).
3.4.21-24. Endoproteinases are the proteinases most commonly used in food 
processing, but in some cases their action is supplemented with exopeptidases.
Endoproteinases cleave polypeptides at susceptible bonds distributed within 
the polypeptide chain, whereas exopeptidases sequentially hydrolyse one amino acid 
from either the N terminus (aminopeptidases; or dipeptidases, in the case of 3.4.13- 
15) or the C terminus (carboxypeptidases).
1.2 Endoproteinases
Endoproteinases can be divided into four major classes, i.e. serine proteinases 
(EC 3.4.21), cysteine proteinases (EC 3.4.22), aspartic proteinases (EC 3.4.23), and 
metalloproteinases (EC 3.4.24).
As the names imply, serine (trypsin, chymotrypsin, proteinases from bacteria 
and moulds which are active under alkaline conditions), cysteine (papain, bromelain, 
ficin, and certain enzymes from micro-organisms), and aspartic proteinases have 
serine, cysteine, and aspartic acid side chains, respectively, as an essential part o f the 
catalytic site. Modification or blocking of these amino acids usually leads to 
complete inactivation o f the enzyme, and is a standard way o f determining the nature 
o f an unknown proteinase.
The serine proteinases have maximum activity at alkaline pH. Those 
proteinases that contain serine residues at their active centres are deactivated by 
diisopropyl fluorophosphate (DIFP) which reacts with this residue. The closely 
related cysteine proteinases usually show maximum activity at more neutral pH 
values. These enzymes are inhibited by oxidising agents and heavy metals. The 
aspartic proteinases generally have maximum catalytic activity at acid pH. Acidic 
proteinases of the pepsin group have asparagyl or glutamyl residues at their active 
centres. Apart from pepsin, a number of proteinases from moulds, which are active 
under acidic conditions also belong to this category. The metalloproteinases contain 
an essential metal atom, usually Zn, and have optimum activity near neutral pH. 
Ca2+ stabilises these enzymes and strong chelating agents, such as 
ethylenediaminetetraacetic acid (EDTA) act as inhibitors.
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Among human digestive enzymes, the aspartic proteinase, pepsin, is secreted 
in the stomach and the serine proteinases, trypsin and chymotrypsin, are excreted in 
the duodenum.
1.3 Exopeptidases
The aminopeptidases (EC 3.4.1 1) are ubiquitous in nature, but are less 
readily available in commercial products, since many are intracellular or are 
membrane bound. The commercial enzyme preparation, Pronase, isolated from 
Streptomyces griseus, contains endoproteinase, aminopeptidase and 
carboxypeptidase activities. Pronase is often used in the laboratory to achieve 
complete hydrolysis o f proteins. However, the preparation is too costly for general 
food use. Animal tissue homogenates also have been applied on a semi-industrial 
scale as a source of aminopeptidase activity (Clegg et a l., 1974).
Carboxypeptidases are subdivided into serine carboxypeptidases (EC 3.4.16), 
metallocarboxypeptidases (EC 3.4.17) and cysteine carboxypeptidases (EC 3.4.18) 
according to the nature o f the catalytic site. Many commercial proteinases, in 
particular from fungi, contain appreciable amounts of carboxypeptidase activity. In 
the digestive tract, the metallocarboxypeptidases A and B are excreted in conjunction 
with the major serine digestive proteinases (trypsin, chymotrypsin, and elastase). 
Therefore, they occur in the impure, commercially available preparation, known as 
pancreatin, which is usually obtained by dehydration o f the pancreas (Gerhartz, 
1990).
The exopeptidase subgroup also includes the dipeptide hydrolases (EC 
3.4.13-15) which are specific for dipeptide substrates and, consequently, cannot be 
classified as amino- or carboxypeptidases.
From a food-processing perspective, the exopeptidases find utility as a means 
o f debittering protein hydrolysates. The most systematic debittering studies have 
been carried out on hydrolysates o f casein, which is particularly prone to yielding 
bitter peptides. Aminopeptidases (Clegg et al., 1974; Minagawa et al., 1989) and 
carboxypeptidases (Umetsu et al., 1983) have been applied successfully to debitter 
casein hydrolysates.
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1.4 Activation and inhibition
Mammalian digestive enzymes are generally secreted in a proenzyme form. 
This proenzyme or zymogen form must be activated, generally by cleavage of specific 
bonds to release the active form of the enzyme. The gastric enzyme pepsin, in addition 
to the pancreatic enzymes trypsin, chymotrypsin, elastase and carboxypeptidases are all 
secreted in inactive zymogen forms.
Enzyme inhibition can be reversible or irreversible. Irreversible inhibition 
generally involves the formation of a stable adduct with the enzyme by covalent 
bonding with an amino acid residue at the active centre. Reversible inhibition can be 
described as, (a) Competitive, where the inhibitor competes with the substrate for the 
active site by forming an enzyme-inhibitor complex. In most cases the chemical 
structure o f the inhibitor resembles that of the substrate; (b) Non-competitive, where 
the inhibitor decreases the catalytic activity of an enzyme without influencing the 
binding relationship between the substrate and enzyme. The inhibition is dependant 
solely on the concentration of the inhibitor; (c) Uncompetitive, where the inhibitor 
reacts only with the intermediate enzyme-substrate complex; (d) Substrate inhibition, 
where a high concentration of substrate or coenzyme may decrease the catalytic 
activity of the enzyme or (e) End-product inhibition which usually occurs in multi­
enzyme systems where the end-product acts as a specific inhibitor of the enzyme at, or 
near, the beginning o f the enzyme sequence. Comprehensive reviews of enzyme 
interactions with proteinase inhibitors are given by Laskowski and Kato (1980) and by 
Birk (1987).
1.5 Pepsin
The purification, molecular properties, kinetics and mechanism of action of 
pepsinogen and pepsin have been reviewed (Ryle, 1970; Fruton, 1971, 1987). The 
main features of this aspartic proteinase are as follows:
1.5.1 Biochemical characteristics o f  pepsin
Pepsin is a gastric proteinase, composed of a single polypeptide chain of 321 
amino acids and has a molecular weight of 35 kDa (Edeloch, 1957). The amino acid
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composition was determined both for the zymogen and active pepsin (Rajagopalan et 
al., 1966) and it is known that two carboxyl groups are involved in the active site. The 
tertiary structure of pepsin is stabilised in part by three disulphide bridges and a 
phosphate group and it is active in acid, in the pH range of 1-5. However, the 
phosphate group which is attached to the hydroxyl group of a seryl residue, can be 
removed without loss o f enzymatic activity. The three dimensional structure o f the 
hexagonal crystal form of porcine pepsin at a resolution of 23 A has been determined 
(Cooper et al., 1990).
Pepsin shows a broad specificity for peptide bonds, favouring those involving 
carbonyl groups of aromatic amino acids such as tryptophan, tyrosine, phenylalanine, 
leucine and isoleucine (Carrey, 1989). Quantitatively, the most important food use of 
pepsin is in a mixture with chymosin in rennet preparations (Fruton, 1987). The 
kinetics of different active forms of pepsin and pepsin-like proteinases, such as rennin 
(chymosin) or cathepsins have been compared and contrasted, in addition to the 
influence of secondary structure on the proposed mechanism of action of pepsin 
(Fruton, 1971,1987).
1.5.2 Purification o f  pepsin
In contrast to the extremely low isoelectric point of pepsin, i.e. between 2-3, 
that of pepsinogen is about 3.7 (Herriott, 1938). This difference is consistent with the 
cationic character of the peptides removed from the zymogen upon its conversion to 
pepsin. The significant difference in net charge between zymogen and active pepsin 
forms means that ion-exchange chromatography is commonly used to separate the 
zymogen from the active form of pepsin (Fruton, 1971,1987).
1.5.3 Activation o f  pepsinogen
Pepsin is secreted in an inactive zymogen form, pepsinogen (40.4 kDa), by the 
cells o f the mucosa o f the stomach lining. Pepsin is converted from the inactive 
zymogen to the active enzyme by an autocatalytic process, not unlike that of trypsin, in 
the presence of HC1. Conversion of pepsinogen to active pepsin involves cleavage of a 
41-residue amino terminal portion o f the zymogen at pH 2. Activation of the zymogen 
form of pepsin also results in the formation of several peptides of low molecular
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weight. The heterogeneity of the peptic secretion is due mainly to autodigestion, as in 
the case of chymotrypsin (a, P, etc.). The differences in amino acid sequences between 
pepsin from different species gives rise to corresponding differences in 
chromatographic and electrophoretic mobility. Peptides are derived from the released 
41 amino acid sequence at the amino terminal portion of pepsinogen. One of these 
peptides, with 29 amino acid residues, acts as a pepsin inhibitor above pH 5 by forming 
a pepsin-inhibitor complex. These fragments have been shown to inhibit further 
autodigestion and also the proteolytic activity toward haemoglobin (Determann et al., 
1969). At pH values below pH 5, this complex is readily dissociated and active pepsin 
is formed (Herriott, 1962).
1.5.4 Stability and denaturation o f  pepsin
Porcine pepsinogen can undergo reversible denaturation following heating to 
60 °C at pH 7 or after treatment with alkali (up to pH 11). Pepsin is quite stable 
between pH 2-5, but in contrast to its zymogen, it rapidly loses activity above pH 5.0 
due to denaturation. The pH optimum for peptic hydrolysis of proteins is about pH 2 
but on synthetic substrates it is around pH 4.0. When hydrophobic groups sensitive to 
pepsin are exposed on the surface of proteins through denaturation, the nature of these 
groups may affect the optimal pH and hydrolysis rate of the enzyme. Hydrophobic 
interaction has been shown to increase pepsin stability to heat, i.e. pepsin activity was 
unaffected at 60 °C and treatment with 4 M urea or 3 M guanidinium (Edeloch, 1958; 
Fruton, 1971). The pH dependence of the kinetic parameters of pepsin, and its active- 
site hydrogen bond mutants have been determined (Lin et al., 1992).
1.6 Trypsin
1.6.1 Biochemical characteristics o f  trypsin
Bovine trypsin was first isolated from pancreatic acinar cells, where an inactive 
zymogen, trypsinogen, is synthesised and subsequently converted to an active form 
(Northrop et al., 1948). Trypsin is commonly isolated in conjunction with insulin by 
extraction from bovine or porcine pancreatic glands. The commercial availability of 
trypsin has, therefore, been linked to the market for insulin for many years. Trypsin
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catalyses the hydrolysis of ester and peptide bonds involving the carboxyl group of the 
basic amino acids, arginine and lysine, and in which a serine and a histidine residue 
participate in the catalytic mechanism (Desnuelle, 1960). Bovine pancreatic trypsin 
consists of a single chain of 233 amino acid residues with six disulphide bonds (Balls, 
1965). Its structure has been established by X-ray crystallography at 1.8 A resolution 
(Keil, 1971; Bode and Schwager, 1975). Trypsin is known to possess two binding sites 
close to each other, one to which charged molecules bind preferentially and the other to 
which neutral molecules bind (Sanborn and Bryan, 1968). The chemical, physical and 
enzymatic properties of the serine proteinase, trypsin have been reviewed (Desnuelle, 
1960; Cunningham, 1965).
The differences between the proportions of enzymes present in bovine and 
porcine pancreatic juice have been reviewed (Desnuelle and Rovery, 1961; 
Marchis-Mouren, 1965). Although bovine, and porcine trypsins have similar pH and 
temperature optima, Michaelis-Menten constants and kinetics of esterolytic activity, a 
number of important differences exist. Some differences which are reviewed here, 
must be considered during purification and activation of trypsin from a particular 
species.
Porcine trypsin differs from bovine in its electrophoretic behaviour and stability 
in alkaline media, although both have similar ion-exchange chromatographic profiles 
using carboxymethyl (CM) or diethylaminoethyl (DEAE) -cellulose as adsorbents 
(Vithayathil et al, 1961; Buck et al., 1962; Hakim et a l, 1962; Van Melle el al., 
1963). Porcine trypsin has a lower isoelectric point, PI = 10.2, than bovine trypsin, PI 
= 10.5 (Buck et al., 1962). Magnesium and calcium ions stabilise bovine trypsin but 
porcine trypsin is less sensitive to the cationic nature of the surrounding medium. 
These differences in electrophoretic behaviour and the stability of porcine trypsin point 
to the fact that structural differences exist between the porcine enzyme and trypsins of 
other species. There are significant differences in amino acid composition between 
bovine and porcine species (Travis and Leiner, 1965). For instance, the N ^-term inal 
residue of the porcine 2ymogen is phenylalanine instead of valine in the bovine 
counterpart and the existence of C-terminal asparagine residues is characteristic of 
porcine trypsin (Charles et al., 1963). In addition, bovine and porcine trypsins have 
different immunological properties (Uriel and Avrameas, 1965). Species variations,
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however, will be found only in the general protein characteristics o f the enzyme and 
not in the properties directly dependant on the active site (Buck et al., 1962).
1.6.2 Purification o f  trypsin
The classical purification of bovine trypsinogen as described by Northrop et al. 
(1948), involves acid extraction of fresh pancreas, ammonium sulphate fractionation 
and removal o f a-chymotrypsinogen as a crystalline by-product (Laskowski, 1956). 
Subsequent purification and crystallisation of trypsinogen involves treatment of the 
liquor and washings from the crystallisation of chymotrypsinogen with acidic 70 % 
saturated ammonium sulphate (SAS) to form a precipitate of crude trypsinogen. Two 
crystallisation methods have been described, one involving M gS04 at pH 8.0 
(Laskowski, 1956), the other crystallisation in ethanol-water mixtures at 4 °C (Balls, 
1965). There are significant differences in the isolation and crystallisation procedures 
of porcine trypsin in comparison to bovine trypsin (Van Melle et al., 1963; Travis and 
Leiner, 1965). Porcine trypsinogen is less soluble than its bovine homologue, since it 
precipitates at 40 % SAS (Charles et al., 1963).
Commercial trypsin is treated with the inhibitor N-tosyl-L-phenylalanine 
chloromethyl ketone (TPCK) to inhibit traces of contaminating chymotrypsin activity. 
Methods such as ion-exchange chromatography have been used to separate 
chymotiypsin and inert proteins from different active forms of trypsin (Schroeder and 
Shaw, 1968). In addition, a simple and rapid purification of commercial trypsin and 
chymotrypsin by reverse phase-high performance liquid chromatography (RP-HPLC) 
has been described (Titani et al., 1982). More recently, large-scale continuous 
purification processes, using a combination of affinity chromatography and 
ultrafiltration have been developed for the purification of trypsin (Luong et al., 1988; 
Powers et al., 1990). For example, trypsin was selectively bound by a water-soluble 
high molecular weight polymer, bearing a potent and specific trypsin inhibitor, 
para-aminobenzamidine. The trypsin macroligand complex was then retained by an 
ultrafiltration membrane. The bound trypsin was eluted with a solution o f arginine or 
benzamidine (Luong et al., 1988).
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1.6.3 Activation o f  trypsinogen
Control o f the rate of activation of the zymogen can be achieved by 
manipulating temperature, pH or by the inclusion o f calcium ions or specific trypsin 
inhibitors. The mechanism of activation o f trypsinogen in the presence of calcium ions 
has been studied (Abita et al., 1969). Activation at pH 8 is catalysed by small amounts 
o f trypsin in the presence of calcium (McDonald and Kunitz, 1946), or by enterokinase 
(Yamashina, 1956). Addition of calcium speeds up the activation o f bovine 
trypsinogen but is less essential for activation of porcine trypsinogen (Vithayathil et al., 
1961).
The predominant single chain product is p-trypsin, resulting from the release of 
a hexapeptide (at the Lys6-Ile7 sequence) from bovine trypsinogen while an octopeptide 
is released from the porcine zymogen (Charles et al., 1963). Subsequent cleavage of 
the Lys131-Ser132 bond at the N-terminal end of the molecule of bovine trypsinogen 
leads to a-trypsin (Schroeder and Shaw, 1968) which is a two-chain structure held 
together by disulphide bonds. A further cleavage of a-trypsin at Lys176-Asp177 yields 
an active bovine form termed pseudotrypsin (Smith and Shaw, 1969).
1.6.4 Stability, denaturation, autolysis and inhibition o f  trypsinogen and trypsin
Porcine trypsin has a superior resistance to self-digestion in neutral or alkaline
solutions in comparison to bovine trypsin (Vithayathil et al., 1961). Porcine trypsin 
has been shown to be more stable than bovine trypsin to thermal, alkaline or acidic 
denaturation (Buck et a l, 1962; Lazdunski and Delaage, 1965). Trypsinogen is stable 
at pH 2 to 4, but at neutral or alkaline pH auotactivation to trypsin takes place. Even 
lyophilised samples undergo slow autodigestion during storage at 4 °C. 
Immobilisation of trypsin improved its stability to autolysis (Swaisgood and Catignani, 
1987) and allowed the use o f trypsin at elevated temperatures which is advantageous in 
minimising microbial growth during the hydrolysis of whey proteins (Section 2 and 3).
Trypsin is fully active in urea solutions up to 6.5 M (Lazdunski and Delaage, 
1965) and in 30 % (v/v) ethanol (Schwert and Eisenberg, 1949). Trypsin can be 
reversibly heat-denatured below pH 8 and the effect of pH on temperature-induced 
reversible denaturation of both bovine and porcine trypsinogen and trypsin has been 
studied. In an investigation of the susceptibility of the different forms of trypsin to
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urea dénaturation, it was shown that substrates or competitive inhibitors can protect 
trypsin from dénaturation (Lazdunski and Delaage, 1965).
Since trypsin contains 14 lysines and 2 arginines residues, it is a substrate for 
its own action, and this autolysis has long been recognised as a potential source of 
artifacts in structural studies (Andrews and Dixon, 1989). The autolysis products 
produced by trypsin can be detected using fast atom bombardment mass spectrometry 
(FABMS) when the product mixture is analysed directly and when it is fractionated by 
HPLC. The autolysis o f porcine pancreatic trypsin produces a different set o f peptides 
from that of bovine trypsin (Vestling et al„ 1990) and it was shown that there is a 
slower proteolysis rate for porcine trypsin at pH 8.5 in 0.1 M NH2H C 03 and 0.1 mM 
CaCl2 buffer (Vestling et al., 1990). The formation of inactive products during the 
activation of bovine trypsinogen can be prevented by the addition of 0.02-0.10 M 
calcium which speeds up the selective splitting of Lys6-Ile7 by a factor of more than 
ten, thus promoting p-trypsin formation and also preventing further non-specific 
cleavage (Abita et al., 1969) by protecting some of the bonds from tryptic attack. The 
protective effects of calcium ions is more pronounced in bovine than in porcine trypsin 
(Lazdunski and Delaage, 1965; Abita et al., 1969). Spontaneous autocatalytic 
activation of trypsinogen can also be prevented by low molecular weight peptide 
inhibitors such as para-amino benzamidine and benzamidine or by natural inhibitors o f 
trypsin e.g. soybean or cereal inhibitors (Mares-Guia and Shaw, 1965; Laskowski and 
Kato 1980; Kroghdahl and Holm, 1983).
Several inhibitors of trypsin have been characterised and reviewed (Keil, 1971). 
Trypsin is inhibited by DIFP and phenylmethyl-sulphonylfluoride (PMSF), which 
interact with the active centre by binding covalently to Ser183 (Speakman and 
Yarwood, 1966; Keil, 1971). Many compounds with a positively charged group and 
hydrophobic moiety such as amidines and guanidines, (Lorand and Rule, 1961; 
Mares-Guia and Shaw, 1965), benzoyl and tosyl arginine (D'Albis and Béchet, 1967) 
and aliphatic and aromatic amines (Inagami, 1964), have also been used to study the 
active site o f trypsin. For example, the structure o f the complex formed by bovine 
trypsin and the bovine pancreatic trypsin inhibitor has been studied (Huber et al., 
1974). Trypsin inhibitors have relatively low molecular weights (6000-8000 Da) and 
their tertiary structure is very compact owing to a high content of disulphide bridges.
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These inhibitors are therefore very stable to denaturation or to the action of proteolytic 
enzymes. The most well known proteinase inhibitors are probably the trypsin 
inhibitors of soybean, e.g. Kunitz soybean trypsin inhibitor (KSBI) and Bowman-Birk 
inhibitor (BBI). Only rarely do natural trypsin inhibitors inhibit trypsin exclusively. In 
most cases they are polyvalent and also inhibit thrombin, chymotrypsin and kallikrein 
(Keil, 1971).
1.7 Chymotrypsin
1.7.1 Biochemical characteristics o f  chymotrypsin
The serine proteinase chymotrypsin is also secreted by the acinar cells of the 
pancreas. Two forms o f the bovine zymogen are present, chymotrypsinogen A, with a 
molecular weight of 25 kDa and an isoelectric point of 9.1, and chymotrypsinogen B, 
of similar weight, with an isoelectric point of 5.2. The isoelectric points of the porcine 
zymogen A is pH 7.2, notably lower than the isoelectric point of the bovine zymogen. 
An additional zymogen form, chymotrypsinogen C was isolated from porcine pancreas 
(Folk and Schirmer, 1963). This zymogen was found in a complex with 
procarboxypeptidase A (PCPA) and proelastase E. Chymotrypsinogen C is often 
known as Subunit II in this complex (Petra, 1970). The separation of this zymogen 
from the other components of the complex has been detailed (Puigserver et al., 1986; 
Cambillaueia/., 1988).
Although porcine chymotrypsinogen B has similar biochemical characteristics 
to the bovine zymogen, it differs in that it is denatured at low pH and cannot be 
isolated by acid extraction of porcine pancreas. Acid lability is also a property of the 
third zymogen chymotrypsinogen C.
Chymotrypsin preferentially catalyses the hydrolysis of peptide bonds 
involving tyrosine, phenylalanine and tryptophan. In addition to bonds involving 
aromatic amino acids, chymotrypsin catalyses, at a high rate, the hydrolysis of bonds of 
leucine, methionine, asparagine and glutamine residues, along with the amides and 
esters o f the above amino acids (Cunningham, 1965; Ardelt and Laskowski, 1985). 
Chymotrypsinogen C has been found to attack the carbonyl side of leucine in a large 
variety of simple substrates (substrates composed of a repeating unit) and larger
14
polypeptides. Chymotrypsin C is specific for the a-amino acids already mentioned but 
more especially for leucine residues.
The structure of bovine a-chymotrypsin from X-ray diffraction studies at a 
resolution of 2 A has been studied (Sigler et al., 1968; Blow, 1971). The amino acid 
sequence of bovine chymotrypsinogen A has been determined (Meloun et al., 1966). It 
contains 241 amino acids residues and the amino acid residues known to participate in 
the mechanism of catalysis are His97, Asp102, and Ser195 (Hess, 1971).
The purification, activation procedures, physical and chemical properties of 
both bovine and porcine chymotrypsin have been reviewed by a number o f groups 
(Desnuelle and Rovery, 1961; Folk, 1970a; Wilcox, 1970; Hess, 1971). In its 
specificity and pH-activity profiles, chymotrypsin resembles the subtilisins (e.g. 
Alcalase) rather than trypsin (Adler-Nissen, 1993).
1.7.2 Purification o f  chymotrypsin
The classical purification procedure of chymotrypsins A and B has been 
detailed (Laskowski, 1956). Briefly, the zymogen of chymotrypsin A is first isolated 
from an acid extract o f pancreatic tissue and purified by recrystallisation from an 
ammonium sulphate solution. The pure zymogen is then activated with bovine trypsin 
under slow activation conditions and the enzyme is isolated by crystallisation at about 
pH 4 from ammonium sulphate. Salt is removed by dialysis and the product is 
lyophilised. Ion-exchange chromatography using CM-cellulose and Sephadex-G25 has 
been used to separate a-chymotrypsin from different active forms, i.e. the 7t, 8, and y 
forms and the neochymotrypsinogen impurities which are produced under different 
activation conditions. Addition of DIFP inhibits chymotrypsin activation of the 
zymogen during the purification process. The purification and properties of porcine 
chymotrypsinogen A have been outlined (Wilcox, 1970) and this zymogen is similar to 
its bovine counterpart.
Purification o f porcine chymotrypsinogens differs from bovine 
chymotrypsinogen, due to their acid labile nature and involves extraction of acetone 
powders of pancreatic tissue followed by ammonium sulphate fractionation and 
DEAE-cellulose chromatography (Folk, 1970a and Wilcox, 1970).
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1.7.3 Activation o f  chymotrypsinogens
The different zymogens o f bovine chymotrypsin A and B have several active 
forms, i.e a , P, 5, y, n chymotrypsin, depending on the purification procedures and 
activation conditions used. Tryptic cleavage of a single peptide bond between Arg15 
and Ile16 results in a fully active enzyme (Wilcox, 1970). However, under conditions 
o f slow activation i.e. at low temperatures and in the absence of calcium ions, 
chymotryptic digestion of the zymogen produces neochymotrypsinogens, which are 
then activated by trypsin to various active forms. The different activation mechanisms, 
properties and types of active chymotrypsinogen A and B have been reviewed 
(Desnuelle and Rovery, 1961; Sigler et al., 1968). It has been noted that the duration 
of activation and presence or absence of ions such as calcium dictates the forms, 
activities and stabilities of the resulting enzymes (Wilcox, 1970). Calcium ions act to 
stabilise the conformation of both the zymogen and active forms during the activation 
process and prevent autolysis. These ions, however, are not essential in the activation 
o f the zymogen form by trypsin to release active chymotrypsin (Wilcox, 1970).
The differences which exist between activation of zymogens from the porcine 
species in comparison to the bovine counterpart, in addition to the types of active 
enzymes formed have been reviewed (Wilcox, 1970). The specific activity of 
chymotrypsin changes during the activation process and further autolytic modification. 
Some of this change is due to inherent differences among the different species of 
chymotrypsin, some due to inhibition by end-products o f autolysis and some due to 
formation of inert protein fragments (Wilcox, 1970). It is known that differences in 
specific activities o f the different forms of chymotrypsin is due to heterogeneity of the 
active forms o f this enzyme (Wilcox, 1970).
1.7.4 Stability and inhibitors o f  chymotrypsins
Chymotrypsin A is most stable at pH 3, nevertheless, even at this pH autolysis 
proceeds, but at a slower rate than at higher pH values (Wilcox, 1970). At pH 6.5 
chymotrypsins aggregate to high molecular weight oligomers. The enzyme is also 
denatured by urea at concentrations above 3.5 M (Harris, 1956). Porcine chymotrypsin 
C can be stored at 4 °C and pH 6 as a suspension in 65 % saturated ammonium 
sulphate, as a salt free solution for up to 4 months. Immobilisation has been used as a
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method o f stabilisation of a-chymotrypsin against different denaturing agents such as 
heat, urea and organic solvents (Guisan et a l, 1991).
Natural inhibitors (Krogdahl and Holm, 1983), in addition to PMSF include,
2+ 2+  2_f-
heavy metals such as Cu , Hg and Ag , organophosphorus compounds, a - 
chloroketone and phenothiazine-N-carbonyl chloride also inhibit chymotrypsin 
activity.
1.8 Elastase
1,8.1 Biochemical characteristics o f  elastase
Elastase, an endoproteinase, is secreted in the acinar cells o f the pancreas in the 
proenzyme form and is activated by trypsin. Pure elastase was first isolated from 
porcine pancreas and the important physicochemical characteristics of this enzyme 
were established (Lewis et al., 1956, 1959). Elastase has a broad substrate specificity 
and is involved in hydrolysis of peptide bonds involving the carbonyl groups of amino 
acids with uncharged non-aromatic side chains i.e. alanine, valine, leucine, isoleucine, 
glycine and serine. It has a molecular weight of approximately 26.5 kDa (Lewis et al, 
1956). It exists as a single peptide chain containing 240 amino acids cross-linked by 
four disulphide bridges and has an isoelectric point of pH 9.5. It has been shown that 
elastase splits peptide bonds in elastin (Partridge and Davis, 1955) and also hydrolyses 
the A and B chains o f oxidised insulin (Naughton and Sanger, 1961). Many of the 
chemical, physical and kinetic properties in addition to the primary and tertiary 
structure o f elastase have been reviewed in detail (Shotton, 1970 and Hartley and 
Shotton, 1971).
Two families o f elastase are known to exist in the porcine pancreas. One 
family, represented by porcine elastase I (Ureil and Aurameas, 1965 and Powers et al., 
1977), is characterised by a general specificity for small amino acid side chains such as 
isoleucine, valine and alanine (Powers et al., 1977). Porcine elastase I has a very basic 
isoelectric point in the region of pH 10.7. The second family, represented by porcine 
elastase 2 and human elastase 2 (Largmann et al., 1976; Gertler et a l, 1977), is 
characterised by a specificity for bulky hydrophobic amino acids (Del Mar et al., 
1980). The porcine elastase II family have a low basic isoelectric point of
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approximately pH 9.6 (Largmann, 1983). Details of the primary and tertiary structure 
of porcine elastase have been reviewed (Hartley and Shotton, 1971). Structural 
analysis o f the active site of porcine pancreatic elastase based on the X-ray crystal 
structures of complexes with trifluoroacetyl-dipeptide-analide inhibitors has been 
recently carried out (Mattos et al., 1995).
1.8.2 Purification o f  elastase
A purification procedure widely used involves ammonium sulphate 
precipitation of a sodium acetate powder of pancreatic tissue and often involves ethanol 
fractionation (Lewis et al., 1956) followed by dialysis against water to yield a 
euglobulin precipitate (Hall, 1957). A variety of materials including elastin, alumina 
gel (Hall, 1957) and various ion-exchange materials have also been used with some 
success to adsorb elastase from crude pancreatic extracts. Elastase can be easily 
crystallised from dilute salt solutions in which the contaminating proteins are fully 
soluble. This has lead to a simple and selective procedure for obtaining pure 
recrystallised elastase (Shotton et al., 1968). Various methods have been used to 
purify the euglobulin precipitate (Lewis et al., 1959, Naughton and Sanger, 1961 and 
Gertler and Birk, 1970). Details of these methods have been reviewed (Shotton, 1970). 
Other purification methods have combined techniques such as affinity chromatography 
with immobilised proteinase inhibitors and CM-Sephadex chromatography (Gertler et 
al., 1977; Largmann, 1983) to isolate the different types of pancreatic elastase from 
within the two families previously mentioned.
1.8.3 Activation and inhibition o f  elastase
The activation and inhibition of elastase has been extensively reviewed 
(Shotton, 1970; and Hartley and Shotton, 1971). The elastolytic activity of elastase is 
appreciably affected by salt. Sodium chloride (50-70 mM) caused 50 % inhibition of 
elastase activity and similar effects were observed with potassium chloride, ammonium 
sulphate and sodium cyanide (Lewis et al., 1956). However, the activity of elastase 
towards the specific substrate benzoyl-L-alanine methyl ester (BAME), while being 
inhibited 14 % by 100 mM sodium chloride, is greatly stimulated by 1.2 M sodium 
sulphate or by 10 mM trishydroxymethylamine (Shotton, 1970). Elastase as in the case
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of the serine protease enzymes, trypsin and chymotrypsin is irreversibly inhibited by 
DIFP. Similarly covalent inhibition has been achieved with sulfonyl fluorides and with 
p-dinitrophenoldiethyl phosphate (Shotton, 1970).
1.8.4 Stability o f  elastase
Elastase is readily soluble in water and dilute salt solutions at concentrations up 
to 50 mg/ml between pH 4 and 10.5. At 2 °C elastase solutions are stable for 
prolonged periods below pH 6 and reasonably stable at higher pH values. Brief 
pH-induced conformational changes are reversible but prolonged incubation at acid pH 
leads to irreversible dénaturation with loss of enzymatic activity (Lewis et al., 1956). 
However, it is a powerful proteolytic enzyme and will rapidly autolyse to a mixture of 
peptides if incubated at room temperature at or near its optimum pH of 8.8. At pH 5.0 
elastase solutions can be stored or used at room temperature with little autolysis. 
Crystals of elastase are stable indefinitely in 1.2 M sodium sulphate, buffered at pH 5.0 
with sodium acetate. Freeze-dried elastase prepared following dialysis against 1 mM 
acetic acid is stable indefinitely at -10 °C with no loss o f activity (Shotton, 1970).
1.9 Carboxypeptidases (CP) A and B
1.9.1 Biochemical characteristics o f  carboxypeptidases
The pancreatic exopeptidases have been reviewed by a number of groups (Folk, 
1970b; Hartsuck and Lipscomb, 1971 and Puigserver et al., 1986). Carboxypeptidases 
(CP) A and B are exopeptidase, zinc-containing peptidases, which are specific for the 
C-terminal amino acid residues of substrates and are secreted in the zymogen 
(proenzyme) form. Both procarboxypeptidases (PCPs) amount to 20 % of the total 
pancreatic secretory proteins (Puigserver et al., 1986). Both enzymes also catalyse the 
hydrolysis of esters and therefore have dual specifies. The zymogen forms have been 
shown to have intrinsic esterolytic activity. For example, when PCPA was assayed 
with the ester substrate hippuryl-DL-phenylacetate, this activity was about 5 % of that 
observed after tryptic activation o f the zymogen (Puigserver et al., 1986).
CPA is secreted in a precursor form, procarboxypeptidase A (PCPA). Porcine 
pancreatic tissue is a rich source o f PCPA (Marchis-Mouren et al., 1961). In most
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species pancreatic PCPA is either monomeric (Marchis-Mouren et al., 1961) or is 
associated with a functionally different protein, described in pig as a proelastase-like 
zymogen of proteinase E which is also a serine proteinase (Kobayashi et al., 1978 and 
Martinez et al., 1981). The fundamental properties o f bovine procarboxypeptidases 
have been characterised and have been compared with the porcine pancreatic 
zymogens (Martinez et a l, 1981 and Vendrell et al., 1982). Carboxypeptidases of 
porcine pancreas are much more water soluble than bovine euglobin CPA and hence 
are easier to separate (Folk and Schirmer, 1963; Venrell et al., 1982). CPA was first 
crystallised from beef pancreas (Anson, 1937). Porcine CPA has also been isolated 
and the relationships of the three forms of this enzyme (a, (3, y ) have been established 
(Folk and Schimer, 1963; Petra, 1970). They have a molecular weight of 
approximately 35.3 kDa (Bradshaw et al., 1969). CPA has been sequenced and is 
composed of a single polypeptide chain of 307 amino acid residues (Bradshaw et al.,
1969). Several kinetic constants and some of the physical properties of porcine CPA 
have been compared with those of bovine CPA (Folk and Schirmer, 1963). The 
kinetics o f PCPA and CPA highlight differences between the zymogen and active form 
of the enzyme. The three dimensional structure of CPA and CPB and the structure of 
activation segment have been studied at 2 A resolution. (Guasch et al., 1992).
The isolation o f PCPB from pancreatic juice or aqueous extracts of pancreatic 
acetone powder has been described (Winterberger et al., 1962). The amino acid 
sequence o f PCPB and CPB has been established (Cox et a l, 1962; Folk, 1971). CPB 
was first isolated from bovine pancreas (Waldschmidt-Leitz et al., 1931). It has a 
molecular weight of 34.3 kDa and requires zinc ions for activation (Wintersberger et 
al., 1962). It displays esterase activity towards carboxyl terminal argininic acid (Folk 
and Gladner, 1958). Many of the physical and chemical properties of CPB, its 
activation and kinetics o f activity have been reviewed (Folk, 1970b).
1.9.2 Differences between CPA and CPB
Ternary complexes o f the zymogen, PCPA, with chymotrypsinogen C and 
proteinase E have been characterised in ruminant species, i.e. goat, sheep and cow 
(Kerfelec et al., 1985). It has been suggested that differences in the three-dimensional 
structure o f the A and B zymogens may explain the differences in intrinsic activity and
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different rates of proteolytic activation of each zymogen (Guasch et al., 1992). CPA 
and CPB are similar in amino acid sequence and mechanism of reaction, however, they 
differ in substrate specificity. CPA preferentially cleaves substrates with aromatic or 
large aliphatic carboxy terminal residues, whereas CPB acts on aromatic and basic 
amino acid such as lysine, arginine, ornithine and homoarginine. Histidine in a 
C-terminal position is not hydrolysed by CPB (Folk, 1970b). These differences may 
reflect the different roles of the enzymes. CPB acts on the products of trypsin digestion. 
CPA, on the other hand, acts on the products of chymotrypsin activity. CPA will not 
release peptide-bound proline, (proline will stop the hydrolysis reaction) arginine or 
glycine residues and acidic amino acids are only released slowly (Guasch et al., 1992). 
The preparation, properties and uses of CPA and CPB for end-group (protein 
sequencing) analysis have been reviewed (Ambler, 1972).
1.9.3 Purification o f  carboxypeptidases
The purification o f PCPA by extraction of acetone powder of pancreatic tissue, 
chromatography on DEAE-cellulose followed by ammonium sulphate precipitation 
serves as a general purification scheme for this procarboxypeptidase (Anson, 1937). 
Methods involving soya-bean trypsin inhibitor followed by DEAE-cellulose, Biogel 
R150 chromatography, or combinations of both have also been used to purify PCPA 
(Martinez et al., 1981). The properties and methods of crystallisation of the PCPA 
complex have been reviewed (Petra, 1970).
CPB is isolated from acetone powders o f porcine pancreas in a process 
involving fractionation with ammonium sulphate followed by chromatography on 
DEAE-cellulose (Folk, 1971). Bovine CPB and porcine CPB have been crystallised 
following tryptic activation of either purified or partially purified proenzyme 
preparations (Winterberger et al., 1962). The purification and properties o f three 
PCPA and two PCPB forms of human procarboxypeptidase by anion-exchange HPLC 
has been demonstrated (Pascual et al., 1989).
1.9.4 Activation o f  CPA and CPB zymogens
CPA and CPB are secreted as zymogens (PCPA and PCPB) from acinar 
pancreatic cells and are activated by trypsin in a two-step cascade system, producing
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the active form o f the enzyme. The sequence of events during activation by proteolysis 
is different for PCPA and PCPB. Transformation of PCPB to CPB by trypsin is a 
faster process than the activation of PCPA. In the activation of PCPB, a 95 residue 
activation segment is released giving rise to intermediates and to a proteolytically 
resistant activation fragment of 81 residues (Pascual et al., 1989; Burgos et al., 1991). 
In the tryptic conversion of PCPA to active CPA, the activation segment remains 
bound to the enzyme until a second trypsin cleavage occurs (Vendrell et al., 1990). 
The kinetics involved in zymogen activation have been reviewed (Guasch et al., 1992).
1.9.5 Stability and inhibitors o f  carboxypeptidases
The inhibition and activation kinetics have been reviewed for both CPA and 
CPB (Folk, 1970b; Puigserver et al., 1986). Both CPA and CPB retain stability when 
stored in 0.01 M Tris/HCl pH 8.0 at 4 °C for several years (Wintersberger et al., 1962). 
For example, concentrated solutions of porcine CPB in dilute Tris buffer pH 7.5 or 
suspensions of crystals of the enzyme in water have been stored at -10 °C for periods 
o f up to one year without detectable loss in enzymatic activity (Folk, 1971). 
Substantial losses (25-45 %) in activity occurred upon lyophilisation of either solutions 
or crystalline suspensions of CPB. CPA is insoluble at low ionic strength and stable 
between pH 7 and 10 (Wintersberger et al., 1962). Different allelomorphs of CPA 
have been isolated and there are differences in their thermal stability (Petra, 1970).
Many substances inhibit CPA and CPB, including metal chelating agents such
as 1,10 phenanthroline (Smith and Hanson, 1949), substrate analogs and products of
2+ . . . . .  
CP hydrolysis. Removing the Zn atom inhibits both peptidase and esterase activities
of the zymogen and active forms of CPA and CPB. CPB is also inhibited by
pyrophosphate and borate buffers above pH 8 (Wolff et al., 1962). Butanol and several
other alcohols influence CPB activity and it was shown in the presence of 0.3 M
butanol that the rate of hydrolysis of hippuryl-l-arginine hydrolysis was increased (by
100 %) but rates o f esterolysis were decreased (by 85 %) (Folk et al., 1962).
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2 P-Lactoglobulin and other whey proteins
Nutritionally, whey proteins are rich in essential amino acids and have a high 
biological value. Therefore, they are suitable for the supplementation of various foods 
and are, for example, often incorporated into infant formulae (Renner, 1983). Whey 
proteins represent 20 % of the total protein in milk. The literature on the manufacture, 
functional properties and uses of whey proteins has been extensively reviewed 
(Marshall and Harper, 1988; Sienkiewicz and Riedel, 1990; Zadow, 1992). In 
addition, the chemistry and physiochemical properties of the whey proteins has been 
reviewed (McKenzie, 1971; Whitney, 1988; Fox, 1992).
Whey has been defined as ‘the product obtained by using acids, rennet and/or 
chemico-physical processes during cheese and casein production’ (Sienkiewicz and 
Riedel, 1990). Depending on the method of recovery whey may be classified into acid 
or rennet wheys. Acid whey (pH 5.1) is ‘the milk serum obtained by separation of 
casein, effected predominantly by acid, but also by P-galactosidase’. Rennet whey (pH 
5.6), also known as sweet whey, is ‘the milk serum obtained by separation of casein, 
effected predominantly by rennet, but also by p-galactosidase’. The types of whey, the 
technology used in the manufacture of various whey powders and the utilisation of 
established whey products have been extensively reviewed (Sienkiewicz and Riedel,
1990). Potential routes for the industrial scale processing o f whey are given in Figure 
2.1.
Whey proteins can have a high degree of functionality. Functionality 
encompasses such properties as solubility over a wide pH range, water-binding and 
water retention capacity, i.e. ability to form heat-induced gels and stable foams, and 
emulsifying properties (Sienkiewicz and Riedel, 1990). A number of processing 
variables, such as heat treatment used in the extraction of whey protein concentrates 
can affect the functional properties of whey (Schmidt et al, 1984; deWit and 
Klarenbeek, 1984; Gauthier et al, 1993). For example, heat treated whey proteins 
frequently lose their ability to form stable gels and to be soluble over a broad pH range. 
Heat or alkali treatment may also generate hydrolysis-resistant intermolecular and 
intramolecular covalent bonds, which in turn, may affect the nutritional quality of 
whey protein or its hydrolysis products (Erbersdobler, 1983).
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CHEESE/CASEIN WHEY
Figure 2.1: Potential routes for the industrial scale processing of whey 
(taken from Morr, 1982).
2.1 M anufacture of whey protein concentrates and lactalbumin
Whey protein powders (10-15 % protein) are usually produced using 
evaporation or spray-drying, while whey protein concentrates, (WPCs 25-95 % 
protein) are produced using ultrafiltration in combination with precipitation and/or 
chromatographic separation. The production of WPC is often coupled with 
demineralisation and lactose crystallisation steps (Marshall and Harper, 1988; 
Sienkiewicz and Riedel, 1990).
Lactalbumin is prepared by washing, in the presence of calcium ions, and 
drying, the proteins precipitated from heat-treated whey (Roger et al., 1981). 
Lactalbumin generally has a protein content greater than 77 % (w/w). The lactose, 
lipid and ash content o f  lactalbumin varies with the degree o f mineral washing during 
the manufacturing process and with the lactation stage of the milk used for
24
manufacture (Robinson el a l, 1976). The protocol for the manufacture of lactalbumin 
is given in Figure 2.2.
Wit o y/Oo ml no rt I iod Whoy/Conconlratod Whey
I pH adjustmonl, optional ] 
( 2.5-3.5. <.5-4.8. 6 0-6.5)
Deprotelnated
Whey
[ Hoaiing ) 
90-1 ?0°C K min
L
I Acidification, optional j 
(pH 4.5-4 8)
J
| Prolein Recovery [
(Settling and decanting:vacuum 
liltrationiseli-desludging ceninluge 
or horozontal solid bowl decanter
1 c*jrd |
| Washing |
1 Drymg |
Spray. Roller. Ring-, 
or Fkndized Bed Drier
LACT ALBUMIN
Figure 2.2 The protocol for the manufacture of Iactalbumin
(taken from Mulvihill, 1992)
Lactalbumin is a gritty and insoluble whey protein powder, having a high water 
binding capacity (Short, 1980). It has been shown that heating whey at 88 to 90 °C 
between pH 2.2 to 3.5 and readjusting to pH 4.6 to precipitate the protein gives a 
lactalbumin product with improved solubility (Modler and Harwalker, 1981). Even 
though it has limited functionality, lactalbumin is o f a high nutritional value (Wingerd,
1970). Solubilisation of lactalbumin occurs at an alkaline pH, i.e. pH values >9.4 
(Smith et al., 1989). However, it has been shown that the solubility of lactalbumin at
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lower pH values was greatly improved by enzymatic hydrolysis (Smith et al, 1989). 
Because of its nutritional value, lactalbumin is often used to fortify foods containing 
cereal proteins (Towler, 1982), in foods where solubility is not an important factor e.g. 
biscuits (Short et al, 1978) and as a meat extender (Jelen, 1975).
The use o f enzymatic hydrolysis to improve lactalbumin functionality is 
reviewed in Section 3. The manufacture, properties and uses of lactalbumin have been 
reviewed elsewhere (Robinson et al., 1976).
2.2 The individual whey proteins
A number of industrially feasible methods have been developed to fractionate 
the major protein components, i.e. p-lactoglobulin (P-lg) and a-lactalbumin (a-la) 
from whey (Amundson et al., 1982; Slack et al., 1986; Maubois et al., 1987; Pearce, 
1987). The major whey proteins, which are also designated serum proteins, are given 
in Table 2.1. The major whey proteins are globular and contain a significant number of 
sulphydryl groups which in turn can be involved in protein/protein interactions during 
processing of whey protein as well as interacting with other proteins in complex food 
systems.
Minor whey proteins are the iron-binding proteins, (lactoferrin and transferrin), 
lactollin, p2-microglobulin, the milk fat globule membrane proteins and hydrolysis 
products of caseins (Walstra and Jenness, 1984; Fox, 1992). In addition, another 
constituent o f rennet and cheese whey is glycomacropeptide, consisting of 64 amino 
acids, a component released from K-casein by the hydrolytic action of rennin.
Traces of various enzymes of primary origin (plasmin, alkaline phosphatase, 
lactoperoxidase, catalase, lipases and proteinases) and are also present in whey and 
their characteristics have been reviewed (Fox, 1992). Peroxidase is the milk enzyme 
present in the greatest proportion (1 % of the total whey protein content).
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Table 2.1: Concentration and physicochemical properties of the whey
proteins of bovine milk
Protein % of whey Concentration Molecular Isoelectric 
protein (g I'1) mass (kDa) point (pi)
P-Lactoglobulin 55-65 3.3 18.4 5.35-5.49
a-Lactalbumin 15-25 1.2 14.2 4.2-4.5
Serum albumin 5-6 0.3 66.3 5.1
Immunoglobulins 10-15 0.5 80-900 5.5-8.3
Proteose peptones 10-20 0.2 4.1-80 5.1-6.0
(taken from Evans, 1980 and Marshall and Harper, 1988)
2.3 B-Lactoglobulin
The globular protein P-lg is an abundant component of the whey fraction of the 
milk o f several animal species and has been characterised both chemically and 
physically (McKenzie, 1971; Whitney, 1988; Hambling et al., 1992). In the bovine 
species, it represents 55-65 % of the total whey proteins (Table 2.1). B-Lg has a high 
content of essential amino acids (McKenzie, 1971; Hambraeus, 1982) which makes it a 
potentially nutritious protein source. But apart from being very nutritious, the 
molecular properties, particularly the acid solubility and ligand binding capability o f p- 
lg leads to the supposition that some other, as yet unclear, more specific function exists 
for this protein. The possible biological functions of p-lg have been reviewed (Pérez 
and Calvo, 1995).
The structure, genetic variants, stability to various pHs and temperatures and 
the biological significance of P-lg will be dealt with in this review. Particular attention 
will be given to how enzymatic hydrolysis has been used to modify the protein. It is 
known that changes in protein conformation brought about by, for example, pH 
adjustment, heat treatment, or ligand binding, can alter the rate of proteolysis (Mihalyi,
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1978; Swaisgood and Catignani, 1987; Puyol et al, 1994). The effects of heating, 
esterification, pressurisation or ligand binding on the susceptibility to enzymatic 
hydrolysis will also be reviewed.
2.3.1 P-Zg structure
The molecular weight of bovine G-lg B (monomeric form) is estimated to be
18.3 kDa corresponding to a polypeptide chain of 162 amino acid residues (Table 2.1). 
The molecule contains two disulphide bridges as well as one free cysteine. The free 
thiol group is of significance in the processing of milk, as it can interact with other 
proteins such as K-casein (Sawyer, 1969) and a-la  (Hunziker and Tarassuk, 1965). p- 
Lg also exists in dimer form. B-Lg contains four tryptophan groups per dimer 
(McKenzie, 1971). The primary structure and function of [3-lg has been reviewed 
(Godovac-Zimmermann and Braunitzer, 1987).
In terms o f secondary structure, B-lg in solution possesses approximately 10 % 
a-helix, 43 % antiparallel B-pleated sheet and 47 % unordered structure (Creamer et 
al., 1983). A core structural motif, a hydrophobic pocket, consisting of an 
eight-stranded B-barrel with another B-strand and a-helix on the surface has been 
identified in P-lg by X-ray crystallography (Green et al., 1979; Monaco et al., 1987). 
P-Lg has a structural similarities to the plasma retinol binding protein (Papiz et al., 
1986; Cho et al., 1994). The structural stability o f P-lg has been studied using circular 
dichroism spectra analysis (Alexander and Pace, 1971; Chen et al., 1993) and by 
differential scanning calorimetry (DSC, deWit and Swinkels, 1980; Puyol, et al., 
1994). In addition, studies using trypsin hydrolysis are frequently used to investigate 
B-lg structure (Dalgalarrondo et al., 1990; Chobert el al., 1991; Chen et al., 1993).
2.3.2 Genetic variants
At least seven genetic variants of B-lg , designated P-lg A, B, C, D, E, F and G, 
differing in overall composition by amino acid substitutions have been reported 
(McKenzie, 1971; Eigel et al., 1984; Hambling et al., 1992). The major variants are P- 
lg A and B which differ at positions 64 and 118, where Asp and Val in variant A are 
substituted by Gly and Ala, respectively in variant B. p-Lg A and B both have 17 
potential tryptic cleavage sites, however, comparative differences exist in a number
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physiochemical properties (Townend et al., 1967; Alexander and Pace, 1971), as 
outlined in section 2.3.3.2. For example, the thermal stability of the A and B variants 
differ as detected using differential scanning calorimetry (deWit and Swinkels, 1980; 
Imafidon et al., 1991 ; Huang et al., 1994a ).
2.3.3 Factors affecting susceptibility o f  (3-Ig to enzymatic hydrolysis
A number o f modifications which change the susceptibility o f P-lg to 
enzymatic hydrolysis are as follows: (1) pH and temperature changes; (2) genetic 
variants; (3) ligand binding; (4) pressurisation and (5) chemical modification. Each of 
these modifications indirectly imparts different physicochemical properties to the 
hydrolysate produced by alteration of the number and type of cleavage points available 
to the digestive enzymes. Because of their globular and mostly stable structure, only 
slight modification in the conformation of the protein can produce significantly 
different digestion products. The correlation between the susceptibility of a peptide 
bond to proteolysis with the flexibility of the residues surrounding that bond has been 
well documented (Mihalyi, 1978; Swaisgood and Catignani, 1987).
2.3.3.1 pH and temperature changes
P-Lg exhibits a unique self-association pattern which is pH dependent 
(Zimmermann et al., 1970). At neutral pH B-lg exists as a dimer. Below pH 3.7 and 
above pH 5.2 dimers are favoured that increasingly dissociate to monomers as the pH 
decreases or increases, respectively. Between pH 3.7 and 5.2, the dimer undergoes a 
progressive reversible tetramerization (Kumosinski and Timasheff, 1966). A reversible 
conformational change above pH 7.5, causes the exposure of tryptophan and tyrosyl 
residues to solvent (Tanford et al., 1959; Townend et a l 1967, 1969; Zimmermann et 
al., 1970). This pH induced dissociation during the so called "Tanford transition", 
exposes a carboxyl group and a sulphydryl group but is not accompanied by gross 
changes in molecular conformation (Timasheff et al., 1966; Mills and Creamer, 1975; 
Teller et al., 1979). It has been suggested that this transition in B-lg structure 
associated with pH changes is reflected in its susceptibility to proteolysis (Monnot and 
Yon, 1964).
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In addition to the influence of pH, B-lg undergoes temperature - dependent 
thermodenaturation and conformational changes (Brunner, 1977). B-Lg is known to 
dissociate to the monomer in the pH region of 5.2-5.9, and as the temperature is 
increased from 20 to 45 °C. P-Lg aggregates above 65 °C with increasing holding time 
involving SH oxidation and disulphide interchange (McKenzie, 1971; Gotham el a l,
1992). Dupont (1965) and deWit and Swinkels (1980) showed that reversible 
conformational changes can occur to p-lg below 70 °C, however, above this 
temperature irreversible denaturation takes place. The monomer-dimer dissociation 
constant varies with the genetic variant and is increased with increasing temperature 
(Imafidon et al., 1991). Heating steps such as pasteurisation, sterilisation and 
evaporation, as used in the preparation of many whey products, and the influence of 
heating on the characteristics of p-lg have been reviewed (McKenzie, 1971). The 
thermal denaturation and gelation of B-lg has been studied (Paulsson and Elofsson,
1994) using DSC and dynamic rheology.
Modification, of B-lg by heating and pH changes makes this protein more 
susceptible to proteolysis by digestive enzymes (Schmidt and van Markwijk, 1993). 
For example, heat treatment followed by enzymatic hydrolysis has been used to 
eliminate the allergenicity induced by this protein (see 2.3.4.1).
2.3.3.2 Variants
It has been previously reported that tryptic hydrolysis o f B-lg A is 3.5 times 
faster than B-lg B (Nakamura et al., 1993b). The difference in hydrolysis rates of B-lg 
A and B by trypsin might be ascribed to the substitution of Asp64 in B-lg A with Gly in 
B-lg B (Dalgalarrondo et al., 1990) and resultant differences in structural stability 
(Huang et al., 1994a ). It was suggested that the variant related differences in 
chymotryptic hydrolysis of B-lg could also be attributed to the amino acid substitution 
at position 64 (Van Willige and FitzGerald, 1995). It has been shown that the variants 
differ in their gelling properties (Huang et al., 1994a, b) and heat stability, in addition 
to resistance to enzymatic hydrolysis (Imafidon et al., 1991; Huang et al., 1994c).
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2.3.3.3 Ligand binding
It is suspected that fi-lg has a role in nutrition in the transport o f essential fatty 
acids, triglycerides, alkanes, minerals such as calcium ions and the vitamin, retinol 
(Puyol et al, 1994; Pérez and Calvo, 1995). It has been suggested that the biological 
role of fi-lg is related to digestion and/or transport of fatty acids or retinol to specific 
receptors in the duodenum of new bom ¿mimáis (Pervaiz and Brew, 1985; Puyol et al.,
1993).
fi-Lg belongs to a family of proteins that interact with small volatile 
hydrophobic ligands (Hambling et al., 1992; Puyol et al., 1994). These proteins share 
a similar three dimensional structure containing an internal hydrophobic pocket 
(Sawyer et a l,  1985). Both the centre o f the fi-barrel (Papiz et a l, 1986) and a surface 
hydrophobic pocket (Monaco et al., 1987) of p-lg have been suggested as possible high 
affinity binding sites for retinol and vitamin A. Ruminant fi-lg binds fatty acids (Diaz 
de Villegas et a l, 1987; Spector and Fletcher, 1970) and retinol (Fugate and Song, 
1980) in vitro. Fatty acids compete in vitro with the binding of retinol to fi-lg (Puyol et 
al., 1991). It has been shown that the binding of fatty acids to fi-lg increases its 
conformational stability and thus resistance to trypsin degradation (Puyol et al, 1993). 
Differential scanning calorimetry (DSC) has been used to study the thermal stability of 
bovine fi-lg as influenced by binding of palmitic acid or retinol (Puyol et al., 1994). 
The findings concluded that binding o f fatty acids to fi-lg may play an important role 
in the stabilisation of fi-lg structure.
2.3.3.4 Pressurisation and its influence on enzymatic hydrolysis
Pressurisation has been used as a method of modification of fi-lg which alters 
the three-dimensional (3D) structure o f the protein during enzymatic hydrolysis and 
increases the enzyme activities. This effect which can in turn promote the reduction of 
allergenicity (Nakamura et a l, 1993a, b). The susceptibility of the fi-lg variants A, B, 
AB to enzymatic hydrolysis at ambient and high pressure has been described (Van 
Willige and FitzGerald, 1995).
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2.3.3.5 Chemical modification and hydrolysis of (3-lg
Chemical modification through cleavage of S-S bonds using permissible food 
additives such as sulphite has been used to improve the digestibility of B-lg (Otani, 
1981; Reddy et al., 1988). Modification of B-lg by esterification using alcohol 
followed by tryptic (Briand el al., 1994) or peptic hydrolysis (Dalgalarrondo et al.,
1995) has also been investigated. It has been suggested that the peptides produced 
following hydrolysis may have different biological or physiological properties. 
Esterification with alcohols blocks exposed carboxyl groups in proteins neutralising 
negative charges of carboxylates and increases protein hydrophobicity.
2.3.4 Properties o f  enzymatically hydrolysed fi-lg
The applications o f proteinases in the hydrolysis o f whey proteins are given in 
Section 3. Some properties related to (3-lg hydrolysates are mentioned briefly here:
2.3.4.1 Reduction of allergenicity
B-lg is absent from human and rodent milk and its inclusion in baby milk 
formulae has focused attention on its potential allergenic properties in infants 
(Nakamura et al., 1993a, b). Since bovine milk contains B-lg, which is a potential 
allergen, it is desirable, in some instances, to selectively eliminate B-lg from whey 
(Okamoto et al., 1991) for inclusion in infant or milk protein formulae. Heat treatment 
has been used to reduce allergenicity of P-lg. However, this has been shown to 
produce new compounds between B-lg and lactose by the Maillard reaction and that 
these compounds in turn show a greater allergenic response than native B-lg. The 
second method used to reduce allergenicity employs enzymatic hydrolysis. Hydrolysis 
results in an increase o f charged groups and hydrophilicity, a decrease in molecular 
weight and alterations in molecular conformation. p-Lg was hydrolysed by trypsin and 
chymotrypsin or porcine pancreatin to give a reduction in its allergenic properties 
(Asselin et al., 1989). High pressure treatments prior to proteolysis have also been 
used to produce hypoallergenic hydrolysates (Okamato et al., 1991; Nakamura et al. 
1993a, b). A brief review of the application of enzymatic hydrolysis to produce low 
allergenic hydrolysates is given in Section 3.1.2.
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2.3.4.2 Bioactive peptide hydrolysates
There are two known bioactive peptides derived from the enzymatic hydrolysis 
of P-lg using digestive proteinases. An opioid peptide, p-lactorphin (Tyr-Leu-Leu- 
Phe) was produced using pepsin and trypsin or a combination of trypsin and 
chymotrypsin hydrolysis of native or heat-treated B-lg (Antila et al., 1991). Another 
tetrapeptide, known as P-lactotensin (His-Ile-Arg-Leu), which acts on smooth muscle, 
was released from the internal sequence of P-lg by the action of chymotrypsin or a 
combination o f pepsin and chymotrypsin (Pihlanto-Leppàlà et al., 1994a). Details of 
milk derived bioactive peptides will be dealt with in Section 4.
2.3.4.3 Emulsification and foaming properties
P-Lg in particular displays a low surface hydrophobicity, but on enzymatic 
hydrolysis, the exposed hydrophobic residues become available for interaction with oil 
surfaces. Therefore, limited hydrolysis of p-lg improves émulsification and foaming 
properties. For example, peptide fragments isolated from P-lg after tryptic hydrolysis 
in an ultrafiltration type membrane reactor, showed enhanced interfacial activities 
(Turgeon et al., 1992). These hydrolysates were suitable for improvement of food 
emulsions and foams. Most research has been carried out on émulsification and 
foaming properties of p-lg in the presence of the other whey proteins, i.e. in 
lactalbumin and WPC, and this research is outlined in Section 3.1.1.2.
2.3.4.4 Gelation
Besides the influence of the inclusion of salts such as sodium chloride and 
calcium chloride on the gelation of B-lg (Mulvihill and Kinsella, 1988; Paulsson and 
Elofsson, 1994; Li et al., 1994), the role of limited enzymatic hydrolysis by 
immobilised trypsin on the gelation of p-lg has also been investigated (Chen et al.,
1994). It has been shown that a hydrolysate giving superior gelling properties to the 
native protein can be produced by limited hydrolysis of P-lg (Chen et al., 1994). 
Partially hydrolysed B-lg had a lower gel point and gelled more rapidly than native B-lg 
at 80 °C. Polypeptide fragments which retain their secondary and tertiary structure 
after limited hydrolysis and which are derived from the core B-barrel domain are 
suspected to be crucial in this gelling process (Chen et al., 1993; Chen et al., 1994).
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2.4 a-Lactalbumin
a-La represents 15-25 % of the total whey proteins in bovine milk (Table 2.1). 
a-L a is nutritionally important because it is the principal whey protein of human milk 
(Heine et al., 1991). This protein is also involved in the final stage of lactose 
biosynthesis (Brodbeck and Ebner, 1966). It functions by promoting the binding of 
glucose to glactosyltransferase and has a role in the formation o f lactose from glucose 
and galactose. The physical and chemical properties of a-la have been reviewed 
(McKenzie, 1967; Gordon, 1971; Brew and Grobler, 1992).
a-La consists of a single polypeptide chain o f 123 amino acids, (14.2 kDa) and 
contains eight cysteines which exist as intramolecular disulphides (Eigel et al., 1984). 
The four disulphide bridges, which are intrinsic to a-la  structure contribute to the 
thermal stability and the very high renaturability of the molecule. Upon heating at pH
6.5, a -la  unfolds at temperatures as low as 62 °C, but on cooling the molecule reverts 
to its native structure (Pfeil, 1981). The cysteine residues, which occur as four 
disulphide bridges, are mainly responsible for this reversible change. a-La is the most 
heat stable whey protein. O f all the normal methods for the heat treatment of liquid 
milk, only indirect ultra high temperature (UHT) heating (15 s above 100 °C, maximum 
141 °C) effects an irreversible denaturation on a-la. a-La is a metalloprotein, capable 
o f binding calcium, zinc and other metals (Stuart et al., 1986). The removal of calcium
by EDTA reduces its heat stability (Bernal and Jelen, 1984). A conformational change
2+
occurs in a-la  around pH 4.0, where the molecule loses the Ca which is tightly bound 
at higher pH values. The thermal stability of a-la in comparison to the other whey 
proteins has been determined (Pfeil, 1981) The 3D structure of a-la  has been 
determined (Acharya et al., 1991) and the metal binding and physicochemical 
properties of a-la  have been studied (Kronman, 1989; FitzGerald and Swaisgood, 
1989; Brew and Grobler, 1992).
There is a large amount of sequence homology between a-la  and type-c 
lysozymes (Brew and Campell, 1967; Hill and Brew, 1975). a-La secondary structure 
includes approximately 26 % a-helix, 14 % (3-sheet and 60 % unordered structure 
which includes P-tums (Hall et al., 1987). Three genetic variants o f a -la  have been 
identified in Western bovine breeds (Fox, 1989). It was suggested that the protective
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effect o f certain lipophilic compounds to a-la  may have physiological significance 
(Hirai et al., 1992).
The effects of the proteolytic digestion of a-la  by trypsin, chymotrypsin and 
pepsin have been studied, with respect to the influence o f ion binding on the stability of 
this protein to hydrolysis (Schmidt and van Markwijk, 1993). a-La has good 
emulsifying and foaming properties, although the native molecule reveals low surface 
hydrophobicity. The increased susceptibility of a-la  to surface dénaturation at oil- 
water or air-water interfaces is involved in its emulsifying and foaming properties 
(Fox, 1989).
Only one bioactive peptide derived from a-la  has been characterised to date. 
An opioid peptide known as a-lactorphin (Tyr-Gly-Leu-Phe) was isolated from a 
proteolytic digest of native a-la  using pepsin or a combination of pepsin and trypsin 
(Antila etal., 1991).
a-La is also a potential allergen (Gjesing et al., 1986) and it has been shown 
that the allergenicity o f a-la  can be reduced using enzymatic hydrolysis by trypsin and 
chymotrypsin (Asselin et al., 1989).
2.5 Serum Albumin
The concentration of serum albumin in milk is approximately 0.3 g I"1, 
corresponding to approximately 5-6 % of the total whey proteins (Table 2.1). Bovine 
serum albumin (BSA) consists of 582 amino acid residues, has a molecular weight of
66.3 kDa and contains 17 intramolecular disulphide bridges and one free thiol group. 
This protein binds several ligands, including fatty acids, which enhance its heat 
stability (Gumpen et a l, 1979). The physiochemical properties of BSA have been 
reviewed (Peters, 1985). It has been suggested that the rigid, disulphide structure of 
this protein acts as a shielding effect against enzymatic hydrolysis. There is no 
apparent function for BSA in milk and it is assumed to be a leakage protein from 
blood.
Like p-lg and a-la, BSA can also elicit allergic responses, indicated by the 
production of IgE antibodies against this protein (Gjesing et al., 1986). It has been 
reported that BSA was poorly hydrolysed by pancreatin or trypsin (Jost et al., 1987;
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Maubois et a l, 1981) during the production of hypoallergenic whey protein 
hydrolysates (Section 3).
2.6 Immunoglobulins and proteose peptones
Immunoglobulins (Igs) and proteose peptones are known to pass into the milk 
from the blood serum. Immunoglobulins are high molecular weight glycoproteins 
synthesised by the cells of the reticuloendothelial system (Roitt, 1984). They represent 
approximately 10 % of the total whey proteins (Fox, 1989) and serve to transfer 
passive immunity to the neonate (Larson, 1992). The production of whey protein 
fractions rich in immunoglobulins as colostrum supplements has been investigated 
(Haines et al., 1990). The literature on the three classes o f Igs (IgG, IgA and IgM) in 
bovine milk has been reviewed (Larson, 1992).
The proteose peptone fraction, also originating from blood serum, has been 
defined as a mixture o f various phosphoglycoproteins that are soluble at pH 4.6 after 
heating at 95 °C for 20 min which can then be precipitated by 12 % trichloroacetic 
acid. These proteins are very stable with respect to heat and acidification (pH 4.6-4.8) 
(Swaisgood, 1982).
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3 The application of pancreatic proteinases in the production of specialised 
whey protein hydrolysates
The literature on enzymatic hydrolysis of food proteins is vast and therefore 
this review is confined to hydrolysis o f whey proteins with food grade proteinases, 
with particular emphasis on proteinases of gastric and pancreatic origin. The uses of 
milk protein hydrolysates are extensive. Limited enzymatic hydrolysis of milk proteins 
has been used to produce changes in solubility, emulsification and foaming properties 
(Ennis and Harper, 1986) and has been used to produce different flavours and textures 
in food (Jost and Monti, 1977; Monti and Jost, 1978; Jolly, 1978). In addition, 
hydrolysates for use in cosmetics (Hidalgo and Jost, 1980) and hair care products have 
been developed. Hydrolysates have been used in nutritional fortification, for example, 
in beverages (Jolly, 1978; Driessen and Van den Berg, 1988) and in microbiological 
media such as peptone broths and in peptoned milk tryptone broth (Marshall et al., 
1982). Hydrolysates can also be used for clinical or pharmaceutical purposes i.e. pre­
digested diets for pre- or post operative patients and in infant foods.
3.1 Properties of whey protein hydrolysates
3.1.1 Functionality o f  whey protein hydrolysates
The functional properties of proteins denote any physicochemical property 
which affects the processing and behaviour of proteins in food systems, as judged by 
the final attributes o f the product. The functional characteristics and properties of 
hydrolysates can be correlated with percentage degree of hydrolysis (DH), (Ennis and 
Harper, 1986; Smith et al., 1989), enzyme specificity and hydrolysate hydrophobicity 
(Chaplin and Andrews, 1989; Turgeon et al., 1992; Mahmoud et al., 1992). Peptide 
size distribution is another important factor in the functionality of protein hydrolysates 
(Adler-Nissen, 1986; Turgeon et al, 1991, 1992). Factors known to affect the size 
distribution of peptides within hydrolysates are enzyme specificity, enzyme to substrate 
ratio (E:S), reaction pH, duration of hydrolysis and ionic strength (Jost and Monti, 
1982; Chobert et al., 1988; Turgeon et al., 1992). Membrane processing of 
hydrolysates is often employed to control the size distribution of peptides in the
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permeate (Olofoson et al., 1980; Gauthier et al., 1993) during ultrafiltration, reviewed 
in Section 5, and membrane processing has been employed to improve the 
émulsification (Turgeon et al., 1991) or non allergenic properties of hydrolysates (Van 
Beresteijn et al., 1994) as reviewed in 3.1.2.
It is often the case that a number of endoproteinases and exopeptidases must be 
used in conjunction with one another to reach the desired change in protein 
functionality/solubility/flavour (Clegg et al., 1974; Adler-Nissen, 1976; Maeda et al., 
1987). For example, in the production of a non-bitter hydrolysate, it is desirable to use 
an endoproteinase, followed by an exopeptidase (Clegg et al., 1974) In the case of 
enzymatic hydrolysis o f milk proteins, mixtures of enzymes which have 
complementary specificities to each other may be used to attain the required degree of 
hydrolysis. The relative proportions of the endoproteinases and the presence or 
absence of large amounts of exopeptidases in a hydrolysis system is important in the 
production of most hydrolysates (Thibault, 1991). In general, studies on hydrolysate 
functionality using limited digestion by endoproteinases and exopeptidases, has 
focused on efforts to improve solubility, émulsification and foaming and to eliminate 
off-flavours, such as bitterness (Clegg and McMillan, 1974).
3.1.1.1 Solubility o f whey hydrolysates
Enzymatic hydrolysis produces peptides of smaller molecular size than the 
native proteins. Thus, functional properties of such peptides are different in 
comparison to the parent protein. Generally following hydrolysis there is increased 
solubility over a pH range (Jost and Monti, 1977; Olofoson et al., 1980), in addition to 
decreased viscosity (Hooker et al., 1982). Insoluble, whey proteins such as 
lactalbumin (Section 2.1) have been digested using porcine trypsin (Adler-Nissen, 
1976; Jost and Monti, 1977; Monti and Jost, 1978), papain (Monti and Jost, 1978), 
Alcalase (Jolly, 1978; Ennis and Harper, 1986; Smith et al., 1989; Perea et al., 1993) 
and Esperase (Kuehler and Stine, 1974; O'Keefe and Kelly, 1981), producing 
hydrolysates that are soluble over a wide pH range. During these studies, the effects of 
temperature, hydrolysis time, pH, and enzyme dosage (at a constant substrate 
concentration) on the final hydrolysate composition and functional properties were 
monitored (Kuehler and Stine, 1974; Ennis and Harper, 1986). Commercial tryptic and
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chymotryptic preparations, such as PTN 3.OS, PEM 2500S (Perea et al., 1993) and 
Corolase PP (Samuelsson and Poulsen, 1987), have also been used to alter the 
functional properties o f whey proteins. However, reaction progress curves of 
solubilization versus time for lactalbumin are very unusual with a maximum 
solubilization of 90 % occurring at DH values of 11-12 %. Further hydrolysis 
produces a decrease in solubility to 67 %, followed by a further gradual increase in 
solubilization on further hydrolysis (Smith et al., 1989).
3.1.1.2 Emulsification and foaming properties of whey protein hydrolysates
Emulsifying capacity is influenced by solubility (Ennis and Harper, 1986; 
Turgeon et al., 1992) and hydrophobicity (Mahmoud et al, 1992) of the protein 
hydrolysate. Emulsification capacity is related to the interfacial area that can be coated 
by the protein (Pearce and Kinsella, 1978). Peptide chain length is an important factor, 
for example, in émulsification, as enzymatic hydrolysis is used to expose hydrophobic 
residues for interaction with the oil-water interface. It has been suggested that in order 
to have good emulsifying properties that the molecular weight of a peptide should not 
be less than 5 kDa (Chobert et al., 1988). Partial hydrolysis is advantageous in 
producing peptides o f such an average size (Thibault, 1991) which in turn display good 
émulsification characteristics (Jost and Monti, 1982). Tryptic hydrolysis of whey 
proteins produces a higher content of larger peptides than chymotryptic hydrolysis 
(Chobert et al., 1988; Turgeon et al., 1991). Chymotrypsin produced peptides with a 
wider range of molecular weights having a slightly higher proportion of small-size 
digestion products. Chymotryptic hydrolysis of WPC resulted in hydrolysates with 
lower émulsification activity than tryptic hydrolysates in the acid pH range. Moreover, 
tryptic peptides can have internal hydrophobic residues which can enhance interaction 
with oil, depending on their conformation (Turgeon et al., 1992).
A low degree of hydrolysis as obtained by peptic hydrolysis, has also been used 
to improved the foam expansion and emulsifying capacity characteristics of WPC 
hydrolysates (Kuehler and Stine, 1974; Nakai and Li-Chan, 1989). However, at higher 
DH values foam expansion decreased and foam stability was reduced (Kuehler and 
Stine, 1974). It has been shown that hydrolysis of WPC or lactalbumin by other 
commercial proteinases showed significant changes in foaming or émulsification
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properties (Kuehler and Stine, 1974; O'Keefe and Kelly, 1981; To et al., 1985) 
depending of percentage degrees o f hydrolysis.
3.1.2 Hypoallergenic hydrolysates
There is a difference in composition between human and bovine milks, and 
particularly the ratio of whey protein to casein (Brockbank, 1984). Human milk is rich 
in whey protein but does not contain (3-lg which is the predominant whey protein in 
bovine milk. This protein is usually associated with cow milk allergy (CMA), 
although any component of bovine milk can potentially cause an allergenic response. 
For example, in addition to IgE antibodies to P-lg, IgE antibodies were found to a-la, 
BSA, and the four caseins (a s l5 a s2, P, and k ) in the sera of infants allergenic to cows 
milk (Gjesing et al., 1986; Otani et al., 1989). The incidence, clinical features, 
diagnosis and treatment of CMA have been reviewed (Freier and Kletter, 1970).
Enzymatic hydrolysis is used to reduce the allergenicity of native bovine milk 
proteins by the elimination of antigenic determinants responsible for creating 
hypersensitivity in some infants (Pahud el al., 1985; Asselin et al., 1988; Jost et al.,
1991). The immunogenicity and allergenicity o f whey protein hydrolysates has been 
demonstrated (Jost et al., 1987, 1991; Asselin et al., 1988, 1989) and the use of 
enzymatic treatment to reduce allergenicity of whey proteins has been studied by many 
groups (Asselin et al., 1989; Akita andNakai, 1990).
Specific amino acid concentrations and specific peptide profiles on gel 
permeation FPLC were shown to be desirable for certain hypoallergenic hydrolysates 
(Thibault, 1991). This requirement of uniformity is important where hydrolysates are 
used for inclusion in non-allergenic foods or for therapeutic purposes. For example, 
pancreatic enzyme mixtures such as PEM 2500S (Novo) which contains trypsin, 
chymotrypsin and porcine elastase 2, have been employed to produce non-allergenic 
hydrolysates with desired levels o f certain amino acids and peptide chain lengths to 
allow maximum tolerance and absorption in the human diet (Thibault, 1991; Kahn et 
al., 1991). In addition, trypsin (Asselin et ah, 1989), or Corolase PP (Poulsen, 1987), 
chymotrypsin or a pepsin-pancreatin digestion step (Olofoson et al., 1980; Jost et al., 
1988; Akita and Nakai, 1990) or combinations of pure trypsin and chymotrypsin in 
specific ratios (Thibault, 1990), have been used to reduce the allergenicity of whey
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proteins. Several patented processes have been developed to produce dietetic foods 
having reduced allergenicity (Heine and Wutzke, 1990; Kahn et ah, 1991).
The minimum molecular mass to elicit immunogenicity and allergenicity of 
whey protein hydrolysates has been shown in some cases to be between 3 kDa and 5 
kDa (Van Beresteijn et ah, 1994). This is an important consideration when choosing 
an enzyme preparation and/or a membrane for the production of hydrolysates intended 
for use in nonallergenic foods (Section 5). Membrane processing using ultrafiltration 
has been used in many cases to remove larger peptides and aggregates, which were 
deemed to be the causative agents in allergenic responses (Olofoson et ah, 1980; 
Poulsen, 1987; Kahn et ah, 1991; Thibault, 1991; Van Beresteijn et al., 1994).
Non-allergenic hydrolysates are often used for infants having gastro-intestinal 
disease (Merritt et al., 1990), reduced digestive or absorptive capacity, extensive 
intestinal inflammatory disease, in addition to those who are allergic to cow's milk 
(Asselin et al., 1989; Buzinco et ah, 1989). Examples o f the above conditions include 
enteropathic conditions; short bowel syndrome; cystic fibrosis (Clegg and McMillan, 
1974), Crohn's disease and atrophy and other minor immunodeficiences which result in 
allergic responses to dietary components.
3.1.3 Bioactive hydrolysates
Biologically active peptides can be produced by hydrolysis o f whey proteins 
and their production and the related literature is reviewed in Section 4.
3.1.4 Therapeutic peptides from whey protein hydrolysates.
Hydrolysates are used in clinical situations where there are digestive disorders, 
limited nutrient absorptive capacity or diminished luminal hydrolysis in the small 
intestine (Cordano et ah, 1988). Therapeutic hydrolysates can be described as those 
hydrolysates which are used in defined formulae diets, enteral nutrition, parental 
nutrition or in preparations which enhance the absorption of minerals (i.e. 
phosphopeptides). Enzymatic hydrolysis of whey protein can produce a product with 
peptides of a critical chain length in dipeptide or tripeptide form which allows rapid in 
vivo absorption (Grimble et ah, 1986). These hydrolysates can therefore be used for 
pre- or post- operative patients, as they are absorbed via a separate and more efficient
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transport system than free amino acids (Grimble and Silk, 1989). Because these 
hydrolysates are more efficient due to their high absorptive capacity and lower 
osmolality they are often used for patients with limited absorptive capacity or 
pancreatic insufficiency in the form of a pre-digested diet (see 3.1.4.1). Whey protein 
hydrolysates have also been used in the treatment of specific metabolic disorders (see
3.1.4.2).
The use of pancreatic proteinases, for hydrolysis of lactalbumin has been 
employed by a number of groups to produce a hydrolysate suitable for dietetic 
purposes and the procedures to obtain such hydrolysates have been outlined (Olofoson 
et al., 1980; Maubois et al., 1981). The hydrolysis of a-la  and (3—lg by trypsin, 
chymotrypsin and pancreatin in the production of low molecular weight peptides for 
dietetic and therapeutic applications has also been examined (Roger et al., 1981).
3.1.4.1 Peptide absorption from whey protein hydrolysates
Generally, intact peptides do not enter the bloodstream, small peptides entering 
absorptive cells are hydrolysed completely within the cells and enter the blood as free 
amino acids (Matthews and Payne, 1980). Alternatively, small peptide fragments 
(approximately 3-4 amino acid residues) may be absorbed after brush-border 
membrane hydrolysis of the peptide. It is known that separate transport mechanisms 
exist for absorption o f free amino acids and small peptides (2-4 amino acid residues). 
Free amino acids are absorbed by at least 4 group specific transport systems (Gray and 
Cooper, 1971) while peptide uptake is independent of the mechanism o f free amino 
acid absorption (Silk et al., 1985). Di- and tri peptides probably share a common 
transport mechanism (Sleisenger et al., 1976). Peptides containing four or more amino 
acid residues are likely therefore, to be hydrolysed by brush border peptidases before 
absorption, but there is evidence to suggest that some tetrapeptides are absorbed 
(Smithson and Gray, 1977; Chung et al., 1979). Because of the independence o f the 
mechanism of peptide uptake there is no competition between peptides and amino 
acids for absorption sites and therefore the efficiency of peptide transport is high (Rerat 
et al., 1988). The mechanism of peptide absorption and nature of peptide transport 
may be of considerable consequence when, for example, physiological aspects of 
therapeutic peptides, such as bioactive peptides are discussed (Section 4).
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The size distribution o f peptides present in a whey protein hydrolysate is of 
importance, when efficient absorption in the gut is to be taken into consideration. The 
intestinal absorption of protein hydrolysates has been reviewed previously (Webb,
1990). In many cases, membrane processing is used following protein hydrolysis by 
digestive proteinases. For example, pancreatic proteinases such as pancreatin were 
used to hydrolyse WPC and the resultant hydrolysate was ultrafiltered using a 
membrane with molecular weight cut-off of < 10 kDa (Olofoson et al., 1980) or < 5 
kDa (Maubois et al, 1981). The permeates of these hydrolysates were intended for 
enteral nutrition.
In specific examples of the use of whey protein hydrolysates as therapeutic 
agents, it has been shown that amino acids that were poorly absorbed from mixtures of 
free amino acids, were absorbed to a substantially greater extent in the form of a 
lactalbumin hydrolysate in the human jejunum (Grimble et a l, 1986). As a nitrogen 
source, there appeared to be no significant difference between peptide containing 
hydrolysates or free amino acid mixtures. However, it has been suggested that the 
lower osmolality o f the peptide diet in comparison to an amino acid diet would be 
advantageous in patients with impaired fluid and electrolyte absorption as less fluid 
would be secreted into the lower part of the proximal intestine due to the peptide diet 
(Silk et a l, 1979). The efficacy of enterally administered protein hydrolysates and 
peptide fractions has been reviewed (Webb, 1990; Mobarhan and Trumbore, 1991).
3.1.4.2 Clinical applications of whey protein hydrolysates
There are a number of inborn errors of amino acid metabolism for which 
hydrolysates are used as therapeutic agents. The production of a low phenylalanine 
peptide foodstuff suitable for treatment of phenylketonuria has been examined using 
peptic hydrolysate of p-lg, followed by hydrolysis by an exopeptidase preparation, i.e. 
Pronase (Maeda et al., 1987). Phenylketonuria is a metabolic disorder resulting from a 
deficiency of the enzyme, phenylalanine hydroxylase, which is responsible for the 
conversion of phenylalanine to tyrosine (Davidson et a l,  1979). In addition, milk 
protein hydrolysates, free o f specific amino acids (Phe, Tyr, Met) are used in the 
treatment o f metabolic disorders such as homocystinuria and tyrosinemia. The 
production of a hydrolysate for human consumption often involves the operation of a
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hydrolysis procedure which attempts to mimic human digestion (Silk et ah, 1973). 
Many groups incorporate a gastric digestion step (Silk et ah, 1973) of whey proteins 
such as a - la  or p-lg by pepsin followed by digestion with a mixtures o f enzymes 
(Haddad et al., 1979; Maeda et ah, 1987; Asselin et al., 1989). The clinical uses of 
protein hydrolysates have been reviewed (Milla, 1991).
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4 Biologically active peptides derived by enzymatic hydrolysis of milk 
proteins
There are a number of the naturally occurring regulatory peptides in milk such 
as the thyro-parathyroid and hypothal-hypophyseal hormone groups, growth factors, 
and gastrointestinal regulatory peptides (Fiat and Jolles, 1989; Koldovsky, 1992; 
Yamauchi, 1992). However, there are various bioactive peptides which can be 
released, from within the sequence of milk proteins, as a result of enzymatic 
hydrolysis. A number of bioactive peptides derived from a-, p-, K-casein have been 
characterised and are summarised in Tables 4.1, 4.2 and 4.3, respectively. There are a 
smaller number of bioactive peptides which can be derived from whey proteins (Table 
4.4). The structure, physiological significance and analytical aspects o f milk derived 
bioactive peptides has been reviewed previously (Maubois and Leonil, 1989; 
Schlimme and Meisel, 1993; Fiat et al., 1993; Shimizu, 1994). This review 
concentrates on the types of bioactive peptides which can be derived from bovine 
casein and whey protein, in addition to the physiological significance of these peptides 
in vivo.
4.1 Types of bioactive peptides derived from milk proteins
4.1.1 Opioid peptides
Many of the endogenous bioactive peptides sequences studied to date are 
opioid peptides. Opioid receptors are classified into subtypes, and the physiological 
response following binding and can be either of an agonistic or antagonistic nature. 
Individual receptors are responsible for specific physiological effects. For example, the 
jj,-receptor for analgesia and suppression of intestinal motility, the 8-receptor for 
emotional behaviour and K-receptor for sedation and control of food intake (Chiba and 
Yoshikawa, 1986). The typical endogenous ligands of opioid receptors have a definite 
N-terminal sequence of the form Tyr-x-x-Phe, (where x = any amino acid residue such 
as Gly), and are derived from precursor molecules, e.g. pro-enkephalin, pro-dynorphin 
and pro-opiomelanocortin (Hollt, 1983). Opioids having a receptor ligand with 
agonistic activity, may have a peptide or alkaloid structure (Teschemacher et al., 1994
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Table 4.1: Biological functions of peptides derived from asl-casein.
Fragment Sequence Function Reference
f (23-34) Phe-Phe-Val-Ala-Pro-Phe-Pro-Glu-Val-Phe-Gly-Lys
f (23 -27) Phe-Phe-Val-Ala-Pro
f(24-27) Phe-Val-Ala-Pro
f (25-27) Val-Ala-Pro
f(27-30) Pro-Phe-Pro-Glu
f(28-34) Phe-Pro-Glu-Val-Phe-Gly-Lys
f(32-34) Phe-Gly-Lys
f(43-47) Asp-Ile-Glu-Ser-Glu
f(59-79) Gln-Met-Glu-Ala-Glu-Ser-Ile-Ser-Ser-Ser-Glu-Glu- 
Ile-Val-Pro-Asn-Ser-Val-Glu-Gln-Lys 
f(66-74) Ser-Ser-Ser-Glu-Glu-Ile-Val-Pro-Asn 
f(90-95) Arg-Tyr-Leu-Gly-Tyr-Leu 
f(90-96) Arg-Tyr-Leu-Gly-Tyr-Leu-Glu 
f( 143-148) Ala-Tyr-Phe-Tyr-Pro-Glu 
f ( 194-199) Thr-Thr-Met-Pro-Leu-Trp 
f( 197-199) Pro-Leu-Trp 
f( 198-199) Leu-Trp
ACE inhibition 
ACE inhibition 
ACE inhibition 
ACE inhibition 
ACE inhibition 
ACE inhibition 
ACE inhibition 
mineral absorp 
mineral absorp
mineral absorp 
opioid agonist 
opioid agonist 
ACE inhibition
Maruyama and Suzuki, 1982 
Maruyama et al .,1985 
Maruyama et a l.,1987 (a)
Maruyama et a l.,1987 (a)
Maruyama et cr/,,1987 (a)
Maruyama et a l.,1987 (a)
Maruyama et al .,1987 (a)
Lorenzen et a/.,1991; Meisel and Schlimme, 1993, 1994 
Lorenzen et a l.,1991; Meisel and Schlimme, 1993, 1995
Lorenzen et a l1991; Meisel and Schlimme, 1993, 1996 
Zioudrou et a l.,1979; Chiba et al., 1989 
Zioudrou et a l1979; Chiba et a l.,1990 
Yamamoto et a l.,1994
ACE inhibition; immuno Maruyama et a l.,1987 (b); Fiat et a l.,1993
ACE inhibition Maruyama et a l., 1987 (b)
ACE inhibition Maruyama et al .,1987 (b)
Immuno; peptides which modulated the immune system; mineral absorp; peptides which stimulate mineral absorption; ACE; Angiotensin I converting enzyme.
T able  4.2: B io log ica l fu n ctio n s o f  p eptides derived  from  ß-casein .
Fragm ent Name Sequence Function
fU-25)
f(60-62)
fi;60-63)
f(60-63)
f(60-64)
fi;60-65)
{(60-66)
f(60-67)
f(60-70)
f(63-68)
f(74-76)
f{84-86)
f(177-181)
f(177-183)
f( 177-179)
fi;i79-181)
f(181-183)
f(191-193)
f( 193-202) -
ß-casomorphin-3 
ß-casomorphin-4 
ß-casomorphin-4 
ß-casomorphin -5 
ß-casomorphin-6 
ß-casomorphin -7 
ß-casomorphin-8 
ß-casomorphin -11
Arg-Glu-Leu-Glu-Glu-Leu-Asn-Val-Pro-Gly-Gly
He-Val-Glu-Ser-Leu-Ser-Ser-Ser-GIu-Glu-Ser-lle-
Thr-Arg
Tyr-Pro-Phe
Tyr-Pro-Phe-Pro
amide; morphiceptin
Tyr-Pro-Phe-Pro-Gly
Tyr-Pro-Phe-Pro-Gly-Pro
Tyr-Pro-Phe-Pro-Gly-Pro-Ile
T  y r-Pro-Phe-Pro-Gly-Pro-I le-Pro
Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-Asn-Ser-Leu
Pro-Gly-Pro-Ile-Pro-Asn
lle-Pro-Pro
Val-Pro-Pro
Ala-Val-Pro-Tyr-Pro
Ala-V al-Pro-T yr-Pro-Gln-Arg
Ala-Val-Pro
Pro-Tyr-Pro
Pro-GIn-Arg
Leu-Leu-Tyr
Ser-Leu-Val-Leu-Pro-Val-Pro-Glu 
T  yr-Gln-Gln-Pro-V al-Leu-Gly-Pro-V al-Arg
mineral absorp
Opioid agonist 
Opioid agonist 
Opioid agonist
Opioid agonist; A C E  inhibition
Opioid agonist
Opioid agonist
Opioid agonist
Opioid agonist
Immuno
A C E  inhibition
A C E  inhibition
A C E  inhibition
A C E  inhibition; Immuno; G stim
A C E  inhibition
A C E  inhibition
A C E  inhibition
Immuno
A C E  inhibition
A C E  inhibition
Reference
Meisel and Frister, 1988;
Meisel and Schlimme, 1993
Meisel and Schlimme, 1990
Meisel and Schlimme, 1990
Chung et a l .,1985
Brantl et a / .,1979
Meisel and Schlimme, 1993
Brantl et a l.,1979; Meisel and Schlimme, 1994
Meisel and Schlimme, 1993
Meisel and Frister, 1989
Parker et a l 1984
Nakamura et a l 1995
Nakamura et a l 1995
Maruyama et al. ,1987 (a)
Maruyama et a /.,1987 (a); Fiat et a l .,1994 
Maruyama et al. ,1987 (a)
Maruyama et al. ,1987 (a)
Maruyama et al. ,1987 (a)
Fiat et al., 1994 
Yamamoto et a l.,1994 
Meisel and Schlimme, 1994
M ineral absorp; peptides th a t s tim ulate  m ineral absorp tion ; Im m uno; pep tides w hich  m odulated  the im m une system ; G stim ; pep tides w hich had 
grow th  stim u la ting  p roperties, A C E ; A ngio tensin  I converting  enzym e.
Table 4.3: Biological functions of peptides derived from K-casein.
Fragm ent Name Sequence Function Reference
f(25-34) Casoxin C  Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg
f(33-38) - Ser-Arg-Tyr-Pro-Ser-Tyr
f(34-38) - Arg-Tyr-Pro-Ser-Tyr
f(35-41) Casoxin A  Tyr-Pro-Ser-Tyr-Gly-Leu-Asn-Tyr
f(35-38) - Tyr-Pro-Ser-Tyr
f(58-61) Casoxin B Tyr-Pro-Tyr-Tyr
f ( 1 0 3 - l l l )  - Leu-Ser-Phe-Met-Ala-Ile-Pro-Pro-Lys-Lys
Asn-Gln-Asp-Lys
fî 106-116) - Met-Ala-Ile-Pro-Pro-Lys-Lys-Asn-Glu-Asp-Lys
106-112) - Leu-Ser-Phe-Met-Ala-Ile-Pro-Pro-Leu-Lys-Lys
113-116) - Asn-Gln-Asp-Lys____________________________
opioid antagonist; A C E  inhibition;ileum contraction
opioid antagonist
opioid antagonist
opioid antagonist; A C E  inhibition
opioid antagonist
opioid antagonist
antithrombic
mineral absorp; antithrombic
antithrombic
antithrombic
Chiba et o/.,1989
Chiba and Yoshikawa, 1986
Chiba and Yoshikawa. 1986
Chiba et a l ., 1989
Chiba and Yoshikawa, 1986
Chiba et a l .,1989
Fiat et a l .,1993
F ia t«  a/., 1989; Chabance ei al., 1995 
Fiat ei a l .,1993 
Fiat et al., 1993
mineral absorp; peptides that stimulate mineral absorption, ACE; Angiotensin I converting enzyme.
Table 4.4: Biological functions of peptides derived from whey proteins
M ilk protein 
W hey
F ragm ent N a m e Sequence Function Reference
ß-lactoglobulin ft 102-105) ß-lactorphin Tyr-Leu-Leu-Phe Ileum contraction;Opioid (agonist) Yoshikawa et a l., 1986; Antila et a l 1991
ß-lactoglobulin ft 146-149) ß-lactotensin His-Ile-Arg-Leu Opioid (agonist) Pihlanto-Leppala et a l., 1994
a-lactalbumin f(50-53) a-lactorphin Tyr-Gly-Leu-Phe Opioid (agonist) Yoshikawa et al., 1986; Antila et a l., 1991
BSA ft208-216) albutensin A Ala-Leu-Lys-Ala-Trp-Ser-Val-AIa-Arg Ileum contraction; A C E  inhibition Chiba and Yoshikawa, 1991
BSA ft399-404) serorphin Tyr-Gly-Phe-Gln-Asn-Ala Opioid (agonist) Tani et al., 1993
A CE; Angiotensin I converting enzyme.
In general, opioid agonistic peptides derived from milk proteins are selective 
for p, receptors. Some of the peptides with opioid antagonistic activity show affinity 
for K-type opioid receptors in addition to affinity for p, receptors. Opioid peptides from 
caseins are called casomorphins (agonists) and casoxins (antagonists) while those from 
whey proteins are called lactorphins (agonists). Opioid peptides which are released 
from the internal structure of milk protein sequences are referred to as exorphins to 
distinguish them from the naturally-occurring opioid peptides, i.e. enkephalins, 
endorphins and dynorphins (Hamosh, 1989). Recent developments in research 
concerning milk derived opioid peptides and their functional significance have been 
reviewed (Chiba and Yoshikawa, 1986; Teschemacher and Scheffler, 1992). The 
existence o f opioid peptides has been described in partial digests for many food 
proteins (Zioudrou et al., 1979; Loukas el al., 1983; Ariyoshi, 1993).
4.1.1.1 Agonists
(3-Casein derived opioid peptides, known as (3-casomorphins, have been 
extensively studied (Brantl et al., 1979, 1981; Hamosh, 1989; Maubois and Leonil, 
1989; Yamauchi, 1992; Schlimme and Meisel, 1993; Pihlanto-Leppala et al. ,1994b). 
For example, two opioid peptides from bovine B-casein, fragment f(60-64) and 
f(60-66) were first found in peptone (Brantl et al., 1979) and were termed 
P-casomorphin 5 and 7, respectively. The opioid activity of sequences corresponding 
to human-casomorphins has also been reported (Yoshikawa et al., 1986; Koch et al.,
1988). It was found that the pentapeptide, casomorphin-5 and the amidated form of the 
tetrapeptide, morphiceptin (P-casomorphin-4-amide) both isolated from in vitro casein 
digests (Chang et al., 1985) were found to be the most potent of the p-casomorphins 
characterised to date (Table 4.2). P-Casomorphin f(60-70) has been shown to be 
released in vivo by digestive enzymes having been found in the duodenal chyme of 
minipigs (Meisel, 1986) and this opioid peptide was later identified as 
B-casomorphin-11 (Meisel and Frister, 1989). In addition, opioid peptides have also 
been located in newborn calf plasma (Umbach et al., 1985), after the ingestion of 
bovine milk.
Similarly, opioid peptides have been derived from a peptic hydrolysis of 
a sl-casein, corresponding to f(90-95) and f(90-96) and were termed a-casein exorphins
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or a-casomorphins (Zioudrou et al., 1979; Loukas et al., 1983; Chiba et al., 1989) and 
these peptides (Table 4.1) were resistant to tryptic hydrolysis (Zioudrou et al., 1979; 
Loukas et al., 1983).
Whey protein derived synthetic peptide sequences (lactorphins), which were 
terminally amidated, were found to possess opioid activity (Yoshikawa et al., 1986). 
a-Lactorphin, corresponded to f(50-53) of a-la in both human and bovine species. 
B-Lactorphin f(102-105) was derived from bovine B-lg. In addition, a-lactorphin and 
(3-lactorphin were shown to be released in vitro using enzymatic hydrolysis of the 
parent protein. a-Lactorphin (Tyr-Gly-Leu-Phe) was isolated from a proteolytic digest 
o f native a-la  using pepsin or a combination of pepsin and trypsin (Antila et al., 1991). 
This appears to be the only bioactive peptide derived from a-la which has been 
characterised to date. (3-Lactorphin (Tyr-Leu-Leu-Phe) was produced using pepsin and 
trypsin or a combination of trypsin and chymotiypsin hydrolysis of native or heat- 
treated B-lg (Antila et al., 1991). The pharmacological activities of the synthetically 
produced tetrapeptides were characterised in vitro using a receptor assay with rat brain 
homogenates and an assay using coaxially stimulated guinea pig ileum. These assays 
showed that these peptides could displace/compete with Naloxone , a potent synthetic 
opioid antagonist (Antila et al., 1991). Another opioid peptide known as serorphin 
f(399-404) was found in serum albumin (Tani et al., 1994).
Opioidergic receptors are located in the nervous, endocrine and immune 
systems. In the context of these systems, casomorphins as opioid ligands have been 
shown to modulate social behaviour, e.g. after intracerebroventricular administration to 
experimental animals (Panksepp et al., 1984; Pároli, 1988). For example, a variety of 
physiological activities have been reported for p-casomorphin-7. It regulates the 
plasma levels of the pancreatic polypeptide (Schusdziarra et al., 1983a) and a plasma 
somatostatin-like substance (Schusdziarra et al., 1983b). Furthermore, it induces the 
accumulation of amino acids at the intestinal brush border (Ermisch et al., 1989), 
increases the short circuit current of the intestinal layer (Tomé et al., 1987) and induces 
histamine release from human peritoneal lympocytes (Kurek et al., 1992). In other 
examples, (3-casomorphins have been shown to influence motor behaviour, increase 
analgesic activity (Pároli, 1988), regulate gastrointestinal motility, exert anti-diarrhoeal 
action (Daniel and Erll, 1992) and influence postprandial metabolism by stimulating
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the secretion of insulin and somatostatin (Maubois and Leonil, 1989; Meisel et al., 
1989; Fiat et al., 1993; Schlimme and Meisel, 1993; Shimizu, 1994; Meisel and 
Schlimme, 1994).
4.1.1.3. Antagonists
Casein derived opioid antagonistic peptides are known as casoxins and these 
are generally derived from K-casein (Table 4.3). Opioid antagonists are ligands which 
suppress the agonistic activity of enkephalin, and function in the same manner as 
Naloxone . Casoxins have been produced in vitro by peptic or tryptic hydrolysis of 
caseins. For example, casoxin C was isolated from a tryptic digest of bovine K-casein 
(Chiba el al., 1989) and was shown to induce contraction of guinea pig ileum 
longitudinal muscle (Loukas et al., 1983). Other antagonist peptides corresponding to 
f(33-38), f(34-38) and f(35-38) of K-casein have been described (Table 4.3).
Furthermore, peptides derived from a peptic hydrolysis of human lactoferrin 
were demonstrated to have opioid antagonistic activity (Yoshikawa et al., 1988).
4.1.1.2 Peptides acting on smooth muscle
A peptide sequence acting on smooth muscle, known as albutensin A, 
corresponding to f(208-216) was found in bovine serum albumin (Chiba and 
Yoshikawa, 1991). Another tetrapeptide, known as p-lactotensin f(146-149), which 
acts on smooth muscle (Chiba and Yoshikawa, 1991), was released from the internal 
sequence of p-lg by the action of chymotrypsin or a combination of pepsin and 
chymotrypsin (Pihlanto-Leppala et al., 1994a). Although these peptides had no affinity 
with opioid receptors, they induced contraction of guinea pig ileum longitudinal 
muscle when the test was performed without electrical stimulation in the absence of 
agonist.
4.1.2 Immunomodulating peptides
The properties o f immunomodulating bioactive peptides derived from milk 
proteins have been reviewed (Parker el al, 1984; Migliore-Samour et al., 1989; Fiat 
and Jolles, 1989; Fiat et al., 1993). These immunostimulants corresponded to f(194- 
199) of a sl-casein and f(63-68) and f(191-193) of P-casein. The hexapeptide derived
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from P-casein corresponds to the COOH-terminal part of p-casomorphin-11. Casein 
derived immunomodulating peptides were shown to stimulate phagocytosis of sheep 
red blood cells by murine peritoneal macrophages. In addition, casein derived peptides 
were shown to exert a protective effect against Klebsiella pneumoniae infection in 
mice following intravenous treatment (Parker el al., 1984).
Several other milk protein derived peptides were shown to act on 
immunocompetent cells i.e. T and B lymphocytes or macrophages (Jolles et al., 1986; 
Chabance et al., 1995). It has been suggested that these peptides may play a role in the 
stimulation of the immune system (Portier et al., 1994).
4. 1.3 Angiotensin-I-converting enzyme (ACE) inhibitory peptides
ACE is a dipeptide-liberating exopeptidase and has been classically associated 
with the renin-angiotensin system, regulating peripheral blood pressure. ACE which 
removes the two amino acids from the C- terminus of angiotensin I to form angiotensin 
II, a very hypertensive compound, is inhibited by certain peptides. Angiotensin II 
reduces blood flow and thereby decreases the renal excretion of fluid and salts. ACE 
also catalyses the degradation of bradykinin and enkephalins (Aoki et al., 1984). 
Therefore, the inhibition of ACE decreases the activity of angiotensin II but increases 
bradykinin and enkephalin activities, thus lowering blood pressure in hypertensive 
humans and animals (Ondetti et al., 1977; Koike el al., 1980). Several endogenous 
peptides such as enkephalins, B-endorphin, substance P and adrenocorticotrophic 
(ACTH) were reported to be substrates and inhibitors of ACE (Philips, 1987). Various 
ACE inhibitory peptides have been identified in hydrolysates of different food proteins 
including fish, yeast, a-zein, maize and gelatin (Ariyoshi, 1993) in addition to various 
fermented foods (Okamoto et al., 1995).
Bioactive peptides, which inhibit ACE, have been were isolated from 
enzymatic casein hydrolysates (Maruyama et al., 1982, 1985, 1987a, b; Kohmura et 
al., 1990; Chiba and Yoshikawa, 1991; Schlimme and Meisel, 1993, Meisel and 
Schlimme, 1994). These potential anti-hypertensive peptides are known as casokinins 
(Table 4.1) and their function as inhibitors of ACE has been reviewed (Meisel, 1992, 
1993a,b). The most potent casokinins were found in the region corresponding to 
f(39-52) in human B-casein and f(63-65) in human K-casein. Bovine a sl-casein
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f(23-27) is one of the most potent inhibitors of ACE having an IC50 of 6.0 (.iM 
(Maruyama et al., 1985; Ariyoshi, 1993). ACE inhibitory activity (IC50 =  3.4 pm) was 
also observed for albutensin A f(208-216), derived from serum albumin (Chiba and 
Yoshikawa, 1991). In addition, numerous antihypertensive peptides have been 
synthesised corresponding to fragments of human caseins (Kohmura et a l, 1990). No 
whey protein derived ACE inhibitors have been characterised to date.
ACE has been identified as a brush border-bound enzyme of the human 
jejunum (Stevens et a l, 1988). Casein derived ACE inhibitors could act on ACE 
localised in the intestinal mucosa and at the luminal surface of the vascular 
endothelium. In this case, the affected functions may include jejunal electrolyte and 
water transport as a result of the decrease of the activity of angiotensin II. Since ACE 
is a multifunctional enzyme, exogenous ACE inhibitors derived from food proteins 
may affect different regulatory systems involved in modulating blood pressure, 
immune defence and nervous system activity (Meisel, 1992). As already stated ACE 
catalyses the activation o f angiotensin II and inactivates bradykinin. The latter is able 
to stimulate lymphocyte migration and to increase secretion of lymphokines (Paegelow 
and Werner, 1986). Inhibitors of ACE would favour bradykinin and thus potentially 
act as immunomodulators.
The physiological significance, i.e. the hypotensive effects of ACE inhibitors 
derived from sour milk has been shown (Nakamura et al., 1995b). In addition, a 
reduction in arterial blood pressure was observed in rat (Yamamoto et al, 1994) using 
casein derived ACE inhibitory peptides. Although, in some studies relatively high 
doses of the peptide were required to have the effect by oral administration (Karaki et 
al, 1990; Yamamoto et al., 1994). The anti-hypertensive effects of a tryptic 
hydrolysate o f casein were also studied in human volunteers with normal and mild 
hypertension (Sekiya et al., 1992). Their blood pressure and pulse rates were 
monitored after oral administration of the hydrolysate. A study was carried out with 18 
subjects suffering mild hypertension and receiving lOg of the tryptic casein hydro lysate 
twice a day. It was shown that blood pressure was significantly (p <0.01) reduced by 
4.6 mmHg/6.6 mmHg. However, the pulse rate did not change. It was concluded that 
the tryptic hydrolysate could be used as a physiological functional food to prevent
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hypertension (Sekiya et al., 1992). In addition, the hypotensive effects o f sake derived 
peptides were sustained for up to 3Oh in murine models (Saito et al., 1994).
4.1.4 Anti- thrombic peptides
Casein derived anti-thrombic peptides are known as casoplatelins and are 
inhibitors of both aggregation o f ADP-activated platelets and binding of human 
fibrinogen y-chain to a specific receptor region on the platelet surface (Fiat et al., 
1989). The interacting region of the fibrinogen y-chain in platelet aggregation is at the 
C-terminal dodecapeptide sequence which itself possesses similar inhibiting effects as 
the bioactive sequences isolated from a tryptic hydrolysate of K-casein (Kloczewiak et 
al, 1984). For example, the sequence of the K-casein peptide f(106-116) is 
homologous to that of the fibrinogen y-chain dodecapeptide f(400-411). Another 
fragment of K-casein f(103-l 11) has been shown to inhibit platelet aggregation but not 
fibrinogen binding to ADP-treated platelets (Fiat et al., 1993).
4.1.5 Mineral binding peptides
These are generally phosphopeptides which bind calcium or trace elements 
such as iron and zinc and are generated by limited hydrolysis of casein by trypsin 
(Schlimme and Meisel, 1993; Lorenzen et al., 1994). Phosphopeptides (Table 4.1 and
4.2) derived from a sl-casein f(43-79) and from p-casein f(l-25) contain a serine 
phosphate cluster and glutamyl as well as aspartyl residues in their sequences (Eigel et 
al., 1984). It is known that phosphopeptides bind calcium preventing formation of 
insoluble calcium phoshate complexes under alkaline conditions. Thus, these peptides 
can increase the soluble calcium concentration in the intestine, this in turn may 
facilitate passive absorption of calcium (Sato et al., 1991) and other minerals, such as 
iron or zinc (Brulé el al., 1982). In addition, the in vivo formation o f an a sl-casein 
derived phosphopeptide has been shown (Meisel and Frister, 1989; Kasai el al., 1995). 
Because casein phosphopeptides form salts with certain trace elements, they have 
found interesting applications in dietary supplements and as medicines (Brulé et al., 
1982).
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4.1.6 Growth stimulating peptides
Peptides derived from tryptic digests of B-easein were shown to stimulate the 
growth o f Balb/c 3T3 cells (Nagaune el al., 1989). The induction of antigen-driven T 
cell proliferation by a C-terminal peptide from B-casein was also reported (Coste and 
Tomé, 1991). Stimulation o f the growth of Lactobacillus lactis by a tryptic digest of 
caseinmacropeptide derived from K-casein has been described (Bouhallab et al., 1993).
4.1.7 M ilk derived peptides with other bioactivities
Casein derived peptides have also been described as exogenous prohormones. 
For example, peptides cleaved from p-casein were demonstrated to stimulate mitosis of 
different cell types (Nagaune ei al., 1989; Coste et al., 1992). Another casein derived 
peptide was shown to inhibit protein synthesis and proteolysis and to enhance 
ureogenesis (Takenakaeia/., 1991).
A two-chain polypeptide consisting of 71 amino acid residues, corresponding 
to f(155-143) and f(144-184), was isolated from tryptic digests of bovine serum 
albumin and had insulin-stimulating activity (Ueno et al., 1985). These peptides which 
were connected to each other by a disulphide bond enhanced the action of insulin in 
fatty acid synthesis and C 0 2 production from glucose in a rat adipose tissue 
preparation.
A bacteriocidal activity was found in a peptic hydrolysate of bovine lactoferrin 
f(17-41) which was more potent than intact lactoferrin (Tomita et al., 1991; Bellamy et 
al., 1992). Bacteriocidal activity was found against Eschericha coli and Candida 
albicans, but not against bifidobacterium. It was suggested that this peptide may play a 
role in the colonisation o f the intestine by bifidobacteria in milk suckling infants. In 
addition, chymotrypsin inhibitors derived from the C-terminal region of para K-casein 
have been characterised (Fiat et al., 1989).
4.2 Multifunctional aspects of certain bioactive peptides
The multifunctional properties of certain peptides have been discussed 
(Shimizu, 1994) and are indicated in Tables 4.1-4.4. Since the immunomodulating 
peptide, P-casein f(63-68), overlaps the p-casomorphin-7, (f60-66), it has been
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suggested that a ‘strategic zone’ i.e. f(60-70) exists within the p-casein sequence 
(Migliore-Samour and Jolles, 1988). Since T lymphocytes have ji receptors on the 
surface, it is conceivable that opioid peptides with high affinity for (j, receptors could 
affect T  cell function (Migliore-Samour and Jolles, 1988). Longer peptides containing 
p-casomorphins and immunomodulating sequences have been detected as P- 
casomorphin f(60-66) or f(60-67) immunoreactive peptides in the plasma o f calves 
following milk ingestion (Umbach et al., 1985). In addition, these peptides have been 
found in the plasma of lactating women (Koch et al., 1988).
P-Casein f(177-183) has been shown to have an ACE inhibitory, 
immunomodulating and cell growth-promoting activity (Table 4.2). Casoxin C, 
showed ACE-inhibitory activity, vasorelaxing activity as well as opioid antagonist 
activity (Chiba and Yoshikawa, 1991).
In addition to the opioid peptides of p- and K-casein, certain ACE inhibitors 
are also implicated in immunodulation (Migliore -Samour et al., 1989). Albutensin A 
(Chiba and Yoshikawa, 1991) is multifunctional, showing ileum-contracting and 
vasorelaxing activities in addition to ACE-inhibitory activity (Chiba and Yoshikawa,
1991). In addition, a sl-casein f(194-199) was reported to have both ACE-inhibitory 
and immunomodulating activities (Maruyama et al., 1987b; Fiat et al., 1993).
An antithrombic peptide from k- casein f( 106-116), which was observed to 
inhibit ADP - induced aggregation and fibrinogen receptor binding to platelet surface, 
overlaps with a sequence involved in the stimulation of mineral absorption (Fiat et al.,
1989).
4. 3 The relationship between bioactive peptide structure and physiological 
function
In order to be of physiological significance, the bioactive effect for a given 
peptide must be demonstrated in vivo. Peptides may be inactivated in the gastro­
intestinal tract by gastrointestinal proteinases or brush-border enzymes and thereby 
may never reach their potential site of action. For example, morphiceptin, the 
amidated P-casomorphin, was unable to cross the epithelial layer because of 
degradation by brush-border dipeptidylpeptidases (Mahe et al., 1989). Unless the
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bioactive peptides act inside the intestinal tract or act upon intestinal epithelial cells 
directly from the luminal side, they must be transferred from the luminal (mucosal) 
side to the serosal side across the intestinal epithelial cell layer. After absorption, the 
intact peptides must then reach their target organs. It has been suggested by Zioudrou 
et al. (1979) that in order for exorphins to function in vivo as opioid peptides in the 
central nervous system they must (a) generally be produced by gastro-intestinal tract 
digestive proteinases (b) survive further degradation by intestinal proteinases (c) be 
absorbed, without degradation, into the bloodstream, (d) cross the blood - brain barrier 
and thereby reach the central opiate receptors and (e) interact as opiates with these 
receptors. It has to be assumed that there are similar criteria for all bioactive peptides.
Bioactive peptides therefore, are often generated using digestive proteinases. 
For example, combinations of pepsin with trypsin or chymotrypsin were used to 
produce in vitro the opioid peptides from a-la and fi-lg (Antila et al., 1991) and from 
caseins (Pihlanto-Leppâla el al., 1994b). Pre-treatment with pepsin prior to enzymatic 
hydrolysis with trypsin or chymotrypsin has been used to mimic in vivo digestion and 
to produce peptides which would have a greater chance of being resistant to further 
digestion in the digestive tract.
4.3.1 Bioactive peptide structure
Many bioactive peptides are resistant to degradation by gastric or pancreatic 
proteinases (Zioudrou et al., 1979). Regarding the physiological function o f the p* 
casomorphins it is known that they are relatively resistant to further proteolytic attack 
by digestive enzymes (Mellander, 1963; Henschen et al., 1979; Brantl et al., 1979; 
Meisel, 1986; Kasai et al., 1995). In general, these peptides are rich in hydrophobic 
residues or have a high proline content in their sequences. For example, the high 
content o f proline in the P-casomorphins appears to make them resistant to further 
proteolysis by gastro-intestinal proteinases (Brantl et al., 1981). It has been suggested 
that these peptides may then be absorbed as inactive long-chain precursors which may 
be further hydrolysed by oligoaminopeptidases at the brush border into small bioactive 
peptides (Meisel, 1990). Because, in general p-casomorphins are very hydrophobic, it 
has also been suggested that they could in principle cross the blood-brain barrier 
(Meisel, 1990).
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The strueture-aetivity relationship of ACE-inhibitory peptides has not yet been 
fully established, however, a number o f common features have been proposed with 
respect to the C-terminal amino acids, conformation states and the ACE binding sites 
(Cheung et al, 1980; Meisel, 1993a, b). The C-terminal dipeptide has been suggested 
to play a major role in the inhibitory activity of the peptides (Cheung et al., 1980). It 
has been suggested that ACE inhibitory peptides are rich in hydrophobic amino acids, 
but contain no acidic residues. For example, with the exception o f B-casomorphin-7, 
all casein derived peptide inhibitors of ACE have Pro, Lys, or Arg as the C-terminal 
residue (Meisel, 1993a, b). Other groups have suggested that hydrophobic residues 
such as tyrosine, proline, phenylalanine are related to the potency of ACE inhibitory 
peptides (Cheung et al., 1980; Kohmura et al., 1990; Saito et al., 1994; Nakamura et 
al, 1995a).
4.3.2 Bioactive peptide size
As can be seen from the Tables 4.1-4.4, the bioactive peptides characterised to 
date range from di- and tripeptides which are involved in ACE inhibition, to very long 
peptides o f 21 to 26 amino acid residues which are involved in mineral absorption. In 
order to exert a physiological effect, these bioactive peptides must be absorbed intact 
and must reach their target organ. Certain of these peptides derived from milk can 
evolve naturally during digestion in the human digestive tract. For example, 0- 
casomorphin-7 was detected in the intestinal contents of human volunteers who drank 
bovine milk (Svedberg et al., 1985).
Since many bioactive peptides characterised to date are di- or tri-peptides, they 
may be transported into the epithelial cells via specific peptide transporters (Fei et al., 
1994). The small amount of peptides and proteins which are absorbed intact and which 
enter the circulation were reviewed (Gardner, 1988; Webb, 1990). It would be 
expected that peptides greater than 3 or 4 amino acids in length would be degraded by 
digestive proteinases, or by brush-border oligoaminopeptidases. However, (3- 
casomorphins have been located in the plasma of newborn calves (Umbach et al., 
1985). In addition, eleven-mer antithrombic peptides from K-casein 
(caseinoglycopeptides) were detected in the plasma of 5-day-old infants after ingestion 
o f cow-milk based formula or human milk. It was suggested that these bioactive
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peptides are released from milk proteins during digestion (Chabance et al., 1995). 
Much work is obviously required to confirm the physiological significance of bioactive 
peptides known to be active in vitro by carrying out extensive in vivo studies with 
animal models.
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5 Application of ultrafiltration in processing of whey protein hydrolysates
The principle of ultrafiltration (UF) has been used in many processes for the 
purposes of concentration, diafiltration or fractionation of molecules which differ in 
molecular size (Glover, 1985; Hallstrom et al., 1989). UF has been used in the 
fractionation of milk proteins hydrolysates to produce hydrolysates which contain a 
certain molecular mass distribution of peptides (Section 3.1.1 and Section 3.1.4.1). In 
most cases UF is used to process batch hydrolysate products. However, UF 
membranes can also be used to physically retain (immobilise) an enzymatic activity if 
the molecular weight cut-off of the membrane is lower than the molecular weight of 
the active enzyme used in the hydrolysate reaction.
Immobilised enzymes are defined as ‘enzymes physically confined or localised 
in a certain defined region of space with retention of their catalytic activities, which can 
be used repeatedly and continuously’ (Chibata, 1978). This definition is applicable to 
enzymes, cellular organelles, microbial cells, plant cells and animal cells. In some 
cases, these biocatalysts are bound to, or within, insoluble support materials (carriers) 
by chemical or physical interaction. In other cases, biocatalysts are free, but confined 
to limited domains or spaces of supporting materials (entrapment). With the advent of 
immobilisation techniques for enzymes and cells, a certain control o f biological 
processes is made possible, as substrates and products can easily be separated from 
catalysts or growing cells respectively. Methods of immobilisation include carrier 
binding, covalent binding, ionic binding, physical adsorption, cross-linking, in addition 
to entrapment. Immobilisation of enzymes to solid supports for the hydrolysis of whey 
proteins and other milk proteins has been used previously (Jost and Monti, 1977; 
Monti and Jost, 1978; Swaisgood and Catignani, 1985; Guisan et al, 1991; Haque, 
1993; Turgeon et al., 1991; Lorenzen et al., 1994). In addition, the method of 
immobilisation which employs affinity ligand chromatography has also been employed 
to recover the active enzyme after hydrolysis of whey protein (Monti and Jost, 1978). 
The method of enzyme entrapment/retention in membrane reactors is o f most interest 
in this review and has been employed by several groups in the hydrolysis of milk 
proteins (Monti and Jo st, 1978; Roger et al, 1981; Haque, 1993; Turgeon et al., 1991; 
Mannheim and Cheryan, 1990; Deeslie and Cheryan, 1981, 1982, 1988, 1991), as seen
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in Table 5.1. The industrial operation of membranes and bioreactors has also been 
reviewed (Daniels, 1987; Belfort, 1989).
The application o f UF type membranes to retain the enzyme during a 
hydrolysis reaction is reviewed here. The substrate (milk protein) is fed to the 
ultrafiltration unit and hydrolysed to low molecular weight products, which can 
permeate through the membrane. Other groups have also reviewed the application of 
this technology within the food industry (Hallstrom et al., 1989; Tragardh, 1988). The 
molecular weight distribution of hydrolysed products from a continuous membrane 
hydrolysis reactor depends upon membrane pore size, mean membrane pressure, 
enzyme to substrate ratio, temperature and residence time of substrate in the reactor 
(Butterworth et al., 1970). Therefore, careful assessment of the above factors would 
allow control over the final molecular characteristics of the hydrolysate.
5.1 Definitions related to ultrafiltration and its application to processing of 
enzymatic hydrolysates.
There are several definitions which are related solely to UF membrane technology. 
The definitions which are used in this review are given below:
5.1.1 Flux
Flux is usually given in units of permeation of the product per unit membrane
2  1 • area over time i.e. (1 m' h’ ). Flux must be optimised for each membrane system and
this requires that concentration polarisation (see below) be minimised. The interrelated
factors which influence flux and the permeation of the hydrolysate product are as
follows: (a) mean membrane pressure; (b) feed crossflow (1 h"1 ) over the membrane;
(c). process temperature; (d) concentration of retained substrate and products and (e)
membrane cleanliness and fouling characteristics of the feed. These factors are
outlined in Chapter 6. The performance of a membrane during processing is usually
represented by permeate flux curves i.e. a plot of flux against the mean membrane
pressure or against the concentration o f a component such as protein under stated
conditions.
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Table 5.1: Summaiy of literature reports on continuous protein hydrolysis
systems
Substrate Enzyme Memb r a n e  System Reference
Casein Alcalase1 Polysulphone hollow 
fibre ultrafiltration (A/G 
Technology MWCO 5- 
lOkDa)
Mannheim & Cheryan 
(1990)
Casein Alcalase Thin channel Boudrant & Cheftel
(glutaraldehye ultrafiltration cell (1976a,b)
cross-linked) (Amicon) MWCO-30 
kDa
Caseinomacro Trypsin Spiral-Wound UF Bouhallab & Touzé
- peptide cartridge (1995)
Soybean protein Pronase2 Hollow fibre 
ultrafiltration (Amicon) 
MWCO-10 kDa
Deeslie & Cheiyan 
(1981)
Soybean protein Pronase Hollow fibre 
ultrafiltration (Amicon) 
MWCO 10 kDa
Deeslie & Cheryan 
(1982)
Soybean protein Pronase Hollow fibre 
ultrafiltration (Amicon) 
MWCO 10 kDa
Deeslie & Cheryan 
(1988)
Soybean protein Pronase Hollow fibre
ultrafiltration (Amicon) 
MWCO 10 kDa
Deeslie & Cheryan
(1991)
Soybean protein Acid
proteinase3
Laminar flow cellulose 
acetate membrane 
MWCO 10-20 kDa
lacobucci et al (1974)
Blood protein Alcalase Hollow fibre 
ultrafiltration (Amicon) 
MWCO 10 kDa
Bressolier et al. (1988)
Fish protein Pronase Dead end ultrafiltration 
cell
Cheftel (1972)
Fish protein Trypsin Dead end ultrafiltration 
cell
Bhumiratana et al. (1977)
Alfalfa leaf Trypsin Dead end ultrafiltration Payne et al. (1978)
protein cell
’Alcalase: from  Bacillus lincheniformis (Novo)
2Pronase: from  Streptomyces griseus (Calbiochem -Behring Corp)
3A cid  proteinase: from  Pénicillium duponti (K ikhom an Shoyu Co.)
M W CO: m olecular w eight cut-off
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5.1.2 Concentration polarisation
Concentration polarisation is defined as the build up o f feed components on the 
surface of the membrane leading to reduced flux. The degree o f concentration 
polarisation in turn is dependant on the type of membrane used, the feed composition, 
crossflow velocity and mean membrane pressure.
5.1.3 Crossflow
Flow of retentate across the membrane or flow through the module is a concept 
o f filtration known as cross-flow or tangential flow. Crossflow allows for long term 
processing with little decline in permeate flux over the course of the processing run e.g. 
in tangential flow UF modules. With conventional filtration, the retained particles on 
the filter media accumulate to a point where no liquid will pass through the filter i.e. in 
dead-end filtration. As the feed cross flow (1 h '1) is increased, concentration 
polarisation effects are alleviated due to the ‘sweeping’ action of the feed across the 
membrane. Cross-flow filtration, therefore, creates a turbulent environment on the 
membrane surface which can prevent accumulation of retained particles.
5.1.4 Fouling
Membrane fouling can be defined as the accumulation of thin molecular layers 
on the surface o f the membrane that cannot be removed by increasing the flowrate of 
the feed across the membrane. Fouling may be reversible where periodic cleanings 
remove this layer and restore performance of the membrane to original levels. The 
response o f a membrane system to fouling is manifested as a productivity decline in the 
first hour o f the process which is followed by a gradual decline to the end of the run.
Macromolecular adsorption and fouling problems during ultrafiltration and their 
relationship to concentration polarisation has been studied (Matthiasson, 1984; 
Nilsson, 1989; Van der Horst, 1995). The fouling layer properties are known to 
depend on the degree of protein adsorption, hydrophobic interactions between the 
proteins and the membrane and membrane ionic interactions. The composition of the 
feed solution is of particular importance (i.e. pH, ionic strength, calcium content and 
degree o f protein aggregation, presence of lipids and other particulates) in the 
formation of the fouling layer (Marshall and Daufin, 1995). A comprehensive
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discussion of the physico-chemical aspects of membrane fouling, strategies to 
minimise fouling and the cleaning of membrane systems has been published recently 
(IDF Bulletin, 1995).
5.2.5 Mean membrane pressure
This is the driving force across the membrane (in the pressure controlled 
region), and is expressed as follows:
AP t = Pi + P o/2-P p
where P, = inlet pressure; P0 = outlet pressure; Pp= permeate back pressure.
By increasing the mean membrane pressure, the fouling phenomena can be 
counteracted by the increase in hydraulic pressure on the membrane.
5.1.6 Area to volume ratio
Normal membrane fouling can be compensated for by increasing the mean 
membrane pressure or by adding membrane area, i.e. increasing the area o f membrane 
to volume reaction ratio. Increasing the area to volume ratio, implies that the capacity 
o f the membrane is increased, thus, decreasing transmembrane pressure and 
minimising concentration polarisation and fouling.
5.1.7 Residence time /Space time
The residence time/space time refers to the contact time between the substrate 
and the enzyme during an hydrolysis reaction in a continuous stirred tank reactor 
(CSTR). Space time has an effect on the molecular mass distribution profiles o f 
peptides in an hydrolysate and the rate of decay of the enzyme in the reactor. These 
parameters can be controlled by the manipulation of space time factors (Deeslie and 
Cheryan, 1982). Space-time (x) is defined as
t  = (E V )/(S 01J)
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where E = enzyme concentration in a reactor (mg of N(nitrogen)/ml); V = volume of 
the substrate in reactor (ml); J = permeate flux (ml/min); S0’= S0-P0 (mg of N/ml), 
where S0 is the initial concentration of the substrate and P0 is the initial concentration 
o f the product. At higher space-time values the rate of build-up of unreacted substrate 
in the reactor is lower (Deeslie and Cheryan, 1982). By manipulation o f space-time 
variables, higher conversions of substrate to product for longer time periods can be 
produced (Deeslie and Cheryan, 1981,1982).
5.1.8 Dilution rate
Dilution rate is defined as follows:
D = J/V
where J = flux (ml/min) and V = reactor volume (ml).
5.2 Enzymatic hydrolysis in a continuous stirred tank reactor (CSTR)
Conventional batch protein hydrolysis has several disadvantages in comparison 
to continuous hydrolysis systems which use the principle of enzyme retention by a 
membrane. The disadvantages of the batch system of protein hydrolysis are as follows 
(a) high cost o f using large quantities of commercial enzymes, (b) difficulty in 
controlling the extent o f reaction that can result in nonhomogenous products, 
consisting of fractions o f varying molecular weight, (c) low yields per unit enzyme 
activity, and (d) the need to inactivate enzymes by using a heat treatment or pH 
adjustment at the end of the reaction, which adds further to processing costs (Cheryan, 
1986; Deeslie and Cheryan, 1988) and potentially changes the nutritional 
characteristics o f the resultant hydrolysate (Erbersdobler, 1983).
However, confinement of the enzyme in a membrane reactor gives some of the 
advantages o f enzyme immobilisation which include the following (a) improved 
efficiency, due to the fact that the enzyme can be reused, as it is retained by the 
membrane and is not heat inactivated or denatured after each run; (b) increased 
productivity per unit enzyme; (c) continuous systems allow for removal of 
substrate/product inhibition, and (d) a control o f the molecular weight distribution of
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the peptides produced in the hydrolysate fractions, within the limits o f the molecular 
weight cut-off o f the membrane (Deeslie and Cheryan, 1988).
The principles of ultrafiltration, types of membranes, membrane modules, plant 
configurations and the physical and chemical properties of milk proteins relevant to 
membrane processing have been reviewed (Glover, 1985). There are a number of 
interrelated factors which are important in the development of UF membrane 
enzymatic hydrolysis systems. These are (a) configuration of the membrane, (b) types 
of membranes, (c) membrane pore size and (d) flux characteristics o f the system.
5.2.1 Membrane configurations used in continuous hydrolysis offood proteins
The primary consideration in developing continuous enzyme reactors should 
be, in addition to those advantages already mentioned, to obtain a high conversion of 
substrate to product and to rapidly establish a steady-state operation. The former is 
controlled by the reaction kinetics of the system i.e. type, specificity and activity of the 
enzyme, E:S ratio and enzyme stability during continual usage. The latter is controlled 
by the operating conditions of the UF system, such as control of concentration 
polarisation, area to volume ratio of the membrane module and the fouling 
characteristics of the system.
In the hydrolysis of food proteins, two membrane configuration types have 
been generally used, the dead-end cell and the continuous stirred tank reactor (CSTR). 
The first description of a laboratory experiment using a membrane reactor for protein 
hydrolysis appears to be the work of Blatt et al. (1968) for the hydrolysis of whey 
protein. However, the reactor configuration used in this and many later investigations 
is the so-called ‘dead-end’ design with no cross-flow over the membrane. In the dead 
end type o f membrane reactor a cell fitted with a membrane at one end is loaded with 
the appropriate enzyme solution and substrate is continuously fed in under pressure 
while the permeate is continuously drawn through the membranes (i.e. the UF cell is 
operated in the continuous diafiltration mode). Agitation is necessary to minimise 
concentration polarisation effects and this is generally provided with a built in 
magnetic stirrer. However, this mode generally gives a higher concentration 
polarisation and a lower flux than for example, CSTR configurations.
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A different configuration was proposed by Porter and Michaels (1972) in which 
a continuous stirred tank reactor (CSTR) is coupled in a semi-loop configuration 
through a hollow fibre UF membrane. Figure 5.1 gives a schematic representation of a 
CSTR in this configuration.
pH
CONTROLLER
V E S S E L
Figure 5.1 Schematic representation of a continuous stirred tank reactor 
( C ST R )  in a semi-closed loop configuration
(taken from Mannheim and Cheryan, 1990).
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In the CSTR configuration, the reaction mixture, consisting of enzyme, 
unreacted and partially hydrolysed protein and hydrolysed protein is pumped through 
the membrane module under pressure. Hydrolysate containing peptides of a particular 
molecular size distribution, smaller than the cut-off of the membrane, pass through the 
ultrafiltration membrane and are collected as permeate. The rest of the reaction 
mixture, consisting o f enzyme and partially hydrolysed protein are returned to the 
CSTR. The residence time of the substrate in the enzymatic reactor is controlled by the 
system parameters such as flux. By careful design and selection o f operating 
parameters, a steady state operation can be achieved within 30-60 min of start up. This 
design has been applied in the more industrially oriented work on membrane reactors 
for protein hydrolysis, as well as for the concentration and purification of proteins 
where the engineering problems are similar (Olsen, 1978). In particular this 
configuration has been used with hollow fibre membranes (Deeslie and Cheryan, 
1981,1988,1991; Bressolier etal., 1988; Mannheim and Cheryan, 1990).
5.2.2 Membranes used in entrapment o f  enzymes during food  protein hydrolysis
5.2.2.1 Types and geometry of membranes
The membranes first employed in ultrafiltration of milk proteins were made of 
organic polymers, such as cellulose. However, these membranes were subject to many 
limitations. They were susceptible to hydrolysis, had a limited operational pH range 
i.e. 3-7 and an upper temperature limit of 35 °C. Therefore, efficient cleaning and 
sterilisation was constrained. Other polymers for use in membranes such as polyvinyl 
chloride, polyacrilonitrile, ploycarbonate, polyamide and polysulphone were thus 
developed. These membranes have proved to be stable to large changes in pH, 
temperature and stable to stringent cleaning procedures. For example, polysulphone 
type membranes, having a repeating (C6 H5)2 S 0 2 unit, can withstand temperatures 
between 50-80 °C and pH values between pH 2-12. Membrane geometry can be 
tubular or flat (rectangular, oval or spirally wound). It is known that flat membranes 
are difficult to clean if badly fouled (Glover, 1985). The membrane types used for 
continuous hydrolysis are normally hollow fibre, although use of a spiral membrane 
has been reported (Bouhallab el al., 1992).
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5.2.2.2 Membrane pore size
For continuous processing of milk protein hydrolysates, an ultrafiltration 
membrane having a defined molecular weight cut-off (MWCO) value can separate a 
product from the substrate-enzyme reaction mixture, thus controlling the molecular 
size o f the peptides product in the permeate. Control of the molecular properties of 
hydrolysate products is one of the major advantages of using UF type membrane 
reactors. This control o f molecular size is important where the hydrolysate product is 
exploited for its functional properties, such as emulsification and foaming properties 
(Adler-Nissen, 1986; Deeslie and Cheryan, 1991; Chobert et al., 1991). The 
importance of control o f peptide size to final product functionality has been outlined 
previously (Section 3). It must be remembered, however, that ultrafiltration 
membranes currently available do not have a sharp cut-off or pores o f a specific and 
uniform size hence certain molecules would also permeate through, depending on 
shape and size of the peptides/molecules (Merin and Cheryan, 1980, Deeslie and 
Cheryan, 1982). Hence, peptide size distribution of hydrolysate products is referred to 
in most cases. Table 5.1 gives the type of membranes and their molecular mass cut-off 
values, which have been used during continuous hydrolysis of food proteins.
5.2.2.3 Flux characteristics o f  a UF membrane system
The flux characteristics of a UF membrane system are dictated by a number of 
factors as mentioned in section 5.1.1 These factors have an influence on the membrane 
flux and permeation characteristics of the hydrolysate product.
5.3 Kinetics of enzymatic hydrolysis reactions in U F  m e m b r a n e  type systems
Kinetic models have long been established for the batch reactor system. The 
normal kinetic model adopted is that of Michaelis-Menten (1913). A number of kinetic 
models have been developed for the continuous hydrolysis of proteins utilising UF 
membranes. Most continuous models demand that certain assumptions be made 
initially and Michaelis-Menten kinetics are then applied to describe the reaction when a 
steady-state is reach, i.e. the solute concentration crossing over the membrane 
(retentate) is equal to the solute concentration in the permeate.
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Most of the literature on kinetics of hydrolysis in UF reactors up to 1979 has 
been thoroughly reviewed by Cheryan and Deeslie (1980). Other later publications 
deal mainly with kinetic investigations of protein hydrolysis in membrane reactors and 
the establishment of mathematical models for batch and continuous enzymatic 
hydrolysis o f food proteins (Sejr Olsen and Adler-Nissen, 1981; Deeslie and Cheryan, 
1981, 1982; Alford et al., 1984). The only other work in relation to the mathematical 
modelling of protein hydrolysis in membrane reactors previous to this was carried out 
by Iacobucci et al. (1974) and Myers et al. (1974). These groups hydrolysed soya 
protein isolate in a membrane reactor with a semi-closed loop configuration, using 
membranes with a nominal molecular mass cut-off value of 10 kDa. Other groups 
hydrolysed casein using Alcalase in a batch and continuous mode CSTR, using a 
hollow fibre membrane with a 10 kDa cut-off (Mannheim and Cheryan, 1990).
All o f the above groups developed mathematical models for the behaviour of 
the membrane reactor. All of these models were based on mass balance considerations 
in steady state, but they differed with regard to the underlying kinetics. Iacobucci et al. 
(1974), Myers et al. (1974) and Deeslie and Cheryan (1981, 1982) used Michaelis- 
Menten kinetics to determine a rate constant, k, which is proportional to the enzyme 
concentration. First-order reaction kinetics are assumed in these models. The rate 
constant is determined under steady-state conditions in the membrane reactors, and is 
found, as expected, to be much lower than the corresponding initial reaction rate 
constant obtained in batch hydrolysis experiments. The assumptions of the models 
were used to describe the hydrolysis of casein by Alcalase (Mannheim and Cheryan,
1990).
A quantitative kinetic model for the continuous hydrolysis o f soy protein has 
been described which used a different approach (Sejr Olsen and Adler-Nissen, 1981). 
The rate constant k  was derived from an empirical batch hydrolysis curve, for which 
zero-order kinetics have been established. By expressing k  as a function of DH, 
however, k  is transformed into a pseudo first-order rate constant.
Ultimately, all the above groups arrive at expressions for the conversion 
percentage in steady state which are roughly mathematically equivalent at high 
substrate to product conversions. The conversion percentage, i.e. the ratio between the
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nitrogen concentration in the permeate and the feed, is a function o f the feed 
concentration, the reactor volume (confined mass), the flux and the rate constant, k.
The economical advantage of using a membrane reactor process depends 
critically on the ability to purge the reactor. Usually, a small fraction of the substrate 
cannot be converted to hydrolysate and when the reactor is run continuously, this 
residue will gradually build up in the reactor. This necessitates that a small part o f the 
hydrolysate is bled continuously from the concentrate side of the membrane (Iacobucci 
et a i,  1974). However, the concomitant loss of enzyme may then in certain cases lead 
to overall enzyme consumption close to that of the batch hydrolysis process (Sejr 
Olsen and Adler-Nissen, 1981).
5. 4 Enzymes used in semi- and continuous m e m b r a n e  systems for the
hydrolysis of food proteins
A summary of some of the enzymes used in the hydrolysis of food proteins in 
continuous systems is given in Table 5.1. Some of the factors controlling high 
conversion rate of substrate to product are (a) the enzyme to substrate ratio and (b) 
type, specificity and stability of the enzymes used in the reaction. The enzyme to 
substrate ratio will dictate the rate of reaction and the type o f product obtained within a 
specific time of hydrolysis (Mullally et al., 1994). The type, specificity and stability 
of, for example, gastric and pancreatic enzymes have been discussed in Section 1. It 
has been suggested that one of the key factors is that the enzyme should have high 
activity and as broad a specificity as possible to prevent build-up of unhydrolysable 
material in the system, particularly when complex protein systems (e.g. milk proteins) 
are used in enzymatic hydrolysis reactions. This may mean having to use a mixture of 
exo- and endopeptidases activities. Problems of enzyme stability has been shown for 
soy protein hydrolysis using Pronase and Alcalase (Deeslie and Cheryan, 1988). It was 
suggested that should one enzyme decrease in activity at a faster rate than the others, 
that this would lead to problems in the hydrolysis reaction, such as those related to 
enzyme decay (Deeslie and Cheryan, 1988).
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5.4.1 Enzyme decay within a membrane reactor.
Problems which arise due to decay of enzyme in a continuous system are as 
follows: (i) build up of unhydrolysed material and (ii) the rate of conversion of 
substrate to products which permeate through the UF membrane is decreased. Enzyme 
decay during an hydrolysis reaction can cause a shift in molecular weight distribution 
to larger peptides. In addition, solubility the substrate decreases as enzyme decay 
increases and there can be an increase in turbidity. The mean membrane pressure in 
the system may rise above an acceptable level or flux rate may drop. This has been 
shown for soy protein hydrolysis with Pronase and Alcalase (Deeslie and Cheryan,
1988). A number of reasons for enzyme decay were shown for hydrolysis of soy 
protein by Pronase (Deeslie and Cheryan, 1982), which may be monitored within a 
particular system and controlled in many cases, (a) Thermal inactivation o f the 
enzyme may occur over time of the reaction. It has been shown, for example, in the 
Alcalase-casein system, that it is generally advisable to operate at lower temperature 
(35 °C), if  long-term enzyme stability is required (Boudrant and Cheftel, 1976a, b ). 
However, higher hydrolysis temperatures (40-50 °C) reduce microbial contamination 
of the product. It is known that in the presence of the substrate that certain enzyme 
preparations may be more thermostable. This is the case for porcine trypsin in the 
presence of whey protein (Jost and Monti, 1977). It is known that porcine trypsin is 
more thermostable than bovine trypsin (Lazdunski and Delaage, 1965), however at 55 
°C and over the enzyme is denatured, even in the presence o f calcium ions. It has been 
shown that in the presence of whey protein as substrate, the enzyme trypsin retains 
over 70 % activity after 1 hour at 55 °C (Buck et al., 1962; Deeslie and Cheryan,
1982). This demonstrates the use of a mesophilic enzyme at thermophilic digestion 
temperature due to the protective effect of the whey protein substrate (Jost and Monti, 
1977). Most control experiments, i.e. in the absence o f substrate, may give a false 
impression of enzyme stability or denaturation. (b) Depending on the membrane type, 
enzyme adsorption to the membrane may occur. Low protein binding membranes are 
used to eliminate this problem, such as certain polysulphone membranes (c) 
Mechanical shearing of the enzyme may occur over time within a continuous system,
(d) In certain cases, the enzyme may be inhibited by the substrate or products. 
However, in a continuous system, where product is continually removed and fresh
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substrate is added, this problem should not occur, (e) Loss of activators such as 
calcium through the membrane was shown to lead to loss o f Pronase enzymatic activity 
in the hydrolysis of soy protein (Deeslie and Cheryan, 1982). (f) Enzyme leakage at 50 
°C was shown to be higher than at 37 °C for a Pronase/soy protein hydrolysis system 
(Deeslie and Cheryan, 1982). Lowering the operating temperatures reduced the rate of 
enzyme leakage due to a general effect of lower solute (enzyme) mass flux at lower 
temperature, a common ultrafiltration phenomena. Enzyme leakage has been shown to 
occur in the first 1-2 h of hydrolysis operation (Deeslie and Cheryan, 1982). 
Generally, it was found that lowering the dilution rate of the system reduced the loss of 
activity within the reactor by lowering flow through of the product and rate of enzyme 
leakage (Deeslie and Cheryan, 1982). However, also it was suggested that product or 
unreacted substrate may act to stabilise the enzyme and a high dilution rate would 
reduce the stabilising factor (Deeslie and Cheryan, 1982). (g) Finally, certain enzymes 
are specific for amino acid residues within their own sequence, which may lead to 
autodigestion and loss of overall enzymatic activity.
5. 5 Hydrolysates which have been produced by continuous hydrolysis of milk
proteins and the application of U F  technology.
Hydrolysis in a continuous stirred tank membrane reactor (CSTR) which links 
enzymatic hydrolysis with simultaneous separation of products from a reaction mixture 
is a process which has been applied to continuous and extensive hydrolysis o f proteins 
from various sources. For example, the application of ultrafiltration to recover low 
molecular weight products from enzymatic hydrolysis of whey protein such as 
lactalbumin has been described (Olofoson et al., 1980; Turgeon et al., 1991). In 
addition, the hydrolysis of casein with a number of proteinases, including 
glutaraldehyde-stabilised Alcalase has been investigated by Boudrant and Cheftel 
(1976a, b).
A considerable number of publications on the development of continuous 
enzymatic hydrolysis of other food proteins in membrane reactors has appeared in the 
last two decades. Hydrolysis o f soya protein has been described by Roozen and Pilnik 
(1973,1979), Iacobucci et al. (1974) together with Myers et al. (1974), Vieth et al.
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(1977), Sejr Olsen and Adler-Nissen (1981), Cheryan and Deeslie (1980, 1983), 
Deeslie and Cheryan (1981, 1982). Other proteins which have been hydrolysed in 
membrane reactors are fish protein concentrate (Bhumiratana et al., 1977), cottonseed 
protein (Cunningham et al., 1978), leaf protein (Payne el al., 1978) and potato protein 
(Roozen and Pilnik, 1979).
Several other groups have employed continuous enzymatic hydrolysis of 
protein in a membrane reactor (Boudrant and Cheftel, 1976a, b; Bressollier et al., 1988; 
Mannheim and Cheryan, 1990), to produce hydrolysates with improved nutritional and 
functional properties (Brulé et al., 1980; Cheryan and Mehaia, 1986). A recent 
example of the use of CSTR is in the production of bioactive peptides from a tryptic 
hydrolysate of caseinomacropeptide. The continuous system was compared to the 
batch process for the production of an antithrombic peptide and it was found that the 
productivity of the continuous process was 3 times higher after 3.5 h of hydrolysis. A 
continuous hydrolysis process has also been described in the production of gram 
quantities of this anti-thrombic peptide during the hydrolysis o f caseinomacropeptide 
(Bouhallab et al., 1992; Bouhallab and Touzé, 1995).
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PROPOSED INVESTIGATION
The objectives of this project were as follows:
♦ To quantify the protease and peptidase activities within commercially available 
pancreatic proteolytic preparations and to characterise the influence of these 
activities on some physicochemical properties of whey protein hydrolysates.
♦ To investigate the effect of different large scale isolation and activation conditions 
for pancreatic zymogens on the ratios of proteolytic activities within an enzymatic 
preparation. As a follow on to the above, to study the effects o f different zymogen 
activation procedures on the development of certain molecular characteristics in 
whey protein hydrolysates.
♦ To investigate the angiotensin-I-converting enzyme (ACE) inhibitory activity of 
synthetic peptides corresponding to whey protein sequences known to possess 
opioid activity.
♦ To characterise the development of ACE inhibitory activity from whey protein 
hydrolysates generated with a range of gastric and pancreatic enzyme activities. To 
develop a fractionation scheme for the identification o f specific P-lactoglobulin 
derived ACE inhibitory peptides.
♦ To perform preliminary studies using differential scanning calorimetry to 
investigate the relationship between the thermal stability of P-lactoglobulin and its 
susceptibility to enzymatic hydrolysis.
♦ Finally, to perform preliminary studies to determine the efficacy of a tangential 
flow ultrafiltration membrane system for the fractionation of a whey protein 
hydrolysate.
76

CHAPTER 1
Proteolytic and peptidolytic activities in commercial 
pancreatic protease preparations and their relationship to 
some whey protein hydrolysate characteristics1
1 This chapter was published in the Journal of Agriculture and Food Chemistry,(1994) Vol 42 
(12), p2973-2981.
1.1 Summary
Endoproteinase and exopeptidase activities in the commercially available 
pancreatic protease preparations Corolase PP, PTN 3.OS, pancreatin, PEM 2500S, 
PEM 2700S and PEM 800S were quantified using synthetic peptide substrates. These 
preparations were generally found to be low in aminopeptidase and dipeptidase 
activity. Trypsin and chymotrypsin, albeit in different ratios, were present in all 
pancreatic preparations. Elastase was present only in Corolase PP and pancreatin. The 
ability o f these protease preparations to hydrolyse the insoluble heat denatured whey 
protein, lactalbumin, was compared and contrasted with that of crystalline trypsin, 
chymotrypsin, and elastase in addition to a commercial exopeptidase preparation, 
Debitrase DBP.20. When the source, number, or ratio of endoprotease activity 
changes, there are distinctive differences in products produced with respect to 
percentage degrees of hydrolysis, gel permeation profile, solubility, and free amino 
acids present in the hydrolysate.
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1.2 Introduction
Proteolytic enzyme preparations are economically the most important group of 
enzymes and their use is well established in the food industry (Godfrey and Reichert,
1983). Commercial protease preparations for use in large scale processes may consist 
of mixtures o f proteinases and peptidases that are isolated from animal tissues, plants 
or micro-organisms. Proteinases split protein molecules into peptides, while 
exopeptidases remove amino acids either from the N-terminus, i.e. aminopeptidases 
(Sanderink et al., 1988) or from the C-terminus i.e. carboxypeptidases (Petra, 1970), of 
peptides. The purification, and physical and chemical properties of pancreatic 
proteinases have been reviewed: trypsin (Northrop et ah, 1948; Desnuelle, 1960; 
Hakim et ah, 1962; Vestling et al., 1990); chymotrypsin (Wilcox, 1970), elastase 
(Hartley and Shotton, 1971; Gertler et al., 1977); and protease E (Kobayashi et ah, 
1981). The exopeptidases of the pancreas include carboxypeptidases A and B 
(Puigserver et al., 1986) in addition to a number of aminopeptidases and dipeptidases.
Enzymatic modification of proteins using selected proteases to hydrolyse 
specific peptide bonds is widely used (Adler-Nissen, 1986; Fox, 1991; Arai and 
Fujimaki, 1991). Whey proteins enzymatically hydrolysed with trypsin and 
chymotrypsin showed superior solubility and in vitro digestibility as compared to their 
chemically treated counterparts (Lakkis and Villota, 1992). The choice of substrate, 
proteases employed and the degree to which the protein is hydrolysed are factors 
known to affect the physicochemical properties of resulting hydrolysates. 
Manipulating the reaction conditions during enzymatic hydrolysis of milk proteins, 
produces hydrolysates with different solubility and emulsifying characteristics 
(Turgeon et ah, 1992), foaming properties (Kuehler and Stine, 1974), or taste 
characteristics (Murray and Baker, 1952; Poulsen, 1987; Vegarud and Langsrud,
1989).
The degree to which milk proteins are hydrolysed depends on the intended use 
for the hydrolysate. Low degrees of hydrolysis are desirable for maintaining functional 
properties, while extensive hydrolysis is necessary when the hydrolysate is to be used 
in, for example, chemically defined or hypoallergenic infant formulas (Merritt et ah, 
1990; Thibault, 1991). Mixtures o f proteases having complementary specificities may
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be used to attain the required degree of hydrolysis. The proportions of different 
proteinases, such as trypsin to chymotrypsin, and the presence or absence of 
exopeptidases, such as carboxypeptidase B, may be significant for production of 
specific hydrolysates such as hypoallergenic hydrolysates (Thibault, 1991) and/or 
hydrolysates with reduced bitterness (Fullbrook el a l, 1987; Plainer and Spropier,
1990).
To date little information has been published which links the 
proteinase/peptidase activity of commercial proteases used for hydrolysis of milk 
proteins to the physicochemical characteristics of the final hydrolysate. Although 
many groups have devised processes for the production of milk protein hydrolysates 
using commercial pancreatic proteases for clinical nutrition (Grimble and Silk, 1989; 
Maubois and Léonil, 1989), hypoallergenic and special dietetic products (Jost et al., 
1988; Asselin et a l, 1988, 1989; Thibault, 1991), the choice of enzyme is usually 
based on empirical screening or by random selection.
The specificity o f the pancreatic proteolytic enzymes dictates the nature of 
peptides and free amino acids found in the hydrolysate. The tissue source, bovine or 
porcine, in addition to the methods of purification used, influences the composition and 
stability o f protease preparations. A knowledge of the proteinase and exopeptidase 
activities in commercial protease preparations would be a useful guide in the selection 
of a particular protease to generate a desired hydrolysate. The objective o f this study 
was to determine the proteinase and peptidase activities in pancreatic protease 
preparations and to characterise the physicochemical properties of lactalbumin 
hydrolysates produced using these preparations.
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1.3 Materials and Methods
1.3.1 Enzymes
Commercial pancreatic proteases were received as gifts from manufacturers. 
Corolase PP (porcine) was supplied by Rohm GmbH, Kirschenallee D6100, 
Darmstadt, Germany; pancreatin (porcine) by Chemicon Ltd., Dublin, Ireland. PEM 
2500S (porcine/bovine), PEM 800S (bovine), PEM 2700S (bovine) and PTN 3.OS 
(porcine) were supplied by Novo Nordisk A/S, Bagsvaerd, Denmark, and Debitrase 
DBP.20 (.Lactococcus lactis, Aspergillus oryzae), was supplied by Imperial 
Biotechnology Ltd., London, U.K. Bovine trypsin (type XII), bovine Chymotrypsin 
(type II), porcine carboxypeptidase A, porcine carboxypeptidase B (Type I) and 
porcine elastase (type I) were obtained from Sigma Chemical Co. Poole, Dorset, UK.
1.3.2 Substrates
Aminomethylcoumarin (AMC) and fluorogenic substrates Alanine-AMC, 
Asparagine-AMC, Arginine-AMC, Glycine-AMC, Histidine-AMC, Proline-AMC, 
Arg-Arg-AMC, Gly-Arg-AMC, Gly-Pro-AMC, Lys-Ala-AMC, acetyl-Ala-Ala-Pro- 
Ala-AMC, N-Suc-Leu-Leu-Val-Tyr-AMC and N-benzoyl-L-Arg-AMC were obtained 
from Bachem, Bubendorf, Switzerland. Carboxypeptidase substrates, hippuryl-L- 
lysine, hippuryl-L-phenylalanine and N-tosyl-l-lysine chloromethyl ketone (TLCK) 
were supplied by Sigma. Lactalbumin (Alatal 560) was from New Zealand Dairy 
Board, Wellington, New Zealand; it is an insoluble heat denatured whey protein, and 
its manufacture has been outlined by a number of groups (Robinson et al., 1976; 
Mulvihill, 1992). Reagents for amino acid analysis were obtained from Beckman 
Instruments, High Wycombe, U.K. All other reagents were of analytical grade unless 
otherwise specified.
1.3.3 Quantification of E n z y m e  activity
Enzyme activities were assayed using a modification of the fluorogenic (AMC) 
assay (Zimmerman et al., 1977) as follows. Proteases (10 mg ml"1 ) were centrifuged 
at 14,400 g  (Microcentaur, MSE, U.K.) for 10 min and 20 (0.1 of supemant was added to
980 |il o f 0.01 M Tris-HCl, pH 7.0, containing 0.02 mM specific substrate. The 
substrate-enzyme mixture was incubated at 37 °C for 1 h. The reaction was stopped by 
the addition of 1 ml of 1.5 M acetic acid and fluorescence developed was measured on 
a spectrofluorometer (Perkin Elmer 1000, Beaconsfield, Bucks, England) at excitation 
and emission wavelengths of 360 nm and 440 nm, respectively. When the substrates 
Arg-Arg-AMC, Gly-Arg-AMC, Arg-Arg-AMC were used, the protease preparation 
was incubated with the trypsin inhibitor TLCK (lm g ml'1 ) in the ratio 1:5 (v/v) at 37 
°C for 10 min, before the assay. One unit of activity is defined as that amount of 
enzyme which will give 1 (imole AMC min"1 (mg protein)’1.
For quantification of carboxypeptidase A and B activities, samples (10 mg/ml of 
powder) were filtered through a 0.45 (am PS Whatman syringe filter, to remove 
aggregated material, and assayed using procedures outlined by Worthington Diagnostic 
Systems Inc., Freehold NJ. One unit of carboxypeptidase A activity was defined as 
that amount of enzyme which catalyses the hydrolysis o f 1 jimol N-a-hippuryl-L- 
phenylalanine min'1 at pH 7.50 and 25 °C. One unit of carboxypeptidase B activity 
was defined as that amount of enzyme which catalyses the hydrolysis of 1 fimol N -a- 
hippuryl-L-lysine min' 1 at pH 7.65 and 25 °C.
1.3.4 Preparation o f  Hydrolysates
A 25 ml solution of lactalbumin, 8 % (w/v) protein, was hydrolysed with 
individual proteases at 50 °C for 240 min. The pH was maintained at constant pH 8.0 
by continuous addition o f 0.5 M NaOH using a pH-stat (Metrohm Ltd., Herisau, 
Switzerland.). The degree of hydrolysis (DH, %), defined as the percentage of peptide 
bonds cleaved, was calculated from the volume and molarity of NaOH used to 
maintain constant pH (Adler-Nissen, 1986). Following hydrolysis, proteases were 
inactivated by heating at 80 °C for 30 min, cooled, and stored at -20 °C for further 
analysis. The enzyme (E) to substrate (S) ratio (0.003) was calculated on the basis of 
total protein content in the enzyme preparations and lactalbumin. The DH was 
calculated as follows:
DH, % = B (Mb) (1/ a)(l/M P)(l/h tot) x 100
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where B = volume of NaOH consumed (mL); Mb = molarity of NaOH; a  is the 
average degree of dissociation of the a-NH 2 groups at pH 8.0 and 50 °C; MP is the 
mass o f protein (g); htot is the total number o f peptide bonds in the protein substrate 
(mequiv/g protein). The htot value, 8.8 mequiv/g protein, and values of 1/a for various 
pH-temperature combinations were those given by Adler-Nissen (1986).
1.3.5 Characterisation o f  Hydrolysates
1.3.5.1 Protein (Nitrogen) Determination
Total protein (N x 6.25) of pancreatic preparations and of whey protein (N x 
6.38) was determined by micro-Kjeldahl (AOAC, 1980).
1.3.5.2 Protein (Nitrogen) Solubility
Hydrolysates were adjusted to pH 6.6 with 1M HC1 and centrifuged at 1300 g  
(Mistral 6000, MSE Scientific Instruments, West Sussex, England.) for 15 min at 20 
°C. The supernatants were then filtered through Whatman no.l filter paper; N content 
was determined as described above and expressed as a percentage of total N  in the 
hydrolysate.
1.3.5.3 Molecular size distribution of peptides in lactalbumin hydrolysates
A fast protein liquid chromatograph (FPLC) fitted with a Superose 12 gel 
permeation column (Pharmacia LKB Biotechnology Ltd., Upsalla, Sweden.) was used 
to monitor the size distribution of peptides in lactalbumin hydrolysates. The column 
was eluted at 1 ml min'1 with 0.1 M Tris-HCl buffer containing 0.1 M NaCl and 10 % 
(v/v) methanol. Hydrolysates were diluted in elution buffer to 0.25 % (w/v) protein, 
filtered through a Whatman 0.45 (im PS syringe filter and 100 |j,l was applied to the 
column. Analyses were performed in duplicate. Eluate was continually assayed at 214 
nm or 280 nm using two single path monitors (UV-1, Pharmacia) and recorded using a 
Minichrom® data handling system (VG, Data Systems, Altrincham, Cheshire, U.K). A 
calibration curve was prepared from the average retention volume (Rv) o f standard 
proteins and peptides.
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1.3.5.4 Free amino acid analysis of hydrolysates
Hydrolysates were deproteinised by mixing equal volumes of 24 % (w/v) TCA 
and sample, which was allowed to stand for 30 min before centrifuging at 14400g 
(Microcentaur, MSE, U.K.) for 10 min. Supernatants were removed and diluted with
0.2 M sodium citrate buffer, pH 2.2, to give approximately 25 nmol of each amino acid 
residue per 50 fil injection volume, and then analysed on a 120 x 4 mm cation 
exchange column (Na+ form) using a Beckman 6300 amino acid analyser (Beckman 
Instruments Ltd., High Wycombe, U.K).
1.4 Results
1.4.1 Characterisation o f  proteolytic activity in commercial pancreatic proteases
1.4.1.1 Aminopeptidase activity
Aminopeptidase activity in the bovine and porcine protease preparations tested was 
generally very low (Table 1). Corolase PP had activity against all the aminopeptidase 
substrates except Asp-AMC. Interestingly, there was essentially no activity against 
Asp-AMC in any preparation except Debitrase DBP.20. Debitrase DBP.20, was used 
as a positive control, as it is known to contain high exopeptidase activity as shown in 
Table 1. Apart from Corolase PP and to a lesser degree pancreatin, there was no 
activity against Ala-AMC in any of the pancreatic preparations. As expected, the two 
crystalline proteinases, trypsin and chymotrypsin, showed least aminopeptidase 
activity; however, activity was observed against His-AMC and Leu-AMC in both 
preparations. While activity towards Arg-AMC was detected in both crystalline 
trypsin and chymotrypsin, it was eliminated by addition of trypsin inhibitor, TLCK. 
The activity against Arg-AMC was decreased to 70-75 % of total activity in all 
preparations in the presence of TLCK.
1.4.1.2 Carboxypeptidase activity
Carboxypeptidase A was present in the porcine preparations Corolase PP, PTN 
3.OS, and pancreatin but was absent in the bovine preparations (Table 1). 
Carboxypeptidase B activity was detected in Corolase PP [1.74 units min '* (mg
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preparation)"1] and pancreatin [14.76 units min"1 (mg preparation)"1]. 
Carboxypeptidase A or B activity was not detected in Debitrase DBP.20.
1.4.1.3 Dipeptidase activity
Corolase PP was the only pancreatic preparation having dipeptidase activity for 
all four of the dipeptidase substrates tested (Table I). Pancreatin, Corolase PP and PTN
3.OS were the only pancreatic preparations showing Gly-Pro-AMC activity, which 
decreased in the order pancreatin > Corolase PP > PTN 3.OS. There was activity in all 
preparations towards Gly-Arg-AMC and Arg-Arg-AMC, but inhibitor studies using 
TLCK showed this activity to be largely due to trypsin (Table 1). Addition of TLCK 
reduced tryptic activity for Arg-Arg-AMC by ~ 33 % in the case of crystalline trypsin. 
Crystalline chymotrypsin had little or no dipeptidase activity. The dipeptidase activity 
o f PTN 3.OS towards Gly-Arg-AMC or Arg-Arg-AMC was reduced by 41 and 30 %, 
respectively, in the presence of TLCK.
Debitrase DBP.20 had activity on all dipeptidase substrates tested; highest levels 
o f activity were obtained with Gly-Pro-AMC as substrate [97.12 (.irnoles min'1 (mg 
protein)’1].
1.4.1.4 Endoproteinase activity
Trypsin activity, measured by hydrolysis of N-benzoyl-L-Arg-AMC, for bovine 
ciystalline trypsin and pancreatic proteases are given in Table 1. The specific activities 
(micromoles of AMC per minute per milligram of protein) for each of the preparations 
in order o f decreasing magnitude were as follows: Trypsin > PTN 3.OS > Corolase PP 
> PEM 2500S > PEM 2700S > PEM 800S > pancreatin. Crystalline chymotrypsin 
showed no activity against this substrate as expected.
All of the commercial preparations tested showed chymotrypsin activity as 
measured by hydrolysis of N-Suc-Leu-Leu-Val-Tyr-AMC (Table 1). Specific 
activities (micromoles o f AMC per minute per milligram of protein) in order of 
decreasing magnitude were as follows: PEM 800S > PEM 2500S > pancreatin > PEM 
2700S > PTN 3.OS > Corolase PP. Crystalline bovine chymotrypsin showed the 
highest specific activity [555.56 (amolesAMC min "* (mg protein)’1], as expected. Low 
elastase activities were observed in PTN 3.OS, PEM 2500S and PEM 800S; however,
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Table 1: Aminopeptidase activity (nmoles AMC/min/mg protein), carboxypeptidase activity (units/min/mg powder) and dipeptidase 
activity (nmoles AM C/min/ mg protein) and endopeptidase activities including trypsin, chym otrypsin and elastase activities (nmoles 
AMC/min/mg protein).
Enzyme preparation Corolase PP PTN 3.0S Pancreatin PEM2500S PEM800S PEM2700S Debitrase Trypsin Chymotrypsin
Aminopeptidase substrates
Ala-AMC 1764.00 0.00 9.49 0.00 0.00 0.00 501.25 0.00 0.00
Arg-AMC 2954.50 3705.85 1021.85 1056.90 616.23 1216.84 2976.20 28.57 30.00
Arg-AMC + TLCK 2090.00 3190.00 740.00 790.00 470.00 880.00 160.00 0.00 0.00
Asp-AMC 0.00 0.00 0.00 0.00 3.08 0.00 181.70 0.00 0.00
Gly-AMC 86.90 19.33 21.90 0.00 2.30 2.64 20.68 0.00 0.00
His-AMC 152.10 8.38 29.20 27.00 26.56 20.28 37.59 1238.10 34.79
Leu-AMC 2520.00 184.30 208.70 104.92 212.50 111.55 64223.00 38.10 330.55
Pro-AMC 34.76 61.87 70.05 12.34 12.40 7.10 25.06 7.62 6.09
Carboxypeptidase substrates
hippuryl-L-phenyalanine 6.73 3.37 4.21 - - - - - -
hippuryl-L-lysine 1.74 - 14.76 * - - - - •
Dipeptidase substrates
Arg-arg-AMC 9558.57 8700.70 6567.43 1974.94 2231.19 2433.68 4699.25 10952.38 34.79
Arg-arg-AMC + TLCK 6600.00 6090.00 4600.00 1380.00 1560.00 1700.00 3290.00 7670.00 20.00
Gly-arg-AMC 7038.58 5317.09 1824.28 1357.77 1460.90 1886.10 839.60 5142.86 26.10
Gly-arg-AMC +TLCK 1880.00 3130.00 240.00 600.00 320.00 610.00 530.00 100.00 0.00
Giy-pro-AMC 225.93 19.33 620.26 0.00 0.00 0.00 97117.79 0.00 0.00
Lys-ala-AMC 391.03 0.00 0.00 0.00 0.00 0.00 313.28 0.00 0.00
Endoproteinase substrates
N-benzoyl-L-arg-AMC 58.65 70.89 6.75 51.84 15.67 41.27 0.00 89.05 0.00
N-suc-leu-leu-val-tyr-AMC 157.80 172.40 226.21 279.27 449.78 185.57 2.19 1.98 555.56
Acetyl-ala-ala-pro-ala-AMC 189.43 0.70 80.27 0.49 0.52 0.11 0.01 0.01 0.03
- not determ inable (i.e activity values <  1 nm ole A M C /m in/m g protein using flurogenic substrates or <  0.0001 unit/m in/m g protein for carboxypeptidases)
Corolase PP and pancreatin displayed much higher elastase activities, having values of 
187.43 and 80.27 mmoles AMC min'^mg protein)'1, respectively, as measured by 
hydrolysis o f acetyl-Ala-Ala-Pro-Ala-AMC.
1.4.2 Characterisation o f  Lactalbumin Hydrolysates
1.4.2.1 Degrees of hydrolysis
The hydrolysis curves (DH,%, vs time, min) obtained by incubation of 
lactalbumin with commercial proteases are shown in Figure 1. Debitrase DBP.20, as 
expected, had low activity on lactalbumin as seen from the low degree o f hydrolysis 
obtained after incubation for 240 min. The curves obtained for crystalline 
chymotrypsin and trypsin began to plateau after ~ 60 min, at DH, 2.77 and 5.23 %, 
respectively, while the DH values after 240 min were 3.93 and 6.04 % respectively. 
The curve obtained for crystalline elastase indicated low activity in the early stages of 
the hydrolysis reaction, but activity continued to increase over the incubation period.
Protease preparations which contained more than one activity (Table 1) 
hydrolysed lactalbumin to higher DH % values than the crystalline preparations, as 
seen for PEM 2500S, PEM 800S, PEM 2700S, Corolase PP and pancreatin. The DH 
curves obtained for Corolase PP and Pancreatin were distinctly different from all other 
proteases and indicated high activity towards lactalbumin. Unlike the other 
preparations, Corolase PP and pancreatin continued to hydrolyse lactalbumin as 
incubation continued, giving DH values of 15.82 and 13.22 %, respectively after 240 
min.
1.4.2.2 Nitrogen solubility of lactalbumin hydrolysates
Incubation o f lactalbumin with bovine crystalline trypsin, chymotrypsin or 
pancreatin produced hydrolysates with high solubility at pH 6.6, i.e., ~ 90-100 % of 
total N (Table 2), while protease preparations such as PEM 2500S, PEM 800S and 
PEM 2700S produced hydrolysates that had similiar nitrogen solubility values, i.e, in 
the range 78-81 % of total N. The hydrolysate produced using Debitrase DBP.20 had a 
very low degree of solubility i.e., 0.15 % of total N.
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Figure 1: Enzymatic hydrolysis of lactalbumin by commercial protcases as a function of time: ( A) Corolase PP; (tilted square 
right solid) pancreatin; (□) PTN 3.0S; (♦ ) PEM 2500S; (V) PEM 2700S; (a) PEM 800S; (0) trypsin; (0) chymotrypsin; (a) 
elastase; (®) Debitrase. Reaction conditions: substrate concentration; 8% (w/v); E:S, 0.003; pH 8.0; 50 °C; time 240 min.
Time (mins)
Table 2: Soluble nitrogen as percentage 
of total N (pH 6.6) and degree of 
hydrolysis (DH %) in the lactalbumin 
hydro lysates after incubation with 
commercial proteases for 20 min.
Protease Soluble N DH %
PTN3.0S 89 8.83
Trypsin (bovine) 100 6.04
Chymotrypsin (bovine) 93 3.93
Elastase (porcine) 78 6.78
Corolase PP 81 15.82
PEM 2500S 78 7.66
Debitrase DBP.20 0.15 0.83
PEM 2700S 78.5 7.22
PEM800S 78.7 8.08
Pancreatin 100 13.22
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1.4.2.3 Production of free amino acids
The concentration of amino acids in free solution produced by incubation of 
lactalbumin with commercial proteases are shown in Table 3. Concentrations less than
0.005 mg/ml were not included in the table. All the commercial pancreatic protease 
preparations produced hydrolysates with Lys, Arg, Ala and Leu in free solution with 
the exception o f the hydrolysates produced by PTN 3.OS, which did not contain Lys, 
and PEM 800S, which did not contain Arg. The hydrolysates produced by Corolase 
PP, pancreatin, PEM 2500S and elastase contained Tyr and Ser free in solution. All of 
the hydrolysates with the exception of Debitrase DBP.20 are deficient in residues Asp 
and Glu and Gly. Tryptophan was not detected. Proline was not found free in solution 
for any of the hydrolysates examined. The elastase hydrolysate had Ala, Val, Leu, Phe, 
Ser and Tyr, in common with the hydrolysates produced by Corolase PP and 
pancreatin. Phenylalanine appeared to be produced only by Corolase PP, pancreatin 
and PEM 2500S. Both Corolase PP and pancreatin produced hydrolysates which 
contained relatively high levels o f free amino acids. The amino acids present in 
hydrolysates produced from both of these proteases were lysine > leucine > arginine > 
tyrosine > phenalanine > valine > isoleucine > methionine > serine > histidine > 
alanine > threonine.
Debitrase, as an exopeptidase preparation, showed only limited hydrolysis o f the 
lactalbumin substrate (Figure 1). However in the hydrolysate produced, all amino 
acids were found.
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Table 3: Free Amino Acids (milligrams per gram of protein) present in Lactalbumin hydrolysates produced by commercial 
protease preparations
Amino Acid Corolase PP PTN 3.OS Pancreatin PEM 2500S PEM800S PEM2700S Trypsin Chymotrypsin Elastase Debitrase
Asp - - - - - - - - - 0.09
Thr 1.11 - 1.49 - - - - - - 0.76
Ser 2.33 - 2.80 0.11 - - - - 0.08 0.63
Glu - - - - - - - - - 046
Pro - - - - - - - - - -
Gly - - - - - - - - - 0.07
Ala 1.38 0.29 2.04 0.28 0.30 0.02 0.30 0.30 0.29 1.01
Met 3.47 - 3.99 - - - - - - 0.65
Val 8.82 - 9.45 - - - - - 0.79 0.73
lieu 5.00 - 5.49 - - - - - 0.04 1.33
Leu 24.07 0.49 25.71 0.60 0.44 0.01 - - 0.27 1.95
Tyr 12.30 - 17.80 0.62 0.22 - - - 0.56 -
Phe 10.74 - 12.25 0.27 - - - - 0.72 0.37
His 2.01 - 2.17 - - 0.07 0.63 - 0.40 0.40
Lys 38.86 6.37 30.07 5.05 1.31 0.17 2.06 0.09 1.76 0.66
Trp - - - - - - - - - -
Arg 22.87 0.12 22.60 1.07 - 0.12 - - - -
a - not detected
1.4.2.4 Molecular size distribution of peptides in lactalbumin hydrolysates
The chromatograms obtained on Superose 12, assayed at 280 or 214nm, of 
lactalbumin hydrolysates are shown in Figures 2-4. The void volume (V0) of the 
column corresponds to 2 x 106 Da, while the total column volume (VJ corresponded to 
174 Da. The molecular size distributions of peptides in hydrolysates produced by 
crystalline elastase or chymotrypsin (Figure 2 (a) and (b) respectively) were similiar,
i.e., between 150,000 and 14,700 Da, while crystalline trypsin (Figure 2 (c)) produced 
a distinctly different profile, particularly in this region. There was a strong similiarity 
in the chromatograms of hydrolysates produced by PTN 3.OS, PEM 2500S, PEM 
2700S and PEM 800S (Figure 3 and Figure 4 (a)). However, hydrolysates produced by 
Corolase PP or pancreatin (Figure 4 (b) and (c) respectively) were substantially 
different, showing increased peak area corresponding to low molecular weight 
peptides, and reduced peak area corresponding to V0
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El u t i on  v o l u m e  (ml)
Figure 2: Chromatograms from FPLC Superóse 12 column, assayed by
absorbance at 280 (— ) and 214 nm (------- ) of (a) elastase, (b) chymotrypsin, or
(c) trypsin. Conditions: elution buffer (pH 7.0), 0.1 M Tris-HCl-0.1 M NaCl-10 
% methanol; flowrate, 0.5 ml min'1. (1) Blue dextran (2 000 000 Da); (2) 
immunoglobulin G (150 000); (3) p-Iactoglobulin (36 000); (4) a-Iactalbumin (14 
700); (5) insulin chain B (3494); (6) L-arginine (174); (7) L-tyrosine (181); (8) 
DL-tryptophan (204).
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El u t i on  v o l u m e  (ml )
Figure 3: Chromatograms from FPLC Superóse 12 column, assayed by
absorbance at 280 (— ) and 214 nm (------- ) of (a) PTN 3.0S,(b) PEM 2500S (c)
PEM 2700S. Conditions as in Figure 2.
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El u t i o n  v o l u m e  (ml )
Figure 4 Chromatograms from FPLC Superóse 12 column, assayed by
absorbance at 280 (— ) and 214 nm (------- ) of (a) PEM 800S,(b) pancreatin (c)
Corolase PP . Conditions as in Figure 2.
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1.5 Discussion
There were low levels of aminopeptidase and dipeptidase activity in PEM 
2500S, PTN 3.0S, PEM 800S and PEM 2700S, unlike Corolase PP and pancreatin 
which had higher levels of these activities. However, for all of the pancreatic 
preparations examined the ratios of the principal endoproteinases trypsin, 
chymotrypsin and elastase were different. Limited hydrolysis of the lactalbumin 
substrate resulted when Debitrase DBP.20 was used, as is seen by the low percentage 
degrees o f hydrolysis; this is because it contains only aminopeptidase and dipeptidase 
activities (Figure 1). The influence the detected activities may have on hydrolysis of 
lactalbumin was determined by characterising hydrolysates obtained after incubation 
with individual protease preparations.
The ratio of proteinases in a pancreatic enzyme preparation is related not alone to 
the degree of purification but also to the source of pancreatic tissue (Marchis-Mouren, 
1965). In this study, trypsin- like activity was highest in preparations of porcine origin,
i.e. Corolase PP, PTN 3.OS and PEM 2500S, and may be attributed to the superior 
stability o f porcine trypsin over the bovine counterpart (Buck et al., 1962; Lazdunski 
and Delaage, 1965; Vithayathil et al., 1961). PEM 2500S is sourced from porcine and 
bovine pancreas, although it is not clear at what stage of the purification that the two 
sources were mixed or if  the bovine and porcine tissues were extracted separately and 
proteases then mixed in a defined ratio. In this study the bovine trypsin preparations 
hydrolysed lactalbumin to a lower degree than those preparations which contained 
porcine trypsin (Table 2 and Figure 1). The most obvious reason for this may be the 
better thermostability of porcine trypsin in comparison to bovine trypsin (Buck et al., 
1962), particularly in the presence of a whey protein substrate (Jost and Monti, 1977).
The low specific activity for chymotrypsin in Corolase PP, PTN 3.OS, and 
pancreatin, which are of porcine origin, may be due to the labile nature of the porcine 
chymotrypsins B and C during acidic extraction (Desnuelle and Rovery, 1961; 
Northrop et a l, 1948). Chymotrypsin also had activity towards Leu-AMC which may 
be attributed to the presence o f chymotrypsin C in porcine preparations (Folk, 1970a). 
All preparations displayed arginine aminopeptidase activity, although TLCK inclusion 
had shown this to be largely associated with tryptic activity. There may, however, be a
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specific arginine aminopeptidase associated solely with porcine preparations which 
would explain the high levels of arginine found in hydrolysates produced by such 
preparations (Table 3). The levels of tyrosine and phenylalanine in hydrolysates 
produced by pancreatic preparations could be attributed to carboxypeptidase A activity, 
particularly in preparations of porcine origin (Table 1 and Table 3) as this 
carboxypeptidase acts on the products o f chymotryptic digestion (Guash et al., 1992). 
Carboxypeptidase B acts on the products of trypsin digestion and therefore the high 
levels o f arginine and lysine found in hydrolysates are not unexpected, particularly in 
hydrolysates produced by Corolase PP or pancreatin which had high levels of 
carboxypeptidase B activity (Table 1).
Similarities in the peptidase activities between Debitrase DBP.20 and the 
pancreatic preparations Corolase PP and pancreatin are evident both from activity 
analysis using fluorogenic substrates and also from the type and concentration of 
amino acids liberated in the hydrolysates produced by these preparations. Debitrase 
DBP.20, is a protease preparation from Lactococcus lactis and Aspergillus oryzae and 
had significantly more aminopeptidase activity than the pancreatic preparations (Table 
1). The increase in area and number of peaks corresponding to peptides of low 
molecular weight in chromatograms of Corolase PP and pancreatin hydrolysates 
probably reflects the contribution of aminopeptidase, dipeptidase and elastase activities 
in these preparations (Figures 1 and 4).
Characteristic products of hydrolysis are obtained following treatment of 
lactalbumin with crystalline pancreatic enzymes. These characteristics are related to 
the specificities o f the enzyme towards lactalbumin and can be seen in the degrees of 
hydrolysis (Figure 1), molecular weight profile of the peptides, within the range of
150.000-14,700 Da (Figure 2), and free amino acid profiles (Table 3). To maintain or 
improve functionality, generally low degrees of hydrolysis are necessary (Kilara, 
1985). Trypsin is specific for lysine and arginine residues; therefore, characteristic 
peptides and concentration o f amino acids are expected after a specific hydrolysis 
period. In the case of chymotrypsin and elastase, the existence of a number of families 
of each enzyme increases the range of specificities of these enzymes, as is evident from 
the existence of a number o f peaks corresponding to peptides, within the same range of
150.000-14,700 Da, o f intermediate chain length in the gel permeation profiles at 280
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nm and 214 nm (Figure2 (a) and (b)). Trypsin, because of its narrow specificity, 
produces larger peptides than chymotrypsin, and these peptides are reported to have 
greater emulsifying properties (Jost and Monti, 1982; Turgeon el al., 1991,1992).
There were very distinct differences in molecular mass profiles o f peptides in 
lactalbumin hydrolysates produced using Corolase PP or pancreatin (Figure 4 (b) and 
(c)) in comparison to the hydrolysates produced using PTN 3.OS, PEM 2500S, PEM 
2700S and PEM 800S (Figure 3 and Figure 4 (a)). Generally, PTN 3.OS, PEM 2500S, 
PEM 2700S and PEM 800S produced hydrolysates of similar molecular mass profiles, 
and with low DH values, while Corolase PP and pancreatin gave more extensive 
hydrolysis.
Pancreatic preparations, PTN 3.OS, PEM 2500S, PEM 2700S, and PEM 800S, 
which contain only trypsin and chymotrypsin as the principal endoproteinase activity 
produce hydrolysates with products within a narrow molecular mass range (Figure 3 
Figure 4 a) seen by lower percentage degrees of hydrolysis than that obtained with 
Corolase PP and pancreatin (Table 2). Interestingly, a similiar DH value ( ~ 8 % ) was 
obtained after 240 min of hydrolysis for the enzymes PTN 3.OS, PEM 2500S, PEM 
2700S and PEM 800S, eventhough the ratio of trypsin to chymotrypsin was different 
in each (Table 1). The lactalbumin hydrolysates produced with these preparations had 
very similar molecular mass profiles as determined by absorbance at 280 and 214 nm. 
The differences between preparations exist mainly in the molecular mass range of
150,000-36,000 Da. It appears that as the ratio of chymotrypsin to trypsin decreased, 
there was less breakdown of large molecular mass peptides such that the size of the 
peak no. 2 eluted within the molecular weight range of 150,000 Da is less substantial. 
Evidence o f this can be seen when PTN 3.OS is compared with PEM 2500S, PEM 
800S and PEM 2700S. This peak does not exist in PTN 3.OS, but as the ratio of 
chymotrypsin is increased, the peak becomes more prominent. This may be attributed 
to the broader specificity of chymotrypsin (Folk, 1970a), the low levels of 
exopeptidase activities (Table 1), or the presence of carboxypeptidase A or B in 
Corolase PP, pancreatin and PTN 3.OS. It is known that the levels of 
carboxypeptidases are higher in porcine tissues (Desnuelle and Rovery, 1961). The 
chromatograms of hydrolysates produced using PTN 3.OS, PEM 2500S and PEM 
2700S were similar; this may be due to presence of only two endoproteolytic activities,
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trypsin and chymotrypsin, with minimal elastase activity (Table 1). Thibault (1991) 
suggested that a specific ratio of trypsin to chymotrypsin was necessary for hydrolysis 
of whey proteins to achieve a particular FPLC molecular mass profile and reduction in 
antigenicity, while the individual enzymes did not produce the desired product 
characteristics. Kahn et al. (1991) also used a specific ratio of trypsin, chymotrypsin 
and porcine elastase to reduce the allergenicity of whey protein. Therefore, incubation 
of substrates with proteinases containing different ratios of endoproteolytic activities 
influences the hydrolysate characteristics.
There was no correlation between final degree of hydrolysis and solubility at pH
6.6 for the hydrolysates produced in this study. Elastase produced a hydrolysate that 
had a high solubility and was comparable to hydrolysates produced by commercial 
preparations containing mixtures of trypsin and chymotrypsin (Table 2). Preparations 
such as Corolase PP and pancreatin produced hydrolysates o f higher solubility than 
hydrolysates produced by PTN 3.OS, PEM 2500S, PEM 2700S and PEM 800S. This 
may be explained by the presence of an additional endoproteolytic activity, elastase, 
and also to the additional exopeptidase activities in the former preparations. Debitrase 
DBP.20, being a preparation that had predominantly exopeptidase activities, produced 
a hydrolysate of low solubility.
The presence or absence o f exopeptidases in commercial proteases may be of 
consequence for enzymatic hydrolysis of food proteins; for instance, in some 
applications, the level o f free amino acids (Table 3) should be controlled so as to 
maintain low osmolality (Duke et al., 1976) in the hydrolysate. Proteolytic 
preparations that contain exopeptidase activities produce less bitter hydrolysates than 
specific proteinases, such as trypsin (Clegg and McMillan, 1974; Cogan et al., 1981; 
Vergarud and Langsrud, 1989; Moll, 1990). Interestingly, analysis of amino acids in 
free solution in the hydrolysates produced using pancreatic preparations (Table 3) did 
not reflect all o f the aminopeptidase activities detected using fluorogenic substrates. 
The apparently low levels of free amino acids (Table 3) observed in hydrolysates from 
preparations containing exopeptidase activity (Table 1) may be due to the 
thermolability o f the exopeptidases at 50 °C for 240 min. Furthermore, 
endoproteolytic digestion of lactalbumin may not result in peptides having N- or C- 
terminal sequences suitable for subsequent digestion by specific exopeptidases.
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Pancreatin and Corolase PP, like Debitrase DBP.20, showed some activity 
towards the Gly-Pro-AMC substrate in addition to high activity for leucine 
aminopeptidase. Post proline dipeptidylaminopeptidase (PPDA), detected using Gly- 
Pro-AMC, has been used in synergy with leucine aminopeptidase (LAP) in the removal 
of bitterness from casein hydrolysates (Whitty, 1993). It could be suggested, therefore, 
that Corolase PP and pancreatin could have the capacity to produce hydrolysates of 
reduced bitterness as shown by other groups (Samuelsson and Poulsen, 1987; Lalasidas 
el al, 1978; Chiang et al., 1982). It may be that the cruder pancreatic preparations 
such as Corolase PP and Pancreatin retain some of the dipeptidase activity, as they may 
have not been subjected to multiple purification steps such as acid extraction, which is 
used in preparation of chymotrypsin (Northrop et al., 1948). The TCA soluble 
hydrolysates produced by Corolase PP and pancreatin are high in hydrophobic amino 
acid residues, free in solution, such as valine, leucine and phenylalanine. The removal 
of these amino acids from peptides is often correlated with debittering of protein 
hydrolysates (IJmetsu et al., 1983).
From this study, it can be shown that depending on the number and ratio of 
activities within a protease preparation, that the molecular characteristics such as 
molecular mass of the peptides, DH values, and concentration of amino acids in 
hydrolysates, differ. As the range of enzymatic activities within commercial 
preparations is increased, the hydrolysate became more complex. The commercial 
proteases in this study can be classified into two distinct groups (Table 4). Group II 
proteases contain only trypsin and chymotrypsin, whereas Group I preparations contain 
exopeptidases, in addition to endoprotease activities.
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Table 4: Commercial pancreatic protease preparations, principal activities, and potential uses.
Commercial protease Principle activities Potential uses References
Group I Corolase PP 
Pancreatin
Trypsin
Chymotrypsin
Elastase
Leucine aminopeptidase 
Diaminopeptidases
enteral feeds 
microbial growth media 
dietetic foods 
removal of bitterness
Lalasidas et al. (1978)
Jost et al. (1988) (patent)
Poulsen, 1987 (patent)
Sameulsson and Poulsen, 1987 (patent)
Group II PTN3.0S 
PEM 2500S 
PEM 800S 
PEM 2700S
Trypsin
Chymotrypsin
functional food ingredients Perea et al., 1993
dietetic foods 
hypoallergenic foods
Kahn et al. ,1991 (patent) 
Thibault, 1991 (patent).

CHAPTER 2
Zymogen activation in pancreatic endoproteolytic 
preparations and influence on some whey protein 
hydrolysate characteristics.1
1 This chapter was published in the Journal of Food Science, (1995), 60 (2), 227-233.
2.1 Summary
A proteolytic preparation from porcine pancreas was isolated. Trypsin, 
chymotrypsin and elastase were characterised and their time-dependent stability at 37 
°C was studied. The supernatant of a 30 % (w/v) saturated ammonium sulphate 
precipitation of a pancreatic extract (30S) was developed to pilot-scale level. The 
influence of zymogen activation time on molecular characteristics of whey protein 
hydrolysates produced by 30S and the commercial pancreatic preparation Corolase PP 
were compared. Amino acid analysis and gel permeation chromatography were used 
to characterise lactalbumin hydrolysates produced. Physicochemical characteristics of 
whey protein hydrolysates could be altered by manipulation of zymogen activation 
conditions in pancreatic proteinase preparations to be used during subsequent protein 
hydrolysis.
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2.2 Introduction
Enzymatic modification of proteins using selected proteolytic enzyme 
preparations to split specific peptide bonds is widely used in the food industry 
(Godfrey and Reichelt, 1983; Adler-Nissen, 1986; Fox, 1991; Arai and Fujimaki, 
1991). Whey proteins enzymatically hydrolysed with trypsin and chymotrypsin show 
better solubility and in vitro digestibility than their chemically treated counterparts 
(Lakkis and Villota, 1992). The choice of substrate, protease employed and degree to 
which the protein is hydrolysed affect physicochemical properties of resulting 
hydrolysates. By controlling reaction conditions during enzymatic hydrolysis of milk 
proteins, hydrolysates with different solubility and emulsifying characteristics 
(Turgeon et al., 1992), foaming properties (Kuehler and Stine, 1974) or taste (Murray 
and Baker, 1952; Poulsen, 1987; Vegarud and Langsrud, 1989) have been produced.
The degree to which milk proteins are hydrolysed depends on the intended use 
for the hydrolysate. Low degrees of hydrolysis are desirable for maintaining functional 
properties. Extensive hydrolysis may be necessary when the hydrolysate is to be used 
for specific purpoese such as chemically defined or hypoallergenic infant formula 
(Merritt et al., 1990; Thibault, 1991). Mixtures of proteases which have 
complementary specificities may be used to attain a required degree of hydrolysis. The 
number and ratio of proteolytic activities is critical to the final hydrolysate 
characteristics. The proportions of different proteinases, such as trypsin to 
chymotrypsin and the presence or absence of exopeptidases, such as carboxypeptidase 
B, may be important in the production of hypoallergenic hydrolysates (Thibault, 1991), 
or those with reduced bitterness (Fullbrook et al., 1987; Plainer and Spropler, 1990).
Little information has been published which relates critical ratios of 
proteinase/peptidase activity of commercial proteases used for hydrolysis of milk 
proteins to physicochemical characteristics of the final hydrolysate. Many groups have 
devised processes for production of milk protein hydrolysates using commercial 
pancreatic proteases, i.e. for clinical nutrition (Grimble and Silk, 1989; Maubois and 
Léonil, 1989), hypoallergenic and special dietetic products ( Jost et al., 1988; Asselin
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et al., 1988, 1989; Thibault, 1991). However, the choice of enzyme preparation has 
usually been based on empirical screening or random selection.
Published methods for purification of pancreatic proteinases have mainly 
focused on the isolation of individual enzymes with elimination of other activities 
(Bergmann and Fruton, 1941; Northrop et al., 1948; Lewis el al., 1959; Balls, 1965). 
Purification, physical and chemical properties of both the zymogen, and active forms 
of pancreatic proteinases have been reviewed, i.e. trypsin (Northrop et al., 1948; 
Desnuelle and Rovery, 1961; Hakim et al., 1962; Vestling et al., 1990), chymotrypsin 
(Wilcox, 1970), elastase (Hartley and Shotton, 1971; Gertler et al., 1977). Limited 
studies have been published on the enrichment of a mixture of pancreatic enzymes 
where the activity of all enzymes was retained, or where a desired ratio of proteinases 
was required to mimic the in vivo digestive system. Prior to any pancreatic protease 
development, factors governing the specific activity of the proteolytic enzymes must be 
considered. Specific activities can be influenced by many factors. These include 
activation of one enzyme by another (Desnuelle and Rovery, 1961); 
autolysis/degradation (Vestling et al., 1990); presence or absence of metal ions; 
hormonal activators in the tissue source (Padfield and Case, 1987), reverse feed-back 
mechanisms in diet (Dagom and Lahaie, 1981) and species differences (Marchis- 
Mouren, 1965).
Our study considered stability (Vestling et al., 1990; Vithayathil et al., 1961; 
Buck et al., 1962; Hakim et al., 1962) and activation of the zymogen forms of 
proteolytic enzymes of porcine pancreas (Desnuelle and Rovery, 1961). This tissue 
was chosen for this study as it is known that porcine trypsin has better stability with 
respect to heat, influence of metal ions and pH changes (Buck et al., 1962). 
Furthermore, porcine pancreatic proteases have similarities with pancreatic proteases of 
human origin (Clemente et al., 1972; Gertler et al., 1977; Largmann et al., 1976).
Our objective was to develop methods for isolation and activation of porcine 
pancreatic proteolytic preparations. These preparations were compared with existing 
commercial proteases. Effects of the enzyme isolation and activation conditions on the 
development and associated physicochemical properties of whey protein hydrolysates 
were compared.
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2.3 Materials & Methods
2.3.1 Materials
Commercial pancreatic proteases were gifts from manufacturers. Corolase PP 
(porcine) was supplied by Rohm GmbH, Darmstadt, Germany. PTN 3.OS (porcine) 
and PEM 2500S (porcine) were supplied by Novo Nordisk A/S, Bagsvaerd, Denmark. 
Bovine trypsin (Type XII) was obtained from Sigma Chemical Co., Poole, Dorset, UK.
Amino-methyl-coumarin (AMC) and the fluorogenic substrates for elastase, 
chymotrypsin and trypsin were, acetyl-ala-ala-pro-ala-AMC, N-succinyl-leu-leu-val- 
tyr-AMC and N-benzoyl-L-arg-AMC respectively, obtained from Bachem, Bubendorf, 
Switzerland. Lactalbumin (Alatal-560) was from New Zealand Dairy Board, 
Wellington, New Zealand. It is an insoluble heat denatured whey protein and its 
manufacture has been described (Robinson et al., 1976; Mulvihill, 1992). The standard 
proteins and peptides for FPLC were from Sigma and were as follows: Blue dextran 
(2,000,000 Da), Immunoglobulin G (150,000), bovine serum albumin (67,500), 0- 
lactoglobulin (36,000), a-lactalbumin (14,700), insulin chain B (3,494), DL-tryptophan 
(204), L-tyrosine (181), L-arginine (174). Reagents and standards for amino acid 
analysis were obtained from Beckman Instruments, High Wycombe, U.K. All other 
reagents were of analytical grade unless otherwise specified.
2.3.2 Preparation of pancreatic enzyme extracts
2.3.2.1 Extraction and ammonium sulphate fractionation
Initial steps in the method of Kunitz, as outlined by Laskowski (1956), were used 
and several modifications were made to account for scale-up. Fresh pancreas (5.25 kg) 
was from Cappoquin Meats Ltd. (Pork and Bacon Processors, Cappoquin, Co. 
Waterford) which was stored cold during transit to the laboratory and was then 
immersed in ice-cold 0.125 M H2S04. Fat was trimmed from pancreatic tissue, which 
was chopped and then macerated in a Waring blender for 5 sec. The macerated tissue 
was suspended in 0.125 M H2S04 (1:1 volume ratio of tissue to acid solution). 
Macerated tissue («5L Sample A) was obtained and this was stirred at 4 °C overnight
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at 130 rpm in an equal volume of cold 0.125 M H2S04. The suspension (10L) was 
filtered through one layer of synthetic cheese cloth and the filtrate (5.2 L) was 
collected. Residual tissue was further macerated, using a large-scale blender, for 3 min 
and was again stirred overnight in an equal volume of 0.125 M H2S04 The 
suspension was centrifuged at 1900 x g (Mistral 6000, MSE Scientific Instruments, 
Crawley, West Sussex, U.K.) for 10 min at 0 °C and the supernatant was combined 
with the previous filtrate to give a total extract volume of 10.95 L (Sample B). A range 
of ammonium sulphate precipitations were carried out on 100-ml aliquots of this 
filtrate for initial studies. Saturated ammonium sulphate (SAS) solution was added to 
Sample B at 4 °C from a separating funnel at a flow rate of 40 ml / min, with 
continuous stirring. The mixture was allowed to stand for 30 min and then centrifuged 
for 20 min at 10,000 x g at 0 °C. The supernatant of the SAS fractionation was 
designated S (for example, 30S refers to the supernatant of the 30 % ammonium 
sulphate precipitation of Sample B).
2.3.2.2 Desalting and concentration of protein in 30S preparation
In a larger-scale experiment the supernatant (1000 ml ) from the 30 % 
ammonium sulphate precipitation (30S) was vacuum-filtered on a Büchner funnel 
through Whatman no. 4 and no. 1 filter papers, consecutively, to remove suspended 
solids. An Amicon® (CH2A Concentrator, Amicon Ltd., Stonehouse, Gloucestershire, 
U.K.) hollow-fiber ultrafiltration system was then used to desalt and concentrate the 
protein. Inlet pressure was maintained at «0.7 kg/cm (10 psi) and the pump speed 
setting was maintained between 4-5. An Amicon® hollow-fiber membrane with a 
molecular weight cut-off of 30,000 Da and surface area of 0.06 m was used (HIP 20- 
30 Serial no. 0032-1A120). A constant permeate flow rate of «7 ml / min was 
maintained during continuous diafiltration with 2.5 L distilled H20  before the retentate 
was reduced to 200 ml (i.e. a volume concentration reduction = 5). Samples from the 
permeate and retentate streams («5 ml) were removed at intervals and assayed for 
trypsin activity. The degree of diafiltration was monitored using continuous 
conductivity measurements (Philips PW9509 digital conductivity meter, Pye Unicam 
Ltd., Cambridge, U.K.).
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2.3.3 Activation of zymogens
Initial experiments were carried out on Sample B and 3 OS to determine the 
activation/de-activation rate of the principal endoproteinases. These fractions were 
buffered with 0.1 M Tris-HCl, pH 7.0, containing 100 mM CaCl2 taking one volume 
protein solution and mixing with 9 volumes of Tris buffer. The protein suspension was 
adjusted to pH 7.0 and further diluted 1.45-fold using Tris buffer. Exogenous trypsin, 
Sigma type XII (lmg/ml), was then added at 2 % ( v/v). A negative control was also 
used (i.e. sample without added trypsin). Subsamples (300 |il) of both extract fractions 
were taken at 1-h intervals, frozen immediately and later assayed for trypsin, 
chymotrypsin and elastase using a modification of the standard fluorogenic assay 
(Zimmerman et al., 1977). To determine the effects of ammonium sulphate on elastase 
activity, a sample of 30S was desalted using a PD-10 Sephadex G25 column 
(Pharmacia LKB, Biotechnology Ltd., Uppsala, Sweden ). Further studies were also 
carried out on desalted, concentrated 30S samples. Aliquots of these were activated, as 
above, for different times at 37 °C (4,16, 20, 28, and 44 h), prior to freeze-drying. The 
enzymatic activity of trypsin, chymotrypsin and elastase was determined in 10 mg/ml 
solutions of each freeze-dried sample for the different activation times. A concentrated
desalted 30S sample was activated for 4 h in the presence and absence of calcium
2+  *chloride (30Snc) to determine the effects of Ca ions on the activation/de-activation 
of the endoproteinases. Freeze-dried samples were stored in plastic containers at -20
2.3.4 Pretreatment of Corolase PP preparation
Before hydrolysis of lactalbumin with Corolase PP, aliquots of this preparation 
(10 mg powder/ml) were incubated at 37 °C for different time intervals (4, 16, 28 and 
44 h).
2.3 5 Quantification of enzyme activity
2.3.5.1 Specific activity
Enzyme activities were assayed using a modification of the standard fluorogenic 
assay (Zimmerman et al., 1977). Aqueous solutions of commercial proteases and
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freeze-dried 30S (10 mg powder/ml) in addition to pellets (redissolved to 100 ml) and 
supernatants (brought to 250 ml) from different SAS precipitations were centrifuged at 
13,000 rpm (Microcentaur, MSE Scientific Instruments, West Sussex, U.K.) for 10 
min. Twenty |il of supernatant was added to 980 fil of 0.01 M Tris-HCl buffer, pH 7.0, 
containing 0.02 mM specific substrate. The substrate-enzyme mixture was incubated 
at 37 °C for 1 h. The reaction was stopped by the addition of 1 ml of 1.5 M acetic acid 
and fluorescence was measured on a Perkin Elmer 1000 Spectrofluorimeter 
(Beaconsfield, Bucks, U.K.) at excitation and emission wavelengths of 360 nm and 
440 nm, respectively. Activity units were defined as (amoles AMC/min/mg protein or 
mmoles AMC/min/total volume in each fraction. All enzymatic analysis was carried 
out in duplicate.
2.3.5.2 Total proteolytic activity
We used a modification of a previous method (Garcia de Fernando and Fox,
1991). Ten ml of 0.4 % (w/v) azocasein in 0.02 M Tris/HCl buffer pH 8.0 was added 
to 1 ml enzyme solutions (0.01-1.00 mg/ml i.e., sufficient to establish a linear activity 
response) and incubated at 50 °C for 15 min. The reaction was stopped by adding 2 ml 
12 % (w/v) trichloroacetic acid (TCA) to an equal volume of the reaction mixture. The 
mixture was filtered through Whatman no.40 filter paper and the absorbance at 440 nm 
of the supernatant was measured using a Cary 1/3 UV-VIS Spectrometer (Varian Ltd., 
Mulgrave, Victoria, Australia). One unit of activity was defined as that amount of 
activity which gave a change of 1 absorbance unit at 440 nm/min/mg of enzyme 
preparation. For the ammonium sulphate precipitation experiments, endoproteolytic 
activity in the pellet and supernatants was expressed as a percentage of total activity in 
the starting material, i.e. Sample B,
2.3.6 Preparation of hydrolysates
A 25-ml solution of lactalbumin, 8 % (w/v) protein, was hydrolyzed with 
individual protease preparations at 50 °C, pH 8.0, for 240 min. The pH was 
maintained constant by continuous addition of 0.5 M NaOH using a pH-stat (Metrohm 
Ltd., Herisau, Switzerland). The degree of hydrolysis (DH, %), defined as the
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percentage of peptide bonds cleaved, was calculated from the volume and molarity of 
NaOH used to maintain constant pH (Adler-Nissen, 1986 ). Following hydrolysis, 
proteases were inactivated by heating at 80 °C for 30 min, hydrolysates were then 
cooled and stored at -20°C for further analysis. The DH was calculated as follows:
DH, % = B x Mb x 1/a x 1/MP x l/htot x 100 
where B = volume of NaOH consumed (ml); Mb = Molarity of NaOH ; a=average 
degree of dissociation of the a-NH2 groups at pH 8.0 and 50 °C; MP = mass of protein 
(g); htot = total number of peptide bonds in the protein substrate (mequiv/g protein). 
The htot value, 8.8 mequiv/g for whey protein, and values of 1/a for various pH- 
temperature combinations were those given by Adler-Nissen (1986). The enzyme-to- 
substrate ratio (E:S) for lactalbumin hydrolysis experiments was calculated on the basis 
of (1) weight of enzyme preparation to weight of protein in the substrate, (2) total 
proteolytic activity units in the enzymatic preparation to weight of protein in the 
substrate, (3) tryptic activity (jimoles AMC/min/mg protein) in enzyme preparation to 
weight of protein in the substrate, or (4) protein in enzyme preparation to weight of 
protein in the substrate (Table 3).
2.3.7 Characterisation of hydrolysates
All protein analysis, molecular size distribution and amino acid analyses were 
carried out in duplicate.
2.3.7.1 Protein (nitrogen) determination
Total protein (N x 6.25) of pancreatic preparations and of whey protein (N x 
6.38) was determined by the micro-Kjeldahl method (AOAC, 1980).
2.3.7.2 Molecular size distribution of peptides in lactalbumin hydrolysates
A fast protein liquid chromatograph (FPLC) fitted with a Superose 12 gel 
permeation column (Pharmacia LKB Biotechnology Ltd., Uppsala, Sweden.) was used 
to monitor the size distribution of peptides in lactalbumin hydrolysates. The column 
was eluted at 1 ml/min using 0.1 M Tris-HCl buffer, pH 7.0, containing 0.1 M NaCl 
and 10 % (v/v) methanol. Hydrolysates were diluted in elution buffer to 0.25 % (w/v)
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protein, filtered through a Whatman 0.45 (om PS syringe filter and 100 (al was applied 
to the column in duplicate. Eluate was continually monitored at 214 or 280 nm using
two single-path monitors (UV-1, Pharmacia) and data were recorded using a
(£) •Minichrom data handling system (VG, Data Systems, Altrincham, Cheshire, U.K.).
A molecular weight calibration curve was prepared from the average retention volumes
(Rv) of standard proteins and peptides.
2.3.7.3 Free amino acid analysis of hydrolysates
Hydrolysates were deproteinized by mixing equal volumes of 24 % (w/v) TCA 
with sample and holding at room temperature for 30 min before centrifuging at 14,400 
x g (Microcentaur, MSE Scientific Instruments, Crawley, West Sussex, U.K.) for 10 
min. Supernatants were removed and diluted with 0.2 M sodium citrate buffer, pH 2.2, 
to give «25 nmoles of each amino acid residue per 50 jfl injection volume. Amino 
acids were analyzed on a 12 cm x 4 mm cation exchange column (Na+ form) using a 
Beckman 6300 amino acid analyzer (Beckman Instruments Ltd., High Wycombe, 
U.K.). Standard amino acids were used to calibrate the analyzer.
2.4 Results and Discussion
Although porcine trypsin is more thermostable than bovine trypsin (Lazdunski 
and Delaage, 1965), both are subject to autolysis. Porcine trypsin is denatured at 55 
°C, but it has been shown that, in the presence of whey protein as substrate, that the 
enzyme retains >70 % activity after 1 h at 55 °C (Buck et al., 1962; Jost and Monti, 
1977). Trypsin is important, not only for its intrinsic activity but also in its activation 
of the other zymogens in the pancreas (Desnuelle and Rovery, 1961; Peanasky et al., 
1969) and control of its activation can determine the extent of hydrolysis by the 
pancreatic proteases. Chymotrypsin and elastase can also act as substrates for 
themselves and for each other. In addition, each pancreatic proteinase can again have 
different active forms which relates to the activation procedure employed (Wilcox, 
1970; Puigserver et al., 1986; Vestling et al., 1990; Guasch et al., 1992; Martinez et 
al., 1981). With a selected ratio of endoproteolytic activities during the activation
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process, in the presence of substrate, (i.e., whey protein) such activities can be 
stabilised as the protein substrate will act as a protective agent (Jost and Monti, 1977).
2.4.1 Ammonium sulphate fractionation of pancreatic endoproteinases
At 35 % SAS almost 90 % trypsin, 20 % chymotrypsin and > 40 % elastase 
original activities remain in solution (Table 1). Preliminary experiments showed that 
only proteolytic solutions with conductivity values less than that corresponding to a 1 
% ammonium sulfate solution would lreeze-dry efficiently. The recovery of freeze- 
dried 3 OS proteolytic preparation was ~ 84g/kg of pancreatic tissue. Trypsin activity 
was used as an index of activation. When the 30S preparation (10 mg/ml powder) was 
activated for 4 h, it had 24 times less trypsin activity (famoles/min/mg protein) than the 
commercial preparation PTN 3.0S (50.4 jamoles/min/mg protein).
2.4.2 Activation of pancreatic zymogens
The stability of trypsin, chymotrypsin and elastase, in addition to possible 
exopeptidase activities, appeared to be dependent on the duration of the activation 
procedure and factors such as storage conditions of the active product. Storage of the 
zymogen form of any of the proteolytic mixtures in 0.01 M Tris-HCl buffer, pH 7.0, 
containing 100 mM CaCl2 for 2 days at 4 °C resulted in an increase in trypsin and 
chymotrypsin activity. However, after incubation at 4 °C over 5-6 days in the same 
buffer, a decrease in activity of these enzymes was observed. Activation of both 
trypsinogen and chymotrypsinogen appeared to be enhanced following freezing and 
thawing at -20 °C. Possibly freeze-thaw action may disrupt cells/granules resulting in 
release of zymogen form which is then activated or, alternatively, freezing may favour 
the formation of a specific optical rotatory form which would speed up the activation 
process (Walsh, 1970; Keil, 1971). We observed that holding extract fraction solutions 
at 37 °C for 24 h resulted in decreased activity for elastase and chymotrypsin.
In our study, the activation of porcine proteolytic preparations was not dependent 
on the provision of Ca ions. The activation effect of calcium is less pronounced m 
porcine trypsin then in bovine trypsin (Lazdunski and Delaage, 1965; Abita et al., 
1969). Interestingly, 30S preparation activated in the absence of calcium (30Snc) had a
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slightly higher DH value at 240 min than the sample activated with these cations 
(Table 2), though the lactalbumin hydrolysis curves were similar (Figure 2). The 
30Snc also produced a hydrolysate with more peptides in the < 570 Da molecular 
mass range. Though trypsin activity levels in both preparations were the same, 
inclusion of Ca ions in the activation process may influence the formation of certain 
types of active enzyme products (Abita eta/., 1969; Smith and Shaw, 1969; Vestling et 
al., 1990).
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Table 1: Activity3 of trypsin, chymotrypsin and 
elastase in supernatants of ammonium sulphate 
purification fractions, expressed as percentage of 
total activity in the starting material (Sample B).
T o ta l  activity (% )
Purification
Fractions Trypsin Chymotrypsin Elastase
Sample B 100.00 100.00 100.00
20S b 70.30 66.70
30S 95.00 33.70 37.80
3 OS (desalted) - - 37.60
35S 87.70 20.00 41.70
40S 73.60 19.70 0.00
30PC - - 47.40
a using fluorogenic assays as described in Materials 
and methods; 
b not determined; 
c P refers to pellet fraction.
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Table 2: Total proteolytic activity, final DH (after 240 min), and E:S ratio for lactalbumin hydrolysis 
experiments using commercial pancreatic preparations, pretreated Corolase PP and pancreatic 
extracts after different activation times.
Proteolytic samples Total proteolytic activity 
(units/min/mg preparation)
Activation time 
00
Pretreatment time
(h)
E:S ratio3 Final DH
(%)
PTN3.0S 0.16 - 0 * c 8.83
PEM2500S 0.90 - 0 * 8.57
CorolasePP 0.15 - 0 * 13.83
CorolasePP - - 4 0.02 13.11
CorolasePP - - 16 0.02 10.73
CorolasePP - - 28 0.02 9.82
CorolasePP • - 44 0.02 6.08
Pancreatic extracts
Sample B - 4 0 0.20 4.09
30S nc b - 4 0 0.02 6.31
30S - 4 0 0.02 5.81
30S - 16 0 0.02 8.44
30S - 28 0 0.02 7.47
30S - 44 0 0.02 7.61
* E:S ratio calculated on the basis o f weight o f preparation to protein in the substrate. 
b 30S nc - preparation activated in the absence o f calcium ions
c E:S ratio was on the basis o f  total proteolytic activity units to protein in the substrate (i.e. 0.16 Azocasein units/g protein).
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Figure 1: Specific activity of trypsin 0  , chymotrypsin  ° ......
and e l a s t a s e o - - - , using fluorogenic substrates (pmoles AMC/min/mg 
protein) in the extraction fractions, Sample B (a) and the dilute form of 30S (b) 
over time at pH 7.0 and 37 °C.
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Activation of pancreatic proteinases was independent of exogenous trypsin 
addition. However, activation was slower if not initiated by trypsin, as shown 
previously (Desnuelle and Rovery, 1961). During activation, time-dependent changes 
occurred in the ratios of pancreatic endoproteinases in Sample B and 30S during 37 °C 
incubation (Figure 1 (a) and (b)). Each proteinase activity reached a maximum at a 
different times. In sample B, trypsin activity started to increase in a linear fashion after 
300 min incubation, reaching a maximal activity after 1220 min incubation. In the 
absence of exogenous trypsin, however, this was delayed by 125 min. In sample B, the 
ratio of trypsin to chymo trypsin and elastase after 1220 min incubation was in the order 
of 17:740:1 (jmole AMC/min/mg protein. After that time, the trypsin activity began to 
decrease. Chymotrypsin activity reached a maximum after 240 min after which the 
activity started to decrease reaching 149,235 |imoles /min/mg protein at 1225 min. 
Elastase activity appeared to remain constant after 245 min. The activity of the 
endoproteinases differed greatly in the dilute solution of SAS, i.e. 30S (Figure 1 (b)) 
from that in the crude sample B (Figure 1 (a)). Trypsin activity increased and reached 
a maximum at ~ 650 units after 600 min and remained stable close to this level over an 
extended period. Chymotrypsin activity was very unstable during 37 °C activation of 
the 3 OS fraction. The activity decreased rapidly from the beginning of the process. 
After 600 min the endoproteinase activity ratios were as follows: trypsin : 
chymotrypsin : elastase (625 : 38,000 : 1). Minimal elastase activity was detected.
Chymotrypsin and elastase appeared to autolyse or deactivate at a faster rate than 
trypsin (Figure 1 (b)) The low levels of elatase (Figure 1 (b)) could be attributed to 
dilution of stabilizing influences which may prevent autolysis. Ammonium sulphate 
and other salts are known to inactivate elastase activity (Lewis et al., 1959; Lamy et 
al., 1961; Gertler and Birk, 1970). In our study, removal of ammonium sulphate by 
desalting had no effect on elastase activity (Table 1); however, deactivation of elastase 
activity may have occurred prior to desalting.
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Figure 2: Time course hydrolysis of lactalbumin by extraction fraction Sample B and 30S, at different 
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substrate conc; E:S (as in Table 2), pH 8.0, 50 °C.
Time (mm)
A concentrated, desalted 30S fraction was used for further study on the effects of 
activation time on endoproteolytic activities. By extension of activation time, the 
ratios of endoproteinases was changed (Figure 1 and Table 3). Furthermore, the 
hydrolysis curves (Figure 2) and the products (Table 4 and 5) from these proteolytic 
preparations used in the hydrolysis of lactalbumin were different for each activation 
time (Table 4).
2.4.3 Characterisation of Lactalbumin hydrolysates
2.4.3.1 Final percentage degrees of hydrolysis and molecular distribution
The hydrolysis curves obtained on incubation of lactalbumin with sample B 
(Figure 2) were compared with those using concentrated desalted and activated 30S 
freeze-dried preparations (Figure 2) and commercial proteases (Figure 3 and 4) under 
different conditions. The molecular weight distribution data (Table 4) are averages for 
two elutions of a given hydrolysate. Peak areas for a specific molecular weight range 
were expressed as percentage of total peak area obtained at 280 nm.
The 30S extract had more activity on lactalbumin than sample B as seen from the 
higher degree of hydrolysis obtained after incubation for 240 min (Figure 2 and Table 
2). Sample B hydrolysate showed a low DH value after 240 min as compared to 30S. 
However, the E:S ratio for sample B used in hydrolysis was calculated on the basis of 
protein, whereas the other preparations were used on the basis of weight of powder. 
Sample B hydrolysates displayed large peak areas corresponding to peptides within the 
molecular mass ranges of 13, 300-570 Da (28.3 %). Less material was produced in the 
< 570 Da region. In comparison to the cruder Sample B profile, the 30Snc activated 
for 4 h showed a reduction in peak area in the 13, 000-570 Da range and an increase in 
peak area corresponding to < 570 Da region. The peptide distributions for 30S and 
30Snc were different. Considerably less peptides occurred in the 13,000-570 Da 
molecular mass region for 30Snc than for 30S.
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Table 3: Proteolytic activity (jxmoles 
A M C / m i n / m g  protein) after different activation 
times for concentrated, desalted 30S 
preparation.
Trypsin Chymotrypsin Elastase
Activation time
nmoles AMC/min/mg protein
o a - - -
4 2.10 879.63 0.30
16 39.90 1008.23 0.41
28 52.80 1440.33 0.51
44 84.90 1152.26 0.31
a In absence of activation, no endoproteolytic activity was 
detected.
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Table 4: Molecular weight distribution (%)* o f protein components in lactalbumin hydrolysates 
prepared using commcercial pancreatic protease preparations and pancreatic extracts activated for 
different times, E:S ratio as given in Table 2.
Molecular mass (Da) 
29,200-13,300 13,300-570 <570
Commercial preparation Pretreatment time
(h)
Corolase PP 0 0.26 ± 0.07b 6.98 ± 0.67 92.90 ± 0.12
Corolase PP 4 0.68 ± 0.29 17.75 ± 0.10 81.52 ± 0.09
Corolase PP 16 0.94 ± 0.05 21.79 ± 0.36 77.10 ± 0.20
Corolase PP 28 0.58 ± 0.36 24.88 ± 0.03 74.40 ± 0.09
Corolase PP 44 0.38 ± 0.00 32.54 ± 0.14 67.10 ± 0.82
PTN 3.0S 0 0.01 ± 0.01 25.00 ± 1.42 75.01 ± 0.20
PEM 2500S 0 0.00 ± 0.00 23.46 ± 0.22 76.43 ± 0.22
Pancreatic extracts Activation time
(h)
Sample B 4 0.01 ± 0.01 28.32 ± 0.53 76.13 ± 2.16
30S nc c 4 0.01 ± 0.01 15.70 ± 0.01 83.92 ± 0.03
30S TP A 4 0.04 ± 0.01 1.45 ± 0.12 98.12 ± 0.05
30S 4 0.00 ± 0.00 26.95 ± 0.30 72.77 ± 0.11
30S 16 0.00 ± 0.00 22.52 ± 0.16 77.18 ± 0.33
30S 28 0.05 ± 0.05 20.21 ± 0.83 79.75 ± 0.22
30S 44 0.00 ± 0.05 10.01 ± 0.09 89.99 ± 0.56
* Integrated peak areas between defined elution volumes corresponding to particular molecular weight distribution was 
calculated using Minichrom.
b Mean value from 2 repetitions +/- standard deviation 
c Proteolytic extract activated in the absence o f  calcium ions.
F igure  3: T im e  course  hydro lysis  of lac ta lbum in  by C oro lase  PP p rep a ra t io n s  p re t rea ted  at different times; 0 h 
—□—  ; 4 h--£r-;16 h -*-o—  ; 28 h -0 -- ; 44 h — fB— (indicated  in T a b le  2). Reaction conditions: 8 %  (>v/v)
su b s tra te  conc; E:S (as in T a b le  2), pH  8.0, 50 °C.
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Figure 4: Time course hydrolysis of lactalbumin by commercial preparations without pretreatmcnt Corolase PP
Time (min)
We studied different activation times as a means of producing a specific ratio of 
endoproteinases. Hydrolysates produced using these preparations revealed significant 
changes in molecular characteristics, i.e. with respect to DH (Figure 2), molecular 
weight distribution of peptides (Table 4), and levels of free amino acids generated 
(Table 5). As activation time was increased the final DH value increased up to 16 h 
(Table 2). At longer activation times, i.e. 28 and 44 h, the final DH value was 
decreased. When the 30S activation times were increased, i.e., 16, 28 and 44 h, a 
corresponding increase in hydrolytic activity occurred (Table 3). Note the small 
reduction of peak area within the 13,300-570 Da range (Table 4). The high final DH 
value of 30S (16h) was apparently contradictory to other data (Table 4). The 
preparations 3 OS (28 h) and 3 OS (44 h), which had lower final % DH values, had 
higher hydrolytic activity in the 13,300-570 Da range. This may indicate the formation 
of different active forms of proteinases during activation of those preparations 
(Vestling et al., 1990).
Similarities occurred between 30S (16 h), PEM 2500S and PTN 3.OS as seen 
from the molecular weight profiles of peptides and hydrolysis curves produced by 
those preparations (Table 4, Figure 2 and 4, respectively). This may be due to the 
presence of two main endoproteolytic activities, i.e. trypsin and chymotrypsin, in 30S 
(16 h) (Table 3), in PEM 2500S and PTN 3.OS (Mullally et al., 1994). This was 
confirmed by the low concentrations of free amino acids in hydrolysates produced by 
those preparations (Table 5 and 6). PEM 2500S and PTN 3.0S appeared to have 
similar activity against lactalbumin (Figure 4) on the basis of total proteolytic activity 
(Table 2). The curves for the treatment of lactalbumin by PTN 3.OS and PEM 2500S 
began to plateau after 40-50 min, while the DH values after 240 min were 8.83 and 
8.57 %, respectively. The 30S purification sample was presumably approaching the 
ratios of proteinases in commercial preparations when the zymogen activation time 
was increased to 16 h, (as indicated by very similar final DH values). The final DH 
value of 30S sample activated for 16 h was 8.44 % (Table 2).
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Table 5: Free amino acids (mg/g protein) in lactalbumin hydro lysates 
prepared using pancreatic extracts activated for different times.
Amino acid Sample B 30S nc b 30S 30S 30S 30S
4
Activation time (h)
4 4 16 28 44
Asp a - - - - -
Thr - - - - - -
Ser - - - - 0.15
Glu - - - - - -
Pro - - - - - -
Gly - - - - - -
Ala 0.36 0.36 0.34 0.35 0.37 0.32
Met - - - - - -
Val - - - - 0.10 -
lie - - - - - -
Leu - - - 0.13 0.14 0.08
Tyr - - - - - -
Phe - - - - - -
His - - - - - -
Lys - - - 1.20 0.59 0.86
Trp - - - - - -
Arg - - - - - -
a not detected;b 30S nc = 30S preparation activated without calcium ions
Table 6: Free amino acids (mg/g protein) in lactalbumin hydrolysates prepared
using commercial preparations and pretreated Corolase PP
Amino acid PTN 3.0S PEM 2500S Corolase PP
0
Pretreatment time (h)
4 16 28 44
Asp a - 0.47 0.43 0.37 0.33 0.23
Thr - - 1.08 1.01 0.58 0.49 0.29
Ser - - 1.86 2.21 1.18 1.04 0.63
Glu - - - 0.02 0.12 0.10 -
Pro - - - - - - -
Gly - - - - 0.22 0.26 -
Ala 0.29 0.29 1.44 1.12 0.84 0.85 0.70
Met - - 3.19 30.70 1.87 1.73 0.58
Val - - 9.12 7.85 4.56 4.01 3.26
lie - - 4.86 4.38 2.69 2.50 1.31
Leu 0.49 0.47 24.37 19.99 11.75 10.28 6.06
Tyr - - 15.91 14.26 10.24 9.11 5.75
Phe - - 12.04 10.83 8.73 7.91 5.94
His - - 2.06 1.66 1.17 0.99 1.00
Lys 6.36 4.30 36.84 32.37 21.42 17.44 10.07
Trp - - - - - - -
Arg 0.12 3.16. 13.79 12.33 9.47 6.19 6.19
a not detected
Pretreatment of a solution (10 mg/ml) of commercial protease preparation 
(Corolase PP) by holding at 37 °C, prior to hydrolysis of lactalbumin, showed that, as 
time of preatreatment increased, the degree of hydrolysis decreased (Table 2). 
Increasing holding times had a progressively negative effect on initial rates of 
hydrolysis and final DH values after 240 min incubation. Material correspoinding to 
the 13,300-570 Da and < 570 Da molecular weight region was hydrolysed to a lesser 
extent with increasing holding times (Table 4). For 16, 28, and 44 h samples a 
decrease occurred in areas corresponding to low-molecular-weight peptides as holding 
time was extended.
2.4.3.2 Production of free amino acids
The concentrations of amino acids in free solution following incubation of 
lactalbumin with pancreatic extracts and commercial preparations were compared 
(Tables 5 and 6). Concentrations < 0.006 (mg/g) were not included. All preparations 
produced hydrolysates which contained alanine in free solution. Both sample B and 
30S activated for 4h produced hydrolysates which only had alanine free in solution.
There was no difference in the hydrolysate produced by the 3 OS preparation activated
2+for 4h in the presence and absence of Ca ions (Table 5). All enzyme preparations 
when applied to lactalbumin hydrolysis on the basis of total proteolytic activity, 
produced hydrolysates deficient in glutamic acid and glycine. All hydrolysates 
contained leucine, with exception of that produced by 30S, activated for 4 h and 16 h,
2_j_
30S activated in the absence of Ca ions and Sample B. As the time of activation of 
zymogen forms of 3 OS preparation was increased, several additional free amino acids 
are released into the hydrolysates, especially lysine and leucine. The hydrolysates 
produced by Corolase PP contained the following amino acids: lysine > leucine > 
tyrosine > arginine > phenylalanine > valine > isoleucine > methionine > serine > 
histidine > alanine > threonine. The concentration of each amino acid was reduced 
with increasing pretreatment time of the Corolase PP preparation, although the levels 
of each appeared to remain in proportion (Table 6). The analysis of free amino acids in 
the hydrolysates of Corolase PP and 3 OS preparations revealed significant differences. 
The low levels of free amino acids in hydrolysates produced by 3 OS indicated an
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absence of exopeptidase activity contrary to levels known to be present in Corolase PP 
(Mullally et al., 1994). Corolase PP also has elastase activity and low levels of this 
activity in 3 OS may have contributed to similarities between preparations with respect 
to shape of DH curves (Figure 2 and 3).
Different published extraction procedures have been used for purification of 
individual pancreatic proteinases. Acidic extraction has been used in the initial step for 
trypsin and chymotrypsin recovery, whereas acetone powder extraction is used in 
protocols for elastase, carboxypeptidase and exopeptidase recovery (Northrop et al., 
1948; Laskowski, 1956; Lewis et al., 1959; Folk and Schirmer, 1963). In our study 
proteolytic preparations Sample B and 30S were prepared using an intial acid 
extraction step. This may have destroyed exopeptidase activities and certain 
endoproteinase activities. Porcine chymotrypsin B and C are acid-labile (Folk, 1970a).
Incubation of elastase at very low pH values for extended times deactivated the 
enzyme (Lewis et al., 1956). This would, therefore, explain the absence of most of the 
free amino acids in the hydrolysates and the extremely low levels of amino acids, such 
as alanine. Levels of carboxypeptidases are higher in porcine tissues (Desnuelle and 
Rovery, 1961), although carboxypeptidase B is subject to de-activation at very low pH 
values and, therefore, the purification procedure employed would not be suitable for its 
isolation. All these factors considered, it is unlikely that exopeptidase activity was 
prominent in the 3 OS preparation.
2.5 Conclusion
The ratio of proteinases in a pancreatic enzyme preparation was related not only 
to the degree of purification or source of pancreatic tissue but also to the activation 
procedure employed. Unless an extensive purification protocol involving 
chromatographic procedures is employed, it seems unlikely that a precise ratio of 
endoproteinases (trypsin, chymotrypsin and elastase) could be maintained. Zymogen 
activation alone, however, can control the ratio of proteinases present in an enzymatic 
preparation, and thus the physicochemical properties of any resultant whey protein 
hydrolysate. During the hydrolysis of proteins, if a number of enzymatic actvities
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work in conjunction with one another, the resulting hydrolysates differ. Properties of 
hydrolysates are dependent on several factors, such as the number and ratio of 
proteases, enyme specificity, enzyme stability, and, possibly auto-digestion. To find a 
desirable ratio of endoproteinases within a proteolytic preparation, a compromise 
between activation and de-activation must be found.
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CHAPTER 3
Synthetic peptides corresponding to a-lactalbumin and 
P-lactoglobulin sequences with angiotensin-I-converting 
enzyme inhibitory activity1
1 This chapter was prepared for submission as a short communication
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3.1 S u m m a r y
Novel angiotensin I converting enzyme (ACE) inhibitory activities were 
detected for p-lactoglobulin and a-lactalbumin derived synthetic peptide 
sequences which are known to possess opioid activity. Using hippuryl-histidyl- 
leucine as substrate, the tetrapeptides P-lactorphin (Tyr-Leu-Leu-Phe), a- 
lactorphin (Tyr-Gly-Leu-Phe) and p-lactotensin (His-Ile-Arg-Leu) were shown to 
have IC50 values of 171.8, 733.3 and 1153.2 fimol/1 respectively. Related 
dipeptides also inhibited ACE with Tyr-Leu being the most potent, having an 
IC50 value of 122.1 ja mol/1.
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3.2 Introduction
Angiotensin-I-converting enzyme (ACE; peptidyldipeptide hydrolase EC 
3.4.15.1) is a dipeptide-liberating exopeptidase which has been classically 
associated with the renin-angiotensin system regulating peripheral blood 
pressure. ACE which removes the two amino acids from the C-terminus of 
angiotensin I to form angiotensin II, a very hypertensive compound, is inhibited 
by certain peptides. Several endogenous peptides such as enkephalins, (3- 
endorphin, substance P and ACTH are reported to be competitive substrates and 
inhibitors of ACE. In addition, several food derived peptides inhibit ACE 
(Ariyoshi, 1993; Meisel, 1993b). Inhibition of ACE may exert an 
antihypertensive effect as a consequence of the decrease in angiotensin II activity 
and the concomitant increase in bradykinin activities. Sekiya et al. (1992) 
reported a significant reduction in blood pressure in human volunteers with mild 
hypertension following oral intake of a tryptic casein hydrolysate.
Several casein derived ACE inhibitory peptides having other biological 
activities have been reported (Meisel and Schlimme, 1994). For instance, it has 
been shown that the casein derived opioid peptide, p-casomorphin-7, also inhibits 
ACE (Meisel and Schlimme, 1994). A multifunctional bioactive peptide, 
albutensin A, derived from bovine serum albumin f(208-216), displaying ileum 
contracting and relaxing activities in addition to ACE inhibitory activity has been 
characterised (Chiba and Yoshikawa, 1991). To date, there appears to be no 
evidence in the literature to suggest that ACE inhibitory peptides have been 
found in the sequences of the major whey proteins i.e. p-lactoglobulin and a- 
lactalbumin. In this study we show that bioactive peptide sequences derived from 
bovine B-lg and a-la can act as inhibitors of ACE.
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3.3 Materials and Methods
The tetrapeptides, i.e. Tyr-Leu-Leu-Phe, Tyr-Gly-Leu-Phe and His-Ile-Arg- 
Leu were synthesised using Fmoc solid phase synthesis by Bioresearch Ireland 
University College Cork, Ireland. Mass spectroscopy was used to confirm the 
purity of these tetrapeptides (Biochemistry Department, University of Nottingham, 
UK.). Dipeptides were obtained from Bachem (Bubendorf, Switzerland). All other 
reagents were of analytical grade unless otherwise specified.
3.3.1 Characterisation of ACE inhibition
The assay system used was the standard spectrophotometric assay of 
Cushman and Cheung, (1971), using rabbit lung tissue as source of ACE, and is 
based on the liberation of hippuric acid by ACE from hippuryl-histidyl-leucine. 
Analyses were carried out by Dr. Meisel at the Institut fur Chemie und Physik, 
Bundesanstalt fur Milchforschung, Keil, Germany. The IC50 values were 
determined using different dilutions of the solubilised peptides to obtain distinct 
molar concentrations.
3.4 Results and Discussion
The ACE inhibitory activities (IC50 values) of tetra- and dipeptides 
corresponding to different whey protein sequences are given in Table 1. The IC50 
values obtained for bradykinin potentiator B and Captopril are in accordance with 
those reported by Maruyama et al. (1985) and Wyvratt and Patchett, (1985), 
respectively. It has been suggested that peptides which contain hydrophobic amino 
acids at each of the three C-terminal positions are potent ACE inhibitors (Cheung et 
al., 1980; Saito et al., 1994). From Table 1 it is seen that the tetrapeptide IC50 
values appear to reflect this observation i.e. B-lactorphin (IC50 = 171.8 (J.mol/1) > 
a-lactorphin (IC50 = 733.3 fimol/1) > B-lactotensin (IC50 = 1153.2 pmol/l). The 
synthetic tetrapeptides in our study corresponding with sequences actually found in 
whey protein hydrolysates have certain bioactive properties. For example, B- 
lactorphin and a-lactorphin possess opioid activity (Antila et al., 1991).
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Table 1: A C E  inhibitory activity of fi-lactorphin, a-lactorphin, fi-lactotensin 
and related peptides.
Peptide sequence Name IC so (pmol/l)a
Tetrapeptides
Tyr-Leu-Leu-Phe ß-Lactorphin (ß-lg (fl02-105))b 171.8
Tyr-Gly-Leu-Phe a-Lactorphin (a-la (f50-53))c 733.3
His-Ile-Arg-Leu ß-Lactotensin (ß-lg (fl46-149)) 1153.2
Dipeptides
Tyr-Leu - 122.1
Leu-Phe - 349.1
Tyr-Gly - 1522.6
Ile-Arg - 695.5
Arg-Leu - 2438.9
Controls
- Captopril 0.006
- Bradykinin Potentiator B 3.2
a IC 5 0  is defined as that amount o f peptide which causes 50 % inhibition o f ACE using 
hippuryl-histidyl-leucine as substrate. b (3-lg; (3-lactoglobulin.c a-la; a-lactalbumin
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Not surprisingly, it has been observed that C-terminal dipeptides are 
generally the more potent fragment of ACE inhibitory peptides (Cheung et al., 
1980). The results obtained using dipeptides indicate that the nature of the amino 
acids and not necessarily peptide size has an effect on ACE inhibitory potency. 
The Tyr-Leu dipeptide, a peptide related to B-lactorphin (Tyr-Leu-Leu-Phe), was 
more potent (IC50= 122.1(imol/l) than the original tetrapeptide (IC50 = 171.8 
|imol/l). However, another related peptide i.e. Leu-Phe had a potency (IC50 =
349.1 p,mol/l) which was lower than B-lactorphin (Table 1). It was interesting to 
note that the substitution of Leu with Gly weakens the inhibitory potency i.e. Tyr- 
Gly has a higher IC50 value than Tyr-Leu (Table 1). However, for the (3-lactotensin 
related peptides, Ile-Arg (IC50 = 695.5 (_imol/l) was more potent than Arg-Leu (IC50 
= 2438.9 jjmol/1). Structure-activity data indeed suggest that a positive charge, as 
on the guanidino group of the C-terminal Arg, contribute substantially to the ACE 
inhibitory activity of several peptides (Meisel, 1993b). Perhaps the penultimate C- 
terminal amino acid, in combination with the C-terminal residue has a strong 
influence on the potency of ACE inhibitory peptides.
It should be noted that peptides derived from food proteins may not have 
the potency of Captopril (D-3-mercapto-2-methylpropanoyl-l-proline; IC50 < 0.03 
(imol/l), a drug commonly used in the treatment of hypertension (Wyvratt and 
Patchett, 1985). However, should peptides derived from whey proteins be shown 
to have significant physiological effects as is the case for tryptic casein 
hydrolysates (Sekiya et al, 1992), their use in the prevention of hypertension could 
be favoured since they are naturally derived. Food derived peptides with a potency 
within the IC50 100-500 pmol/1 range are reported to be of nutritive/physiological 
importance in that they could be active following oral administration (Sekiya et al.,
1992). A nutraceutical is any substance that is a food or part of a food and provides 
medical or health benefits, including the prevention and treatment of disease 
(DeFelice, 1995). Accordingly, the ACE-inhibitory peptides derived from food 
proteins, such as bovine whey proteins, represent potential nutraceuticals and may 
be useful ingredients in functional foods for the prevention of hypertension.
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CHAPTER 4
Angiotensin I converting enzyme inhibitory activities derived 
from whey proteins following hydrolysis with gastric and
pancreatic enzymes.
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4.1 Summary
There is a strict requirement for enzymatic hydrolysis in the production of 
angiotensin I converting enzyme (ACE) inhibitory activity from whey proteins. 
Several whey protein hydrolysates were examined for ACE inhibitory activity. Heat 
treatment of WPC, a-lactalbumin (a-la) and |3-lactoglobulin (P-lg) fractions resulted in 
higher degrees of hydrolysis after 240 min with gastric and pancreatic enzymes. 
However, the corresponding indices of ACE inhibition for the hydrolysates from the 
native and heat-treated proteins did not differ greatly. A tryptic hydrolysate of (3-lg 
was fractionated using solid phase extraction and acetonitrile elution fractions with 
highest indices of ACE inhibition were further characterised. Mass spectrometry of 
three acetonitrile elutions showed peptide sequences worthy of further study. One of 
these peptides (Ala-Leu-Pro-Met-His-Ile-Arg) was synthesised. This peptide, 
corresponding to a tryptic fragment of (3-lg, appeared to be resistant to further 
hydrolysis by pepsin and had an IC50 value of 42.6 (imol/1. This peptide was shown to 
be a more potent ACE inhibitor than p-lactotensin and two other related peptides 
examined in a previous study. Enzyme specificity was shown to be more important 
than percentage degree of hydrolysis in the production of ACE inhibitory peptides. 
This study shows that angiotensin I converting enzyme inhibitors can be obtained from 
natural sources, such as whey protein, and as a consequence may have the potential for 
use in physiological functional foods.
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4.2 Introduction
Milk proteins and in particular whey proteins are well recognised for their 
nutritional properties and for the provision of dietary amino acids (Hambraeus, 1982). 
However, peptide fragments of milk proteins resulting from the action of the digestive 
tract proteinases function not only as a source of amino acids, but also as potential 
physiological regulators (Maubois and Leonil, 1989). There are numerous bioactive 
peptides which exist in an inactive form within the amino acid sequence of milk 
proteins. These regulatory peptides can be released during in vitro hydrolysis of milk 
proteins and also in vivo by gastric and/or pancreatic enzymes. The significance of 
milk protein derived oligopeptides in biological regulation suggests an important 
physiological role for milk proteins. These include peptides with opioid agonist and 
antagonist activity (Teschemacher and Scheffler, 1992; Tani et al, 1994; Pihlanto- 
Leppala et al., 1994a, b), immunostimulating activity (Fiat et al, 1993), anti-thrombic 
activity (Chabance et al, 1995), mineral binding activity and growth stimulating 
activity (Sato et al., 1991; Bouhallab et al., 1993). Currently, the majority of milk 
protein derived bioactive peptides originate from the caseins. However, some whey 
protein derived bioactive peptides have been described. For example, combinations of 
pepsin with trypsin or chymotrypsin have previously been used to produce in vitro 
opioid peptides from a-la and (3-lg (Antila et al., 1991). Furthermore, a vasorelaxing 
tetrapeptide from P-lg, designated (3-lactotensin was produced in vitro using 
chymotrypsin or a combination of pepsin and chymotrypsin (Pihlanto-Leppala et al., 
1994a, b). The structure and physiological nature of milk protein derived bioactive 
peptides has been reviewed (Fiat et al., 1993; Schlimme and Meisel, 1993; Shimizu, 
1994).
Angiotensin-I-converting enzyme (ACE) is a dipeptide-liberating exopeptidase 
(peptidyldipeptide hydrolase EC 3.4.15.1) which has been classically associated with 
the renin-angiotensin system regulating peripheral blood pressure. The enzyme can 
raise blood pressure by converting angiotensin I (a decapeptide) to the potent 
vasoconstrictor angiotensin II (an octapeptide). Angiotensin II reduces peripheral 
blood flow and thereby decreases the renal excretion of fluid and salts. ACE is a
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multifunctional enzyme (Figure 1) which also catalyses the degradation o f  bradykinin, 
(a vasodilating nonapeptide) and enkephalins (Aoki et al, 1984). Several endogenous 
peptides such as enkephalins, p-endorphin, substance P and ACTH were reported to be 
substrates and inhibitors o f  ACE (Maruyama et al., 1987a). Therefore, inhibition o f  
ACE decreases the activity o f  angiotensin II but increases bradykinin and enkephalin 
levels, thus lowering blood pressure in humans and animals (Ondetti et al., 1977; 
Koike et al., 1980). Consequently, ACE inhibitory peptides may exert 
antihypertensive and immunostimulating effects (Migliore-Samour et al., 1989) and 
may increase neurotransmitter activity (Figure 1).
I mmune- S ystem 
I mmunocyi es
R enlrvA nglotensln-Syslem
aj-Gtobuftvlraciion
l mmunopept*des]  — ¡
I—  I-  - I—  - I ¡
Angiolensinogen
A sp  A rg  V a l-Tyr-H e-H is-P ro  P he  H>s L eu  
A n g io te n s in  I
ly m p h o c y te s  m ig ra tion  
Lymphocytes secretion 
Macrophages stimulation
Nervous-System
0-Lipotropin
Neuroiransmitiei
K iM kreJn-KlnJn-Syitem
í^-Gto&utin-íraction
Kinínogen
Asp-P ro -P ro -G ly  P he  S er-P ro -P he -A rg  
—  —  —  — B radyk in in—  —  — J va sod ila tion ]
L  _  Tyr G iy  G iy Phe M et mact»ve degradation  
E nkepha lm  i  p roducts
4 —  _  A n g io te n s in  C o n v e o n g -E n z y m e  (A C E ) —  — * — -----------------   ►—
4
Asp-Arg-Val-Tyr-He-His-Pro-Phe I
Angiotensin I I  [vasoconstrictionI ACE inhibitors
-«*. Kmmases
inactive degradation products
■ — Angiolensinase
inactive degradation producís
Figure 1: The effects of inhibitory peptides on systems for regulation of blood 
pressure, immune system and neuroendocrine information transfer in 
the organism (taken from Meisel, 1992).
Peptides which inhibit ACE have been isolated from many different food 
sources, including gelatin (Oshima et al., 1979), a-zein (Miyoshi et al., 1991), 
sardine (Ukeda et a l., 1992; Matsufuji et al., 1994), sake and sake lees (Saito et al.,
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1994) and fermented milk (Nakamura et al., 1995a, b). ACE inhibitory activity has 
also been found in cheese (Ito et al., 1987), tea (Young et al., 1993) and other 
fermented foods (Okamoto et al., 1995). Peptides which inhibit ACE, were also 
isolated from enzymatic casein hydrolysates (Maruyama et al., 1982, 1985, 1987a, b; 
Chiba and Yoshikawa, 1991; Meisel and Schlimme, 1994; Yamamoto et al., 1994). 
Fragments of K-casein which inhibit ACE have also been synthesised (Kohmura et 
al., 1990). Casein peptides with potential anti-hypertensive activities are known as 
casokinins and their function as inhibitors of ACE has been reviewed (Meisel, 1992). 
Only limited studies have been carried out on whey protein derived ACE inhibitors. 
A peptide, known as albutensin A, derived from serum albumin (Chiba and 
Yoshikawa, 1991) was to our knowledge the only reported whey protein derived 
ACE inhibitor prior to our recent findings (Chapter 3). Table 1 and 2 respectively 
summarise the current status with respect to casein and whey protein derived ACE 
inhibitory peptides.
The multifunctional aspect/nature of certain bioactive peptides has been 
described (Schlimme and Meisel, 1993; Shimizu, 1994). For example, the casein 
derived casoxin C which has been shown to induce contraction of guinea pig ileum 
longitudinal muscle (Loukas et al., 1983) also has ACE inhibitory activity. In addition, 
casomorphins can inhibit ACE (Meisel and Schlimme, 1994). Albutensin A f(208- 
216) is also multifunctional, showing ileum-contracting and vasorelaxing activities in 
addition to ACE inhibitory activity (Chiba and Yoshikawa, 1991). In an earlier study 
(Chapter 3), we have shown that opioid peptide sequences derived from the whey 
proteins, B-lg, a-la and a muscle acting peptide derived from (3-lg, can also act as 
inhibitors of ACE.
In this study, it was shown that both purified and commercially available 
proteinase preparations of gastric and pancreatic enzymes can be used to hydrolyse 
WPC, enriched fractions of p-lg and a-la, and the heated- treated forms of these whey 
proteins, to generate peptides which are inhibitors of ACE.
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Table 1: Summary of casein 1 derived angiotensin I converting enzyme inhibitory peptides.
Milk protein Fragment Synthetic
peptide
Hydrolysate
derived
Name Sequence IC 50 b 
(nmol l '1)
Reference
Casein
a , ,  - casein f  (23-34) + Phe-Phe-Val-Ala-Pro-Phe-Pro-Glu-Val-Phe-Gly-Lys 77.0 Maruyama and Suzuki, 1982
f  (23-27) + Phe-Phe-Val-Ala-Pro 6.0 Maruyama et a l. ,1985
f(24-27) + Phe-Val-Ala-Pro 10.0 Maruyama et a l.,1987 (a)
f  (25-27) + Val-Ala-Pro 2.0 Maruyama et a l.,1987 (a)
f(27-30) + Pro-Phe-Pro-Glu >1000 Maruyama et a l.,1987 (a)
f(28-34) + Phe-Pro-Glu-Val-Phe-Gly-Lys 140.0 Maruyama et al., 1987 (a)
f(32-34) + Phe-Gly-Lys 160.0 Maruyama et a l ., 1987 (a)
f  (194-199) + Thr-Thr-Met-Pro-L eu-Trp 16.0 Maruyama et al., 1987 (b)
¡(197-199) + Pro-Leu-Trp 36.0 Maruyama et a l ., 1987 (b)
f ( 198-199) + Leu-Trp 50.0 Maruyama et al., 1987 (b)
f(143-148) + Ala-T yr-Phe-T yr-Pro-Glu 106.0° Yamamoto et a l. ,1994
ß-casein f (57-64) + Ser-Leu-Val-Leu-Pro-Val-Pro-Glu 39.0 c Yamamoto et a l., 1994
f(60-66) + ß-casomorphin -7 T y r-Pro-Phe-Pro-Gly-Pro-Ile-Pro 500.0 Meisel and Schlimme, 1994
f(74-76) + - Ile-Pro-Pro 5.0 Nakamura et a l., 1995(a)
¡(84-86) + - Val-Pro-Pro 9.0 Nakamura et al. ,1995 (a)
¡(177-181) + - Ala-Val-Pro-Ty r-Pro 80.0 Maruyama et al.,  1987 (a)
¡(177-183) + - Ala-Val-Pro-Tyr-Pro-Gln-Arg 15.0 Maruyama et a l ., 1987 (a)
¡(177-179) + - Ala-Val-Pro 340.0 Maruyama et a l .,1987 (a)
¡(179-181) + - Pro-Ty r-Pro 220.0 Maruyama et a l. ,1987 (a)
¡(181-183) + - Pro-Gln-Arg >400.0 Maruyama et a l. ,1987 (a)
¡(193-202) + ß-casokinin-10 Tyr-Gln-Gln-Pro-Val-Leu-Gly-Pro-Val-Arg 300.0 Meisel and Schlimme, 1994
K-casein -
¡(25-34) + Casoxin C Tyr-Ile-Pro-lle-Gln-Tyr-Val-Leu-Ser-Arg na Chiba and Yoshikawa, 1991
¡(35-41) + Casoxin A Tyr-Pro-Ser-Tyr-Gly-Leu-Asn-Tyr na Chiba and Yoshikawa, 1991
a - further details o f other peptide sequences and/or related sequences o f casein which inhibit ACE are given elsewhere (Yamamoto et al. ,1994; Maruyama et al. ,1987 a, b); b - 
Concentration o f  peptide producing 50 % inhibition of ACE activity; c - IC 50 value reported in ng/ml; - name not given; na- value not available
Table 2: Whey protein derived angiotensin I  converting enzyme inhibitory peptides.
Whey protein Fragment Synthetic
derived
Hydrolysate
derived
Name Sequence IC 50 3 
(|imol I'1)
Reference
p-lactoglobulin f  (50-51) + - Tyr-Gly 1522.6 Chapter 3
P-lactoglobulin f ( 102-105) + + P-lactorphin T y r-Leu-Leu-Phe 171.8 Chapter 3
P-lactoglobulin f  (102-103) + - Tyr-Leu 1 2 2 . 1 Chapter 3
P-lactoglobulin f  (104-105) + - Leu-Phe 349.1 Chapter 3
P-lactoglobulin f (146-149) + + P-lactotensin His-Ile-Arg-Leu 1153.2 Chapter 3
P-lactoglobulin f(147-148) + - Ile-Arg 695.5 Chapter 3
p-lactoglobulin f(148-149) + — Arg-Leu 2438.9 Chapter 3
a-lactalbumin f(50-53) + + a-lactorphin T yr-Gly-Leu-Phe 733.3 Chapter 3
Bovine serum albumin f ( 208-216) + albutensin A Ala-Leu-Lys- Ala-T rp- 3.4 Chiba and Yoshikawa, 1991
Ser-Val-Ala-Arg
a - C oncentration o f  peptide producing 50 %  inhibition o f  A CE activity; - nam e no t given.
4.3 Materials and methods
4.3.1 Enzymes
Commercial pancreatic proteases were received as gifts from the 
manufacturers. Corolase PP (porcine) was supplied by Rohm GmbH, Darmstadt, 
Germany. PTN 3.OS (porcine) was supplied by Novo Nordisk A/S, Bagsvaerd, 
Denmark. Porcine trypsin (Type IX, 13,700 BAEE units/mg protein), bovine trypsin- 
TPCK treated (Type XIII, 12,700 BAEE units/ mg protein), bovine chymotrypsin- 
TLCK treated (Type II, 40-60 BTEE units/mg protein), porcine elastase (Type I, 25- 
100 units/mg protein, one unit of elastase will solubilise 1 mg of elastin in 20 min at 
pH 8.0 at 37 °C) and porcine pepsin A, (3,200-4,500 units/mg protein, one unit will 
produce an dA 2&o of 0.001 per min at pH 2.0 and 37 °C for TCA soluble products of 
haemoglobin) were obtained from Sigma Chemical Co. Poole, Dorset, UK.
4.3.2 Substrates
Whey protein concentrate, i.e. Lactalbumin-80 (Soluble UF-WPC) was from 
Milei GmbH., Leutkirch, Germany and had the following composition: protein (80 %), 
lactose (4.7 %), minerals (2.8 %), fat (6 %) and moisture (5 %). The enriched fractions 
of (3-lg AB and a-la were isolated according to the method of Maubois et al. (1987) on 
a pilot scale with some modifications. Details of the production and composition of 
the (3-lg and a-la enriched fractions are given by Mehra (1994). The composition of 
the (3-lg enriched fraction was as follows: total solids (95.2 %), total protein (82.7 %), 
true protein (76.3 %), (3-lg (89.8 %), a-la (10.2 %), fat (0.3 %), ash (4.7 %), calcium 
(0.79 %), sodium (0.68 %) and chloride (0.91 %). The composition of a-la was as 
follows: total solids (95.2 %), total protein (71.0 %), true protein (69.3 %), P-lg (8.5 
%), a-la (~50 %), fat (16.9 %), ash (1.4 %) and calcium (0.2 %). The degree of 
denaturation for the enriched whey protein fractions was determined on the basis of 
solubility over a wide range of pH values and details are given in Mehra (1994). The 
P-lg enriched fraction had approximately <5 % denaturation versus ~60 % for a-la 
(Mehra, 1994). Purified bovine (3-lg AB (3x crystallised and lyophilised) and a-la
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(Type III: approx. 85 % by polyacrylamide gel electrophoresis) were also obtained 
from Sigma Chemical Co. Poole, Dorset, UK.
The (3-lg peptide, Ala-Leu-Pro-Met-His-Ile-Arg corresponding to f(142-148) 
was synthesised using Fmoc solid phase synthesis at Bioresearch Ireland, University 
College Cork, Ireland. Mass spectroscopy was carried out at the Biochemistry 
Department, University of Nottingham, UK, to confirm the purity of this peptide 
(Section 4.3.8.3).
4.3.3 Solid phase extraction columns
Bond Elut® C18 columns, (2.8 ml) were from Varian Sample Preparation 
Products, Harbour City, CA, USA. All other reagents were of analytical grade unless 
otherwise specified.
4.3.4 Analysis of substrate molecular mass distributions using gel permeation
HPLC
Whey protein substrates were analysed by gel permeation (GP) HPLC on a 
Beckman (High Wycombe, Bucks, UK) Spherogel-TSK 2000 SW column (600 x 7.5 
mm), equilibrated and run with 30 % (v/v) acetonitrile containing 0.1 % (v/v) 
trifluoroacetic acid (TFA) in water. Chromatography was conducted using a Waters™ 
HPLC detector, autosampler and pumping systems (Millipore Corp. Bedford, MA 
01730, USA), at room temperature. The flowrate was 1 ml m in1 and the absorbance at 
214 nm was recorded. The injection volume was 20 (j,l.
The column was calibrated with the following standard proteins and peptides: 
bovine serum albumin (66,000 Da); carbonic anhydrase (29,000 Da); ribonuclease A 
(13,700 Da); cytochrome C (13,000 Da); aprotinin (6,500 Da); insulin (5,700 Da); 
bacitracin (1,400 Da); tryptophan (204 Da); phenylalanine (165 Da) and glycine (75 
Da). A Minichrom® data handling package (V.G. Data Systems, Manchester, 
England) was used to record and integrate chromatograms (Chapter 1 and 2).
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4.3.5 Substrate pre-treatment
In certain instances the P-lg and a-la substrates were held at 80 °C for 20 min 
to heat denature the protein. Protein samples which were not heat-treated were 
designated to have native structure.
4.3.6 Preparation of hydrolysates
Porcine trypsin was used for the generation of all tryptic hydrolysates, with the 
exception of the experiment in which the enriched fraction of p-lg was hydrolysed for 
subsequent solid phase extraction fractionation, i.e. in the generation of f(142-148).
4.3.6.1 Laboratory scale whey protein hydrolysis with pepsin, trypsin and commercial 
proteinase preparations.
A 25 ml solution of substrate, 8 % (w/v) protein, was hydrolysed with 
individual protease preparations at 50 °C and pH 8.0 for pancreatic proteases or at 37 
°C and pH 3.0 for pepsin for a total hydrolysis time of 240 min. Where a combination 
of individual proteinases were used (i.e. pepsin and trypsin), each enzyme was 
incubated firstly at 50 or 37 °C for 120 min at the pH optimum of the enzyme. The pH 
of the reaction was then adjusted to the pH optimum value for the action of the second 
proteinase (120 min). The pH was maintained constant by continuous addition of 0.5 
M NaOH (for tryptic reactions) or 1 M HC1 (for peptic reactions) using a pH-stat 
(Metrohm Ltd, Herisau, Switzerland). The degree of hydrolysis (DH %), defined as 
the percentage of peptide bonds cleaved, was calculated from the volume and molarity 
of NaOH used to maintain constant pH (Adler-Nissen, 1986). Following hydrolysis, 
proteases were inactivated by heating at 80 °C for 20 min, hydrolysates were then 
cooled and stored at -20 °C for further analysis. Details for the calculation of DH are 
given previously (Chapter 1 and 2). The enzyme-to-substrate ratio (E:S), 0.003, was 
calculated on the basis of total protein content in the enzyme preparations and the 
substrate. The standard deviation for hydrolysis reactions using this pH-stat system 
was determined previously to be DH ± 0.1 % (O’Callaghan, 1994).
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4.3.6.2 Pilot scale hydrolysis of WPC
(§)WPC Lactalbumin -80 was reconstituted using a Silverson mixer (Machines 
Ltd., Waterside, Chesham, Bucks, U.K.). Generally, a 5 1 solution of WPC at 8 % 
(w/v) protein, was hydrolysed with PTN 3.OS at 50 °C in a jacketed vessel, until a 
defined degree of hydrolysis was reached (i.e. 8 %). The pH was maintained at pH 8.0 
by continuous addition of 4 M NaOH using a pH-stat (Metrohm Ltd, Herisau, 
Switzerland.). The degree of hydrolysis (DH %), was calculated as above. During 
hydrolysis, samples were taken at various intervals and the protease (5 ml) was 
inactivated by heating to 80 °C and holding for 20-30 min. These samples were later 
freeze-dried. Again the enzyme to substrate ratio used (0.003) was calculated on the 
basis of total protein content in the enzyme preparation and in WPC.
4.3.6.3 Enzymatic hydrolysis of the P-lg derived synthetic peptide f(142-148).
The synthetic peptide of (3-lg corresponding to residues 142-148, i.e., Ala-Leu- 
Pro-Met-His-Ile-Arg was presented to chymotrypsin and pepsin solutions. For each 
reaction, 500 |_il of enzymatic solution (0.1 mg/ml) was added to 500 |il of peptide 
solution (6 mg/ml), mixed and incubated at 50 °C for 45 min. Enzymes were 
inactivated by heating at 80 °C for 20 min. Chymotrypsin reactions were buffered 
using 20 mM Tris-HCl, pH 8.0 while the pepsin reactions were carried out in 0.1 M 
HC1, pH 3.0. Controls containing peptide, pepsin and chymotrypsin were treated in the 
same manner as the test sample. Peptide blanks were was also made up in 
corresponding buffers. The enzyme to substrate ratio (E:S) was 1: 60. Acid-washed 
glassware was used throughout.
4.3.7 Fractionation of hydrolysate peptides by solid phase extraction
The solid phase extraction column was first conditioned using methanol (2.8 
ml), and then washed with distilled water (2.8 ml), followed by 5.6 ml 0.1 % (v/v) 
TFA. The hydrolysate solution (1 ml at 80 mg/ml (protein)) was then applied to the 
column. Peptide material was slowly removed from the solid phase extraction column 
by stepwise elution (i.e. 2.8 ml volumes) with increasing concentrations of acetonitrile 
(ACN) in 0.1 % TFA. Each fraction was then freeze-dried or analysed directly,
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following filtration through a 0.22 |J.m filter (polysulphone membrane -Whatman Inter. 
Ltd., Maidstone, England), by reversed-phase HPLC.
4. 3.8 Characterisation of whey protein hydrolysates
4.3.8.1 Reversed-phase high performance liquid chromatography
Peptides from whey protein hydrolysates were separated by reversed-phase 
(RP) HPLC on a Phenomenex (Phenomenex Ltd., Macclesfield, Chesire, England) C 18 
column (250 x 3.2 mm, 5jxm ), equilibrated with solvent A (0.1 % TFA in H20) and 
elution was with a linear gradient to 80 % solvent B (60 % acetonitrile, 40 % H20, 0.1 
% TFA ) during the first 50 min, to 90 % in the next 10 min, to 100 % in the next 5 
min and the column was re-equilibrated at 0 % solvent B for the last 20 min. Runs 
were conducted at room temperature using a Shimazu HPLC system controller, 
autoinjector, pumps, UV-VTS detector and chromatograph integrator (Shimadzu Corp., 
Analytical Instruments Nakagyo-ku, Kyoto, Japan); the flowrate was 0.30 ml min'1 and 
the absorbance of the column effluent was recorded at 280 nm and 214 nm. The 
injection volume was generally 50 fil and the concentration of the peptide applied was 
generally 0.1 mg/ml. However, peptides from solid phase extraction were applied 
directly to the column without further dilution. Different injection volumes (15-50 jjJ) 
were used in order to have similar peptide concentrations to compare peptide fractions 
and to determine the efficiency of the solid phase extraction procedure. All samples 
were filtered through a 0.22 jj.m filter prior to application to the C18 column.
4.3.8.2 Characterisation of ACE inhibition
The assay system used was the standard spectrophotometric assay of Cushman 
and Cheung (1971), using rabbit lung tissue as source of ACE, and is based on the 
liberation of hippuric acid by ACE from hippuryl-histidyl-leucine. Analyses were 
performed at the Institut fur Chemie und Physik, Bundesanstalt fur Milchforschung, 
Kiel, Germany (Dr. H. Meisel). In most cases, hydrolysates were in freeze-dried 
form. Initial screening of whey protein hydrolysates was carried out using a single 
assay to give an index of ACE inhibition. In general, 50|al of a lOmg/ml solution of
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hydrolysate was taken to screen for ACE inhibitory activity. Certain hydrolysate 
samples with ACE inhibition index values >80 % were selected for determination of an 
IC50 value, i.e. that amount of peptide/hydrolysate which gives 50 % inhibition of ACE 
activity. The IC50 value was expressed in terms of mg freeze-dried hydrolysate/1. The 
% inhibition versus Log10 [hydrolysate] (mg/1) curves or the % inhibition versus Log10 
[peptide] (|j.mol/l) curves, in the case of synthesised peptides, were constructed using at 
least five separate analyses.
4.3.8.3 Mass spectroscopy
The solid phase extraction fractions of a tryptic hydrolysate of the enriched P-lg 
fraction which gave high indices of ACE inhibition (i.e. peptide fractions eluting 
between 20-25, 25-30 and 50-60 % ACN) were subjected to mass spectroscopy. 
Samples were forwarded in ACN and/or in freeze-dried form for analysis to the 
Biochemistry Department, University of Nottingham, UK.
Peptide masses were determined by plasma desorption mass spectroscopy 
(PDMS) using a Bio-Ion 20 instrument (Applied Biosystems AB, Uppsala, Sweden). 
The lyophilised peptides were taken up in 50 % methanol in water. Sample (20-100 
pmol of solution) was then applied on a nitrocellulose-covered aluminised mylar target. 
The sample was then allowed to air dry, before washing with 50 (il of 100 mM 
ammonium bicarbonate which removes the alkali ions (in order to minimise 
interference from alkali metal ions). The spectra were recorded for lxl06 fisson events 
at 15kV acceleration voltage and the spectra calibrated on the H+ and NO+ ions. The 
resolution of the instrument was 0.1 %, i.e. 1 in 1000 Da.
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4.4 Results
4.4.1 Gel permeation HPLC of the whey protein substrates
The gel permeation profiles obtained at 214 nm of WPC, Sigma P-lg, the P-lg 
enriched fraction, Sigma a-la and the a-la enriched fraction are shown in Figure 2. 
The enriched fraction of p-lg has a profile which resembles that of the purified Sigma 
fraction. WPC gave a number of peaks as expected corresponding to a combination of 
whey proteins. The enriched a-la fraction has several peaks corresponding to 
contamination with other whey proteins.
4.4.2 Hydrolysis of whey proteins using gastric and pancreatic proteinases
Table 3 gives the DH obtained for enzymatic hydrolysis of the native and heat- 
treated P-lg enriched fraction. Table 4 gives the DH for the hydrolysis of native and 
heat-treated a-la enriched fraction. Table 5 gives the DH for the hydrolysis of WPC.
In general, the native (i.e. non-heat treated) forms of P-lg had lower DH values 
than the heat treated forms. However, it appeared that the effect of heat-treatment was 
not as pronounced for enzymatic hydrolysis of a-la by the individual enzymes, trypsin 
or pepsin, or for combinations of these enzymes, for 240 min. Trypsin hydrolysed 
native a-la to a DH of 7.92 % but hydrolysed the heat-treated form to a DH of 7.23 %. 
In the case where trypsin and pepsin were used in series to hydrolyse a-la the 
hydrolysis of the heat-treated forms had similar DH values to the native hydrolysis 
after 240 min. For example, the hydrolysis of the native a-la by trypsin followed by 
pepsin gave a total DH of 9.95 % after 240 min. A similar value was generated by 
trypsin followed by pepsin hydrolysis of the heat-treated a-la, which gave a total DH 
of 10.02 % after 240 min (Table 4).
P-Lg and a-la were hydrolysed by pepsin in the native form (Table 3 and 4) 
giving DH values of 4.03 and 5.10 % at 50 °C after 240 min hydrolysis. The degree of 
hydrolysis obtained with this endoproteinase was relatively low, when using the native 
forms of p-lg, in comparison to the other proteinases (Table 3). a-La, however, was 
more susceptible to hydrolysis by pepsin than p-lg. Pepsin generated similar DH 
values after 240 min in comparison to the values of DH obtained by the other
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Figure 2: Gel permeation chromatograms from H P L C  Spherogel - T S K  S W  
column showing millivolt response, assayed at 214 nm, and retention times of 
(a) w h e y  protein concentrate (b) Sigma P-lactoglobulin (c) p-lactoglobulin 
enriched fraction; (d) Sigma a-Iactalbumin (e) a-lactalbumin enriched fraction.
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Table 3: Native and heat treated (3-lactogIobulin, temperature of enzymatic hydrolysis, proteinases used,
degrees of hydrolysis (DH%) obtained after 240 min (in case of one enzyme), after 120 min (in the case of
two enzymes) and index of ACE inhibition (%) in resulting hydrolysates.
Substrate Temperature Proteinase 
(°C)
% DH % DH ACE inhibitiona
(first enzyme) (second enzyme) index (%)
Native ß-lactoglobulin 
Unhydrolysed control
Heat treated ß-lactoglobulin 
Unhydrolysed control
na na na na 9.6
37 Pepsin 2.69 na 66.7
50 Pepsin 4.03 na 85.3
37 Trypsin 5.69 na 80.2
50 Trypsin 6.52 na 84.3
50 Chymotrypsin 7.64 na 87.6
50 Elastase 5.50 na 63.4
50 PTN 3.OS 11.23 na 87.6
50 Corolase PP 16.72 na 77.7
50 Pepsin/PTN 3.OS nd nd 84.8
50 Trypsin+pepsin 7.66 2.48 89.8
50 Pepsin+trypsin 2.36 7.58 86.1
na na na na 8.9
50 Pepsin 6.64 na 85.1
50 Trypsin 7.15 na 81.9
50 Trypsin+pepsin 5.26 4.06 86.6
50 Pepsin+trypsin 5.34 5.96 86.4
a - 50 |il of 10 mg/ml solution of hydrolysate (8% protein) was taken for the determination of ACE inhibition; 
na-not applicable.
Table 4: Native and heat treated a-lactalbumin, temperature of enzymatic hydrolysis, proteinases used,
degrees of hydrolysis (DH%) obtained after 120 min (in the case of one enzyme) and 240 min (in the case of two
enzymes) and index of ACE inhibition (%) in resulting hydrolysates.
Substrate Temperature
(°C)
Proteinase % DH 
(first enzyme)
% DH 
(second enzyme)
ACE inhibition indexa
(%)
Native a-lactalbumin
Unhydrolysed control na na na na 3.5
50 Pepsin 5.10 na 84.4
50 Trypsin 7.92 na 86.9
50 Chymotrypsin 5.16 na 58.7
50 Elastase 5.27 na 56.8
50 PTN 3.0S 11.51 na 79.7
50 Corolase PP 20.50 na 73.1
50 Trypsin + Pepsin 6.69 3.26 87.1
50 Pepsin + Trypsin 1.36 6.68 84.8
Heat treated a-lactalbumin
Unhydrolysed control na na na na 7.6
50 Pepsin 5.48 na 84.5
50 Trypsin 7.23 na 85.1
50 Trypsin + Pepsin 7.16 2.86 87.8
50 Pepsin +Trypsin 2.99 7.39 88.0
a - 50 fal of 10 mg/ml solution of hydrolysate (8 % protein) was taken for indices of ACE inhibition determination; 
na-not applicable; nd- not detected.
Table 5: Whey protein concentrate, temperature of enzymatic hydrolysis, proteinases
used, degrees of hydrolysis (DH%) obtained after 240 min and index of ACE inhibition
(%) in resulting hydrolysates.
Temperature Proteinase 
(°C)
% DH 
(first enzyme)
ACE inhibition index3 
(%)
W h e y  protein concentrate
Unhydrolysed control na na 7.1
50 Trypsin 6.71 88.6
50 Chymotrypsin 5.08 87.7
50 Elastase 2.49 35.5
50 PTN 3.0S 10.43 80.8
50 Corolase PP 19.05 78.2
a - 50 jil of 10 mg/ml solution of hydrolysate (8% protein) was taken for determination of ACE inhibtion; 
na-not applicable.
individual proteinases for hydrolysis of a-la. For example, the peptic hydrolysis of a- 
la generated a DH of 5.10 % after 240 min, in comparison to the tryptic or 
chymotryptic hydrolysis of a-la which gave DH values of 7.92 and 5.16 % , 
respectively. The DH value for the peptic hydrolysis of heat-treated a-la was only 
slightly higher, i.e. 5.48 % (Table 4). For the heat-treated form of the enriched fraction 
of P-lg, however, higher DH values were obtained using pepsin after 120 min, i.e. 5.34 
% and after 240 min, i.e. 6.64 % (Table 3).
In most cases there appeared to be no real difference in the total DH obtained 
after 240 min when pepsin and trypsin were each incubated with the native enriched P- 
lg fraction in a different sequence for 120 min (i.e. pepsin following by trypsin 
hydrolysis, or trypsin followed by pepsin hydrolysis). The sequence of addition of 
pepsin and trypsin gave only slight differences (0.2 %) in the total DH values obtained 
(i.e., after a total of 240 min) for hydrolysis of native p-lg at 50 °C (Table 3). The 
total degree of hydrolysis (i.e. after 240 min) was higher when pepsin was used before 
trypsin in the hydrolysis of heat-treated p-lg. Differences, however, were seen in the 
hydrolysis of native a-la by pepsin or trypsin in succession. It was seen that a total DH 
value of 8.04 % was generated after 240 min when pepsin was used to hydrolyse native 
a-la before trypsin. However, a total DH value of 9.95 was obtained when trypsin was 
used before pepsin in the hydrolysis of native a-la (Table 4).
The commercial pancreatic proteinases, which contain combinations of trypsin, 
chymotrypsin and elastase in differing ratios, gave the highest DH values when 
presented to the native P-lg, a-la or WPC substrates. Corolase PP and PTN 3.OS, when 
used in the hydrolysis of the native enriched fraction of p-lg for 240 min gave higher 
DH values after 240 min of 16.72 and 11.23 % respectively than the individual 
proteinases, trypsin, chymotrypsin or elastase (6.52, 7.64, and 5.50 % respectively) 
over the same hydrolysis time (Table 3). In addition, Corolase PP and PTN 3.0S when 
used to hydrolyse a-la generated a DH of 20.50 and 11.51 % respectively (Table 4) 
and generated a DH of 19.05 and 10.43 % when used to hydrolyse WPC (Table 5). 
The final DH in all cases showed that combinations of proteinases, as found in PTN
3.OS and Corolase PP, always produced an hydrolysate with a higher final DH than 
individual proteinases over the same time period (Table 3, 4 and 5).
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As expected it was seen that the higher temperature, i.e. 50 °C versus 37 °C, 
resulted in higher DH values after 240 min. For example, the values obtained for a 
tryptic hydrolysis of (3-lg generated a DH of 5.69 % at 37 °C versus a DH value of 6.52 
% at 50°C (Table 3).
4.4.3 Evolution of ACE inhibitory peptides
4.4.3.1 ACE inhibitory activity generated with gastric and pancreatic hydrolysis of 
whey proteins
It was seen from Table 3, 4, and 5 and Figure 3 that hydrolysis of both heat 
treated and native forms of whey proteins is necessary in the evolution of ACE 
inhibitory activity. The ACE inhibitory activity was very low for the unhydrolysed 
substrates (Table 3,4 and 5), giving ACE inhibition values < 10 %.
Hydrolysis is necessary in order to release ACE inhibitory peptides from an 
inactive form within the sequence of whey proteins. This requirement for hydrolysis 
was illustrated for the pilot scale hydrolysis of WPC by PTN 3.OS. In the first 20 min 
of the hydrolysis reaction it was seen that evolution of > 70 % of the ACE inhibitory 
activity occurs (Figure 3).
Indices of ACE inhibition are given in Table 3, 4, and 5 for the various 
hydrolysates tested. These inhibition values while qualitative are nevertheless 
informative. All hydrolysates of (3-lg, a-la and WPC, except for hydrolysates 
generated using elastase, gave very high indices of ACE inhibition after 240 min 
hydrolysis. Hydrolysates generated using elastase gave indices of inhibition in the 
range of 35-63 %, while other proteinases generated hydrolysates which gave indices 
of inhibition in the range of 57-85 %. Trypsin and combinations of trypsin and pepsin, 
in addition to the commercial pancreatic preparations, PTN 3.OS and Corolase PP, 
generated hydrolysates which gave % inhibition values in the range of 78-90 %. 
Surprisingly, peptic hydrolysates of a-la and (3-lg gave indices of inhibition in the 
range of 84-85 %. The temperature (37 °C or 50 °C) at which the hydrolysates were 
generated appeared to have no influence on the indices of inhibition obtained after 240 
min hydrolysis.
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Figure 3: Development of A C E  inhibitory activity during hydrolysis of W P C  using a pancreatic 
enzyme preparation
Hydrolysis time (min)
ACE inhibition, (%)
4.4.3.2 ACE inhibitory activity for fractionated hydrolysates
In this study, a tryptic hydrolysate of the enriched (3-lg preparation was 
fractionated using solid phase extraction. Analysis of each fraction on Clg RP-HPLC 
revealed the efficacy of the fractionation procedure (Figure 4 (i) and (ii)). It was seen 
that there was a shift in the peptide profile from left to right for the peptide fractions 
eluted at higher ACN concentrations. The more hydrophobic the peptide material, the 
higher the % ACN required for elution. Table 6 gives the indices of ACE inhibition 
(%) corresponding to various acetonitrile elutions. In general, at the lower 
concentrations of ACN, the eluted peptides gave relatively high ACE inhibition values, 
in comparison to the peptides eluted at higher concentrations of ACN. Three fractions 
of the tryptic hydrolysate of (3-lg were selected for further study i.e., the peptide 
material eluting between 20-25 , 25-30 and 50-60 % ACN (Figure 4 (i) c, d and 4 (ii) 
d). The peptides eluting between 20-25, 25-30 and 50-60 % ACN gave corresponding 
ACE inhibition indices of 93.6, 98.6 and 41.8 %, respectively. It should be noted that 
for the 50-60 % ACN elution that a 3mg/ml solution was used for the assay instead of 
the usual 10 mg/ml solution.
4.4.3.3 Mass spectroscopy
Three ACN elutions from the solid phase extraction of the tryptic hydrolysate 
of (3-lg, chosen on the basis of the index of ACE inhibition, were analysed using mass 
spectroscopy. A number of peptides were seen to dominate in the three fractions 
examined. Figures 1, 2 and 3 in Appendix A, give the mass spectroscopy profiles 
obtained for the 20-25, 25-30, and 50-60 % ACN elutions, respectively. The results 
compared favourably with the theoretically expected masses for tryptic digest products 
of the (3-lg sequence as given in Table 7. From the observed masses of the major 
peptides in the different ACN elutions it was possible to predict the peptide sequences 
corresponding to these masses (Table 7 and Figure 5).
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Figure 4 (i): Reversed P h a s e - H P L C  (C18) chromatograms of the peptides in (a) 
tryptic hydrolysate of enriched p-lactoglobulin fraction and in the solid phase 
extraction fractions corresponding to (b) 1-20 %  Acetonitrile (A CN )  elution (c) 
20-25 %  A C N  elution and (d) 25-30% A C N  elution. T h e  A C N  gradient used 
throughout is indicated in Fig 4 (i)(a).
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Figure 4 (ii): Reversed P h a s e - H P L C  ( C 18) chromatograms of the peptides in the 
solid phase extraction fractions corresponding to (a) 30-35 %  A C N  elution (b) 
35-40 %  A C N  elution (c) 40-50 %  A C N  elution and (d) 50-60 %  A C N  elution. 
T h e  A C N  gradient used throughout is indicated in Fig 4 (ii)(a).
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Figure S: Amino acid sequence of bovine p-lactoglobulin variant B  and positions of potential 
bioactive fragments as indicated using mass spectroscopy.
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Leu-Ile-Val-Thr-Gin-Thr-Met-Lys-Gly-Leu-Asp-Ile-Gln-Lys-Val-Ala-Gly-Thr-Trp -Tyr 20 
Ser-Leu-Ala-Met-Ala-Ala-Ser-Asp-IleSer-Leu-Leu-Asp-Ala-Gln-Ser-Ala-Pro-Leu-Arg 40 
Val-Tyr-Val-Glu-Glu-Leu-Lys-Pro-Thr-Pro-Glu-Gly-Asp-Leu-Glu-Ile-Leu-Leu-Gln-Lys 60 
Trp-Glu-Asn-Gly-Glu-Cys-Ala-Gln-Lys-Lys-lle-lle-Ala-Glu-Lys-Thr-Lys-lle-Pro-Ala 80 
Val-Phe-Lys-lle~Asp-Ala-Leu-Asn-Glu-Asn-Lys-Val-Leu-Val-Leu-Asp-Thr-;\sp-Tyr-Lys 100
Lys lyr-Leu-Leu-l’he^ys-hiehGlit-Asn-Ser-Ala-Glu-Pro-Glu-Gin-Ser-Leu-AI^Cys-Ghi^O
His
i^ys-Leu-Val-Ar}
7!W Ala-Leu-Pro-Met fiis-Ile-Arg-Le, t-Ser-Phq-Asn-Pro-Thr-Gln-ljiU-Glu-Glu- 
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f - e; if rro- r- l .eu 1 tln~Cys 160
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Peptides with masses corresponding to 142-148), 125-
135), and 102-124) o f P~lg appeared to be respectively 
present in the 20-25,25-30 and 50-60 %, ACN elutions 
fractions.
ila-Leu 140
(from Hill, 1994); variant A Asp 64 Val118; variant B (as shown). Shaded ■■¡indicates 
pepdde sequences previously characterisated as having opioid/muscle acting peptides.
Table 6: Indices of A C E  inhibition (%) 
corresponding to various sequential 
acetonitrile elutions from solid phase 
extraction of a tryptic hydrolysate of (3- 
lactoglobulin
Acetonitrile elution 
(%)
ACE inhibition indices a 
(%)
1 41.2
20 62.5
25 96.9
26 91.0
27 95.2
28 76.2
29 73.0
30 66.9
35 91.9
40 63.1
50 49.0
51 28.5
52 51.0
53 23.6
54 8.6
55 10.2
56 7.6
57 1.2
58 18.9
59 4.1
60 7.9
a - 50 f.il o f 10 mg/ml solution o f hydrolysate (8%  
protein) was taken for A C E  inhibition determination; 
(method as described Meisel, 1992)
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Table 7: Expected peptide masses corresponding 
to tryptic fragments of P-Iactoglobulin.
Peptide n u m b e r Fragment Expected peptide
masses
1 1-8 933.17
2 9-14 672.18
3 15-40 2708.07
4 41-60 2313.67
5 61-69 1063.13
6 70-70 146.19
7 71-75 572.70
8 76-77 247.29
9 78-83 673.85
10 84-91 916.00
11 92-100 1065.23
12 101-101 146.19
13 102-104 2645.05
14 125-135 1245.30
15 136-138 408.45
16 139-141 330.43
17 142-148 837.05
18 149-162 1657.83
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In Figure 1, Appendix A, a peptide, giving a charge to mass ratio o f 838.4 was 
observed and this approximates to the theoretical mass (Table 7) of f(142-148) of the 
P-lg sequence. Figure 2, Appendix A shows a peptide which gave a charge to mass 
ratio o f 1201.4. This peptide may correspond to f(125-135) of the (3-lg sequence as 
indicated in Table 7 and Figure 5. Figure 3, Appendix A, shows a peptide eluting 
between 50-60 % ACN, which had a charge to mass ratio of 2710.4 and this peptide 
may correspond to f(102-124), as indicated in Table 7 and Figure 5. The peptide, 
f(142-148), which was found to be prominent in the fraction eluting between 20-25 % 
ACN (Figure 1, Appendix A) was synthesised and used for further studies.
4.4.3.4 ACE inhibition-IC50 values
In order to obtain an accurate value for the ACE inhibitory potency for a given 
hydrolysate sample/fraction or peptide it is necessary to generate an activity curve and 
to calculate precisely an IC50 value. A typical activity curve for the determination o f an 
IC50 value is given in Figure 6 (courtesy of Dr. H. Meisel). This curve was generated 
for the peptide material eluting between 20-25 % ACN for a tryptic hydrolysate of P- 
lg. The IC50 value was calculated as 159.8 mg/1. In the same way, an hydrolysate 
produced from WPC using PTN 3.OS (240 min, Table 5), and a peptic hydrolysate of 
the enriched p-lg fraction (240 min, Table 3) gave IC50 values of 374.0, and 318 mg/1, 
respectively. The synthetic peptide fragment corresponding to f(142-148) o f P-lg gave 
an IC50 value of 42.6 jjmol/1.
4.4.5 Treatment o f  § -lg f(142-148) with peptic and chymotryptic activities
The synthetic peptide corresponding to p-lg f(142-148) was incubated with 
pepsin and chymotrypsin. Figure 7 (i) gives peptide profiles at 280 nm and Figure 7 
(ii) gives peptides profile at 214 nm. Figure 7 (i) and (ii), (a) gives the RP-HPLC 
profile for peptide f(142-148) of P-lg. Figure 7 (i) and (ii), (b) gives the profile for 
chymotryptic control which had been incubated at 50 °C for 45 min. Figure 7 (i) and 
(ii), (c) gives the profile for the chymotryptic incubation with the peptide at 50 °C for 
45 m in. Figure 7 (i) and (ii), (d) gives the profile for the pepsin control which was 
incubated at 50 °C for 45 min. Figure 7 (i) and (ii), (e) gives the profile for the pepsin
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incubation with the peptide under the same reaction conditions. It appeared from 
reversed phase HPLC profiles obtained at 280 nm that little or no hydrolysis of f  (142- 
148) occurred using chymotrypsin (Figure 7 (i) a, b and c) or pepsin (Fig 7 (i) a d and 
e). The profiles produced by pepsin and Chymotrypsin alone following incubation at 
50 °C for 45 min, revealed the existence o f peptide material due possibly to 
autodigestion o f the proteinases. Profiles at 214 nm (Figure 7 (ii), a-e) however, 
appear to indicate that there is low degrees o f hydrolysis by chymotrypsin o f f(142- 
148) and there appears to be no hydrolysis of this peptide by pepsin.
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Figure 6 : ACE inhibition curve of peptides eluted between 20-25 % ACN of a
tryptic hydrolysate of p-iactoglobulin, IC50 = 159.8 mg /I (courtesy of Dr. H
Meisel).
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Figure 7 (i): Reversed Phase H P L C  ( C i8) chromatograms detected at 280 n m  of 
(a) peptide f(142-148) of ß-lactoglobulin (b) Chymotrypsin (c) Chymotryptic 
incubation with peptide (d) Pepsin and (e) Peptic incubation with peptide 
Gradient elution used throughout is indicated in (a).
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Figure 7 (ii): Reversed Phase H P L C  ( C 18) chromatograms detected at 214 n m  of 
(a) peptide f(142-148) of ß-Iactoglobulm (b) Chymotrypsin (c) Chymotryptic 
incubation with peptide (d) Pepsin and (e) Peptic incubation with peptide 
Gradient elution used throughout is indicated in Figure 7 (i) (a).
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4.5 Discussion
4.5.1 Effect o f  hydrolysis by gastric and pancreatic proteinases on the release o f  ACE  
inhibitory activity.
Initial screening of a range of whey protein hydrolysates revealed that 
hydrolysis was necessary to release ACE inhibitory peptides from an inactive form 
within the sequence of the whey proteins. Low endogenous ACE inhibitory activity 
existed for the unhydrolysed whey protein substrate controls (Table 3, 4, and 5). It can 
be noted from Table 3, 4, 5, that DH values of 2-3 % can give rise to 70-90 % ACE 
inhibition indices. In addition, inhibitory activity levels of this magnitude could be 
produced on a larger scale, i.e. 10 1 hydrolysate, as was seen in the hydrolysis of WPC 
by a pancreatic proteinase preparation, PTN 3.OS, which at DH values of < 5 % 
resulted in a high level of ACE inhibition, i.e. > 70 % inhibition (Figure 3).
It was not unexpected that heat treatment of the whey protein substrates 
resulted in higher percentage degrees o f hydrolysis, particularly in the case of (3-lg. It 
is known that heat treatment causes protein unfolding and reduction o f disulphide 
bonds thereby making proteins more susceptible to proteolytic attack (Reddy el al., 
1988; Mihalyi, 1978). In Chapter 5, it is shown using differential scanning calorimetry 
that temperature and pH influence the conformation of P-lg and therefore the 
susceptibility of this protein to hydrolysis. However, heat-treatment did not appear 
from our initial screening of all the whey protein hydrolysates to have a detrimental 
effect on the evolution of ACE inhibitory activity.
Furthermore, sequential hydrolysis with combinations o f pepsin and trypsin or 
trypsin and pepsin increased the DH values obtained after 240 min in comparison to 
the values obtained for the individual proteinases. However, this increase in DH did 
not appear to affect the indices of ACE inhibition in the resultant hydrolysates. 
Combinations of enzymes have been used previously to mimic in vivo digestion in the 
evolution of bioactive peptides (Antila et al., 1991; Pihlanto-Leppala et al., 1994a, b). 
It was seen from this study, that while the inclusion of pepsin in addition to trypsin, 
increased the final DH value, it did not appear to affect the evolution of ACE inhibitory 
peptides. For example, the evolution of f(50-53) from a-la  was unaffected when
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pepsin was used to hydrolyse the protein before trypsin (Antila et al., 1991). In 
addition, with the exception of (3-lg, the order of usage of individual proteinases did not 
appear to have any great effect on the final DH values obtained (240 min) when pepsin 
(120 min hydrolysis) followed by trypsin (120 min hydrolysis) were each presented to 
the native or denatured whey protein enriched fractions. Although as expected, (3-lg 
appeared to be more resistant to peptic hydrolysis, the treatment of this substrate with 
pepsin prior to hydrolysis with trypsin did increase the final DH after 240 min. Pepsin 
treatment has been shown to make the (3-lg molecule more susceptible to enzymatic 
hydrolysis with other proteinases (Porter et al., 1984; Antila et al., 1991).
Corolase PP which contains more than two major proteinase activities 
(Mullally et al., 1994), hydrolysed the whey protein fractions to a greater extent than 
PTN 3.OS. The final DH found in all cases showed that a combination of proteinases 
always produces an hydrolysate with higher final DH values than individual 
proteinases over the same time (Table 3, 4 and 5).
Overall, the apparent indices of ACE inhibition did not appear to be affected by 
the use of enzyme combinations, the order of usage of enzymes, or commercial 
preparations such as PTN 3.OS and Corolase PP. However, the molecular mass 
distributions o f whey protein hydrolysates are greatly dependent on the proteolytic 
activities used (Mullally et al., 1994). It appeared, that DH could not be directly 
correlated to indices of inhibition, as low degrees of hydrolysis for one particular 
substrate/enzyme combination produced inhibition of apparently similar potency to the 
peptides from a hydrolysate of higher DH. For example, the peptic hydrolysis o f [3-1 g, 
having a low DH (i.e. 2.69 %) released peptides which had a higher ACE inhibition 
index than an hydrolysate of P-lg produced using PTN 3.OS (DH of 11.23 %), as seen 
in Table 3. The ACE inhibition index for the peptic hydrolysate was 92.7 % whereas 
the index for the PTN 3.OS hydrolysate was 87.6 %. It would be reasonable to assume 
that the types/size o f individual peptides produced depends on the specificity of the 
proteinase first presented to the substrate. However, evidence of the importance of 
enzyme specificity was not seen during initial screening of the hydrolysates for indices 
of ACE inhibition, due perhaps to the complexity of peptides present in each 
hydrolysate.
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4.5.1.1 ACE inhibition in peptide fractions of whey protein hydrolysates.
Solid phase extraction proved to be an efficient method of enriching for ACE 
inhibitory peptides (Table 6 and Figure 4 (i) and (ii)). Fractionation using solid phase 
extraction has been used previously as an enrichment step in the purification o f casein 
derived bioactive peptides such as the P-casomorphins (Meisel, 1993a). Solid phase 
extraction, therefore, allowed for enrichment of peptides with high indices ACE 
inhibitory activity.
Overall, the IC50 values of the fractionated peptides were relatively high 
indicating a lower potency in comparison to synthetic drugs, such as Captopril (D-3- 
mercapto-2-methylpropyl-L-proline) which has an IC50 value of 0.006 jxmol/1 (Chapter 
3).
However, the IC50 values found in this study for whey proteins are comparable 
to those found for casein hydrolysates (Table 1). The IC50 values of freeze-dried 
hydrolysate material would, however, reflect the total inhibitory effect of more than 
one peptide. A number of research groups have demonstrated the physiological 
significance o f individual peptides or mixtures of peptides generated as a result of 
hydrolysis o f casein (Maruyama et ah, 1987a, b; Sekiya et ah, 1992; Yamamoto et al.,
1994) or other food proteins such as fish (Suetsuna and Osajima, 1989), a-zein 
(Miyoshi et ah, 1991), sake (Saito et al., 1994), or sour milk (Nakmura et al., 1995b). 
It was shown that peptides from these sources have significant physiological effects 
when administered in vivo. The hypotensive effects of sake derived peptides were 
sustained for up to 30 h in murine models (Saito et ah, 1994). The hypotensive effect 
of fish hydrolysate was shown to be effective for up to 6 h after oral administration 
(Sugiyama et ah, 1991). In some studies, however, it was found that relatively high 
doses of the peptide were required to have an effect following oral administration 
(Karaki et ah, 1990; Yamamoto et ah, 1994) in comparison to synthetic drugs. It has 
been shown that peptides with molecular masses of 1-2 kDa obtained by enzymatic 
hydrolysis of sardine muscle have a hypotensive effect after oral administration 
(Suetsuna and Osajima, 1989). It has been stated that peptides/hydrolysates with IC50 
values within the 100-500 jj.mol/1 range could be physiologically active (Sekiya et al.,
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1992). A summary of recent findings in relation to physiologically active ACE 
inhibitory food protein hydrolysates is given in Table 8.
The source of ACE used in this study was from rabbit lung tissue. It is known, 
that care should be taken when comparing degrees of potency or IC50 values, if 
different sources of ACE are used in determining the inhibition activities of 
peptides/hydrolysates (Aryioshi, 1993).
4.5.2 Proteinase specificity in the production o f  angiotensin I  converting enzyme 
inhibitory activities - hydrolysis offi-lg f ( 142-148).
In order for peptides to exert a physiological effect, they must interact with 
ACE at various sites around the body. One of the first requirements for this 
physiological effect is that inhibitory peptides should be resistant to further proteolytic 
attack by digestive proteinases.
The synthetic fragment of (3-lg f(142-148), shown to be present in a tryptic 
digest of (3-lg was incubated in the presence of pepsin and chymotrypsin, in order to 
investigate the possible formation of further hydrolysis products. It is known that 
bioactive peptides are often resistant to further degradation by gastric or pancreatic 
proteinases (Zioudrou et al., 1979; Henschen et al., 1979) as is the case with (3- 
casomorphins (Meisel, 1986). It was therefore of interest to investigate the 
susceptibility of f(142-148) to further digestion by pepsin and chymotrypsin. Pepsin is 
a broad spectrum proteinase and possible cleavage sites in (3-lg have been suggested by 
Maeda et al. (1987). However, it appeared from C18 reversed phase HPLC analysis 
that no hydrolysis of f(142-148) occurred using pepsin. Chymotrypsin is specific for 
Tyr-X, Phe-X and Trp-X bonds and is less active against Leu-X, Met-X and Ala-X 
bonds (Ardelt and Laskowski, 1985). It was seen from RP-HPLC peptide profiles at 
214 nm that there was a low degree of hydrolysis of f(142-148) by chymotrypsin. The 
low degrees of hydrolysis was indicated by two ‘extra’ peaks in the peptides profile 
(Figure 7 (ii), c). However, the intensity of the peaks corresponding to the synthetic 
peptide changed only slightly, indicating a low degree of hydrolysis of f(142-148) with 
chymotrypsin. There may have been partial autolysis of pepsin and chymotrypsin at 50 
°C for 45 min, as these control samples (Figure 7 (i) (b) and (d) respectively), revealed
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Table 8: Examples of food derived protein hydrolysates shown to reduce hypertension in animal and human models.
Source E n z y m e Material Animal model Administration
format
Reference
Casein Trypsin Peptide b SHR Intravenous Maruyama et al., 1987b
Trypsin Hydrolysate human O ra l3 Sekiya et a l.,1992
L. helveticus protease Peptided SHR Oral Yamamoto et al., 1994
L.helveticus protease Peptidec SHR Oral Y amamoto et al., 1994
Trypsin Hydrolysate SHR Oral Karaki et al., 1990
Fish Alkaline proteinase Hydrolysate SHR Intravenousc Suetsuna and Osajima, 1989
Alkaline proteinase Hydrolysate rabbit Intravenous Suetsuna and Osajima, 1989
Alkaline proteinase Hydrolysate SHR Oral Sugiyama et a l.,1991
a-zein Thermolysin Peptide rabbit Intravenous Miyoshi et al., 1991
Calpis sour milk L. helveticus protease Peptide SHR Oral Nakamura et a l.,1995b
L. helveticus protease Peptide SHR Oral Nakamura et a l.,1995b
Sake Pepsin or pancreatin Hydrolysate SHR Oral Saito et al., 1994
or Sake lees
SHR- Spontaneously hypertensive rats; a-oral administration; b- synthetic peptides were administered which corresponded to peptides produced in 
hydrolysates; c-effect was dose dependent; d- ocspcasein; e- p-casein.
the presence o f peptide material which was detected at 280 nm. The tryptic peptide 
Ala-Leu-Pro-Met-His-Ile-Arg has sites which would potentially be susceptible to 
hydrolysis by chymotrypsin. It would be expected that the peptide chain length (i.e. 7 
amino acid residues) would be too short for the further hydrolytic action by 
endoproteinases, e.g. chymotrypsin. However the hydrolysis conditions (as used in the 
experiment) with an E:S ratio of 1:60 may have forced the hydrolysis of f(142-148) by 
chymotrypsin. The question remains as to whether the chymotryptic hydrolysis 
products o f f(142-148) are more or less potent in the inhibition of ACE than the parent 
peptide.
There appeared to be no hydrolysis of f(142-148) by pepsin. It might be 
concluded that this peptide would be resistant to further hydrolysis in the digestive 
tract, prior to absorption in the gut. The presence of proline in the sequence of this 
peptide may also contribute to its resistance to hydrolysis. Proline rich peptides are 
known to be resistant to enzymatic hydrolysis (Henschen et al., 1979; Brantl et al., 
1981; Saito etal., 1994).
It is therefore evident from these findings that the specificity of the proteinases 
first presented to the substrate will dictate the type and potency of the resulting 
bioactive peptides formed. In the study by Pihlanto-Leppala et al. (1994a, b), the 
peptide fragment corresponding to His-Ile-Arg-Leu was formed from (3-lg by the action 
of chymotrypsin. However, His-Ile-Arg did not appear to be released in the present 
study (as shown by C 18 RP-HPLC analysis) by the action of chymotrypsin on the 
tryptic peptide Ala-Leu-Pro-Met-His-Ile-Arg. In general, knowledge of the specificity 
o f the enzyme and information on the sequence of the substrate is sufficient to predict 
the sequence of peptides formed, only when using purified substrates and enzymes. 
However, it has been shown in vitro that cleavage may occur at sites normally not 
susceptible to the enzyme. In the production of casomorphins from (3-casein, it has 
been shown that trypsin cleaves the Asn-Ser bond (Meisel, 1992). In the present study 
on hydrolysis of f(142-148), it was evident that the type o f peptides produced in the 
hydrolysis o f (3-lg is dependent on the sequence of addition of the enzymes to the 
substrate. When a number of enzymes are working in conjunction with each other, 
products which are not predicted may occur. This should be particularly evident where
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commercial pancreatic proteinase preparations are used to generate whey protein 
hydrolysates on a large scale for inclusion into various food products.
4.5.3 Structure-activity relationships and the importance o f  gastric and pancreatic 
proteinases in the production o f  biologically active peptides.
The multifunctional properties of certain peptide sequences has been discussed 
previously (Shimizu, 1994). A sequence within p-casein, f(60-70), is known as the 
‘strategic zone’ for the production of bioactive peptides (Fiat et al., 1993). There is an 
overlap o f opioid, ACE inhibitory and immunomodulating activities within sequences 
derived from this fragment. For example, p-casomorphin f(60-64) was shown to have 
opioid agonist and ACE inhibitory activities (Brantl et al., 1981; Meisel and Schlimme,
1994). In the present study, it was observed that certain peptide sequences, found to be 
present in the solid phase extraction elutions of the tryptic hydrolysate of P-lg, showed 
an overlap with other known bioactive sequences (Figure 5). It would be interesting to 
investigate the possibility o f a so-called ‘strategic zone’ or ‘zones’ within the sequence 
of whey proteins. Two such potential ‘zones’ were seen in this study for P-lg. For 
example, the mass spectroscopy of the 50-60 % acetonitrile elution (Appendix A, 
Figure 3) gave a prominent peak which corresponded to f(102-124). This peptide 
showed an overlap with the opioid peptide, p-lactorphin f(102-105), as seen in Figure
It was also noted that the ‘zone’ corresponding to f(142-149) had overlapping 
bioactivies. The tryptic fragment f(142-148) which was prominent in the analysis of 
the 20-25 % ACN elution showed some overlap with the sequence of P-lactotensin, 
which is a muscle-acting peptide produced using chymotrypsin and combinations of 
chymotrypsin and pepsin (Pihlanto-Leppala et al., 1994a, b). The IC50 values o f p- 
lactotensin (His-Ile-Arg-Leu) and related dipeptides Ile-Arg and Arg-Leu were 1153.2,
695.5 and 2438.9 respectively (Chapter 3). The IC50 value of the peptide 
corresponding to f(142-148) with the sequence Ala-Leu-Pro-Met-His-Ile-Arg was 
more potent (IC50 = 42.6 pmol/1) than P-lactotensin, and a related dipeptide (Ile-Arg) 
corresponding to the C-terminal dipeptide, which gave an IC50 = 695.5 pmol/1. Table 9
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summarises the recent findings in relation to overlap of sequences of novel ACE 
inhibitory peptides from this study and Chapter 3.
The structure-activity relationship of ACE-inhibitory peptides has been 
discussed by an number of groups (Meisel, 1993a, b; Saito et al., 1994). It has been 
suggested that peptides with hydrophobic amino acids at the C-terminus act as potent 
ACE inhibitors i.e., those amino acids which interact with the active site. Cheung et al. 
(1980) concluded that the C-terminal dipeptide fragment of peptides was important in 
inhibition o f ACE. This theory would be supported by the fact that ACE is a 
carboxydipeptidase. The results of a previous study (Chapter 3) appeared to concur 
with this theory. It was shown that dipeptides related to P-lactotensin, a-lactorphin and 
p-lactorphin were more potent than the parent tetrapeptides. However, ACE also 
displays peptidyl tripeptidase and endopeptidase activity on some peptides, such as 
substance P and luteinizing hormone-releasing hormone (Erdos and Skidgel, 1989). In 
addition, it has been reported that ACE showed high specificity for the amino acid 
residue at position 3 from the C-terminal end of peptides, but showed little specificity 
for amino acids at position 4 (Oshima et al., 1979). It has also has been suggested that 
the C-terminal tripeptide may by important in the inhibition of ACE (Maruyama et al., 
1987b). The results o f the present study would contradict some o f the suggestions that 
the C-terminal dipeptide dictates inhibitory potency. It might be suggested, however, 
that the proline residue may contribute to the potency of f(142-148). Proline residues 
were shown to contribute to the potency of ACE-inhibitory peptides from food protein 
sources (Saito et al., 1994; Yamamoto et al., 1994; Nakamura et al., 1995a, b). In 
addition, the first potent ACE inhibitors, reported from snake venom, also had proline 
in their C-terminal sequence (Ondetti and Cushman, 1982). It was seen that f(142-148) 
which has proline in its sequence is more potent than related peptides (Table 9). 
Different conformational states of peptides must also be considered. For example, 
bradykinin has an inverse y-tum conformation around Pro7 (Meisel, 1992) and this 
may be significant in ACE inhibitory activity.
The DH produced in the generation of ACE inhibitory peptides may be 
important from the point o f view of efficient absorption of the peptides. Peptide chain 
length is important as it is believed that peptides can be absorbed intact and enter the
175
circulation (Gardner, 1988; Silk and Grimble, 1992). In the case of di- and tri­
peptides, these may be transported into the intestinal epithelial cells via specific peptide 
transporters (Webb, 1990; Fei et al., 1994).
Several reports exist on the physiological significance of protein hydrolysates 
from different sources in the reduction of hypertension and these are summarised in 
Table 8. Further studies on human subjects is obviously required to fully elucidate the 
physiological significance of the ingestion of food protein hydrolysates/peptides 
containing ACE inhibitory activity. The fact that the whey protein hydrolysates 
developed in this study have lower ACE inhibitory potencies than the synthetic 
antihypertensive drug Captopril (IC50 = 0.006 |jmol/l) does not negate against the 
application of whey protein derived peptides in the treatment/prevention of 
hypertension. It is to be expected that milk protein derived ACE inhibitory peptides, 
unlike Captopril would have no undesirable side-effects.
As a consequence, whey protein derived ACE inhibitory peptides could find 
applications as a nutraceutical in various ‘physiologically functional foods’.
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Table 9: Summary of ACE inhibitory activity within P-lg sequence f(142-149).
Peptide sequence Fragment IC50(|amol/l)a
Ala-Leu-Pro-Met-His-Ile-Arg f(142-148) 42.6
His-Ile-Arg-Leu f( 146-149) 1153.2
Ile-Arg f( 147-148) 695.5
Arg-Leu f(148-149) 2438.9
a IC 50 is defined as that amount of peptide which causes 50 % inhibition o f ACE using 
hippuryl-histidyl-leucine as substrate.
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Appendix A
Mass spectroscopy profiles obtained from Dept Biochemistry, University of 
Nottingham, UK.
(Sum o f 6 c h a n n e ls )
Ma s s / C h a r g e  (m/z) ratio
Figure 1: Mass spectroscopy profile for the 20-25 % acetonitrile elution
obtained from a solid phase extraction of a tryptic hydrolysate of ß-
lactoglobulin.
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Figure 2: Mass spectroscopy profile for the 25-30 % acetonitrile elution of a
tryptic hydrolysate of (3-IactogIobulin.
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Figure 3: Mass spectroscopy profile for the 50-60 % acetonitrile elution of a
tryptic hydrolysate of P-lactoglobuIin.

CHAPTER 5
Temperature and pH effects on the conformation and 
susceptibility of p-lactoglobulin to enzymatic hydrolysis.
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5.1 Summary
A protein fraction enriched in bovine p-lactoglobulin (P-lg) variants AB was 
hydrolysed with pepsin, trypsin, chymotrypsin and elastase activities. In addition, this 
fraction was hydrolysed with combinations of trypsin and pepsin activities. Hydrolysis 
was also performed with two commercially available enzyme preparations, i.e. 
Corolase PP and PTN 3.OS. Peptic hydrolysis was performed at pH 3.00 while 
hydrolysis with other enzymes was at pH 8.00. In general, the hydrolysis reaction 
temperature was 50 °C. The enriched P-lg preparation was also heat treated (80 °C for 
20 min) prior to hydrolysis with pepsin or trypsin and or with combinations of these 
enzymes. As expected, the extent of the reaction during the first 20 min of hydrolysis, 
also referred to as the initial rate (A DH/min), and the final degrees o f hydrolysis (DH) 
after 240 min incubation obtained were higher at 50 °C than at 37 °C.
The final DH value obtained after 240 min incubation at 50 °C for a peptic 
hydrolysate o f the native enriched P-lg was lower (i.e. 4.03 %) than for hydrolysates 
obtained with pancreatic enzymes, i.e. trypsin, chymotrypsin and elastase (6.52, 7.64 
and 5.50 % respectively). Combinations of pepsin and trypsin gave higher degrees of 
hydrolysis after 240 min incubation at 50°C than the individual enzymes. The highest 
degree of hydrolysis of native p-lg was obtained using the commercial proteinase 
preparations, Corolase PP and PTN 3.0S. The complexity of the RP-HPLC profiles 
and the apparent degree o f hydrophobicity of the various hydrolysates could be related 
to the DH values obtained. As the number of enzymatic activities was increased for a 
given hydrolysis reaction, the appearance of peptides with less hydrophobic 
characteristics was evident.
Differential scanning calorimetry (DSC) was used to determine the effect of 
heating on the structure and stability of the enriched P-lg preparation. The DSC 
thermograms showed that the P-lg preparation had a higher thermal/structural stability 
at pH 3.00 than at pH 8.00, i.e. pH values which are suitable for peptic or pancreatic 
hydrolysis reactions, respectively. The protein showed greater resistance to pepsin 
hydrolysis at pH 3.00 (DH = 2.69 % at 37 °C and 4.03 % at 50° C), due to greater 
structural and thermal stability of the protein at this pH (Tm = 82.98 C ± 0.62 °C).
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Holding the native enriched fraction of (3-lg at 50 °C for 120 min, appeared to affect 
the structural stability o f the protein, even at pH 3.00 as shown by the appearance of 
shallow and diffuse DSC thermograms.
The structure o f the (3-lg substrate was removed completely after pre-heat 
treatment (80 °C for 20 min). Pre-heating greatly increased the susceptibility of an 
enriched fraction of (3-lg to enzymatic hydrolysis by pepsin or trypsin. In addition, 
peptic hydrolysis of the heat-treated form of the enriched (3-lg fraction allowed for 
more efficient hydrolysis, if subsequently followed by a tryptic hydrolysis reaction.
This study confirmed that the susceptibility of (3-lg to hydrolysis by gastric or 
pancreatic enzymes is dependant on the pH and temperature used in the hydrolysis 
reaction.
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5.2 Introduction
P-Lg is a globular protein which represents approximately 50 % of the total 
whey protein in bovine milk. The monomer molecular weight is 18.4 kDa and the 
molecule contains two disulphide bridges and one free thiol group. At physiological 
pH, P-lg exists as a homodimer and has a molecular weight of 36.8 kDa (Godovac- 
Zimmermann and Brautnitzer, 1987). P-Lg has been extensively characterised both 
physically and chemically (McKenzie, 1971; Swaisgood, 1982; Eigel et al., 1984; 
Hambling et al., 1992).
Structural studies have revealed that p -lg  belongs to a family of ligand binding 
proteins. It is known to bind fatty acids and retinol (Spector and Fletcher, 1970; Fugate 
and Song, 1980; Puyol et al., 1991; Pérez el al, 1992) and it is thought to have a 
biological role in the binding and digestion of fatty acids and/or in the transport of 
retinol (Pérez and Calvo, 1995). It was shown using DSC that palmitic acid and retinol 
binding to P-lg increases the thermal stability of the protein (Puyol et al., 1994).
The effects of pH and temperature on P-lg unfolding and aggregation have been 
investigated (deWit and Swinkels, 1980; Park and Lund, 1984). P~Lg is known to 
have an unusual unfolding pattern and self association equilibria at different pH values.
At pH values less than pH 3.5, P-lg is most stable in a monomer state (Mills and 
Creamer, 1975). Between pH 3.5 and 5.2, the dimer undergoes a progressive 
reversible tetramerization (Kumosinski and Timasheff, 1966). A transition, referred to 
as the ‘Tanford transition’ which involves a reversible conformational change at pH 
7.5, causes the exposure o f tryptophan and tyrosyl residues to solvent (Tanford et a l, 
1959; Townend etal., 1969; Zimmermann et al., 1970). At values greater than pH 8.5, 
p-lg undergoes a polymerisation which progresses with time and which seems to be 
mainly associated with the oxidation o f the sulphydryl groups (McKenzie and Sawyer, 
1967). It has been suggested that this transition in B-lg structure associated with pH 
changes is reflected in its susceptibility to proteolysis (Monnot and Yon, 1964). Heat 
treatment causes dimer dissociation, denaturation of the monomer with the exposure of 
sulphydryl groups and subsequent polymer formation (Caligant et al., 1991). When the 
di sulphide groups are reduced, the protein becomes more susceptible to enzymatic
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attack (Otani, 1981; Reddy et al, 1988). There has been a certain degree of 
controversy in the literature with regard to the kinetics of this denaturation process, i.e. 
as to whether it is first (deWit and Swinkels, 1980; Puyol et al., 1994) or second order 
(Park and Lund, 1984; Relkin and Launay, 1990). Recently, a multi-state thermal 
unfolding and aggregation model for (3—lg has been postulated (Gotham et al., 1992; 
L in Q ie i al., 1995)
Differential scanning calorimetry (DSC) has been used by several groups to 
study the thermal stability of p—lg or the susceptibility of this protein to enzymatic 
hydrolysis (deWit and Swinkels, 1980; deWit and Klarenbeek, 1984; Park and Lund, 
1984; Paulsson and Dejmek, 1990; Puyol et al., 1993; Chen et al., 1993; Paulsson and 
Elofsson, 1994). For example, it has been shown using DSC, that p-lg  containing 
bound fatty acids has an increased resistance to tryptic hydrolysis (Puyol et al., 1993).
Differences in the relative structural stabilities (Imafidon et al., 1991; Huang et al., 
1994a, b) and/or susceptibility to enzymatic hydrolysis (Van Willige and FitzGerald,
1995) has been investigated for the A  and B variants of p—lg. It was shown that p~lg A 
is more thermostable than P-lg B. Although this difference in thermostability is not as 
yet fully understood, it is thought to be due to differences in structure which may be 
ascribed to the substitution of Asp64 in p-lg  A with Gly in p-lg  B. It has also been 
shown, that limited enzymatic hydrolysis improves the gelling properties of the 
protein, by changing the denaturation characteristics of the protein as indicated using 
DSC (Chen et al., 1993). In addition, the interaction with other milk proteins and the 
influence of ionic strength on gelling properties and thermal stability of p-lg  have also 
been examined using DSC (Paulsson and Elofsson, 1994).
This study examined the thermal stability at pH 3.00 and 8.00 (using DSC) and 
susceptibility of p—lg to enzymatic hydrolysis by gastric and pancreatic proteinases.
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5.3 Materials and methods
5.3.1 Materials
5.3.1.1 Enzymes
Commercial pancreatic proteases were received as gifts from the manufacturers. 
Corolase PP (porcine) was supplied by Rohm GmbH, Darmstadt, Germany. PTN 3.OS 
(porcine) was supplied by Novo Nordisk A/S, Bagsvaerd, Denmark. Porcine trypsin 
(Type IX, 13,700 BAEE units/mg protein), bovine Chymotrypsin (Type II, 40-60 
BTEE units/mg protein), porcine elastase (Type I, 25-100 units/mg protein, one unit of 
elastase will solubilise 1 mg of elastin in 20 min at pH 8.0 at 37 °C) and porcine pepsin 
A, (3,200-4,500 units/mg protein, one unit will produce an dA  280 of 0.001 per min at 
pH 2.0 and 37 °C for TCA soluble products o f haemoglobin) were obtained from 
Sigma Chemical Co. Poole, Dorset, UK.
5.3.1.2 Substrate
An enriched fraction of ß-lactoglobulin (ß—lg) variant AB was isolated according to 
the method of Maubois et al. (1987) on a pilot scale with some modifications. Details 
o f the production and composition of the ß -lg  enriched fraction are given by Mehra 
(1994). The details of the composition of the ß -lg  enriched fraction was given in 
Chapter 4. The degree of denaturation of the enriched ß-lg  fraction was determined on 
the basis o f solubility over a wide pH range (Mehra, 1994). The enriched ß-lg  fraction 
had approximately < 5 % denaturation (Mehra, 1994) and therefore was designated as 
a native fraction in this study. Purified bovine ß-lg  AB (3x crystallised and 
lyophilised) was obtained from Sigma Chemical Co. Poole, Dorset, UK. The degree of 
denaturation was not determined for the Sigma protein. All other reagents were of 
analytical grade unless otherwise specified.
5.3.2 Substrate pre-treatment
In certain instances ß -lg  was heat treated prior to hydrolysis by holding at 80 °C for 20 
nun.
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5.3.3 Characterisation o f whey protein substrates
5.3.3.1 Differential scanning calorimetry
DSC thermograms were recorded on a thermal analyser (model DSC 2910 TA 
Instruments, Surrey, England) using a thermal analyst 2000 system. Indium standards 
were used for temperature and energy calibrations of the DSC 2010 cell. Under the 
experimental conditions, the indium standard gave a melting point o f 157.95 °C, and 
an enthalpy value of 45.85 J/g. Using these values, the instrument was calibrated and a 
baseline was established. The instrument was calibrated according to the 
manufacturers instructions (TA Instruments, Leatherhead, England). (3-Lg solutions (8 
% (w/v) protein) were adjusted to pH 3.00, using 1 N HC1, or to pH 7.00 or 8.00, using
0.5 M NaOH, then equilibrated for 20 min at both 37 or 50 °C. Samples (in the range 
of 12-18 mg o f this solution) were sealed in aluminium pans (provided by the 
instrument manufacturers) and exact weights were recorded. The reference sample 
consisted o f an identical empty pan. Protein samples were analysed using two different 
programs, as follows; (1) equilibration of sample for approximately 5 min at 50 °C 
followed by heating at a rate of 5 °C/min to 100 °C; and (2) equilibration at 50 °C for 
approximately 5 min, holding at this temperature for 120 min, followed by heating at a 
rate of 5 °C /min to 100 °C. The second program was set up in an attempt to mimic 
possible changes in p -lg  conformation due to temperature alone over 120 min during 
the normal course of an enzymatic hydrolysis experiment. Overall enthalpies were 
calculated by numerical integration of the transition peak obtained from heat capacity 
versus temperature curves using the instrument manufacturers program. The 
temperature of maximum deflection from the baseline (known as the transition 
temperature), was observed when heat flow (dH/dt) is plotted as a function of the 
sample temperature. The transition enthalpy is a measure of the released heat during 
the change in protein conformation from the native to the denatured state. All reported 
values are the means of three independent replicates.
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5.3.4 Preparation o f  hydrolysates
Hydrolysates were prepared according to the method described in Chapter 4 for 
laboratory scale whey protein hydrolysis with pepsin, trypsin and commercial 
preparations. (Chapter 4, Section 4.3.6.1). Details of DH calculation were given 
previously (Chapter 1 and 2). The enzyme-to-substrate (E:S) ratio, 0.003, was 
calculated on the basis of total protein content in the enzyme preparations and the 
substrate. The initial rate of change of DH over time (A DH/min) was taken as the 
extent o f the hydrolysis reaction achieved following the first 20 min of each hydrolytic 
reaction. The standard deviation for hydrolysis reactions using this pH-stat system was 
determined previously to be DH ±0.1 % (O’Callaghan, 1994).
5.5.5 Characterisation offi-lg hydrolysates
5.3.5.1 Reversed phase high pressure liquid chromatography (RP-HPLC)
Peptides in P-lg hydrolysates were separated by reversed-phase (RP) HPLC 
according to the method described in Chapter 4. The flowrate was 0.30 ml min"1 and 
the detector response (mV) at 280 nm was recorded. The injection volume was 50 |_U 
and the concentration of the peptide applied was equivalent to a protein concentration 
o f 0.1 mg/ml.
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5.4 Results
5.4.1 Degrees o f  hydrolysis o f  native and heat-treated p-lg.
Native (3-lg was hydrolysed with pepsin at 37 °C and 50 °C (Figure 1 and 
Table 1), giving DH values of 2.69 and 4.03 % respectively, after 240 min hydrolysis. 
At 50 °C, peptic hydrolysis of the Sigma fraction o f P~lg gave a DH of 2.72 % after 
the same time. The degree of hydrolysis obtained by pepsin was relatively low, when 
using the native forms of (3-lg, in comparison to the other proteinases (Table 1). In this 
study, trypsin, chymotrypsin and elastase showed high activity at 50 °C against p-lg 
with DH values after 240 min of 6.52, 7.64 and 5.50 % respectively (Table 1). For the 
heat-treated form of the enriched fraction of P-lg, however, higher DH values were 
obtained for the peptic hydrolysis reactions after 120 min, i.e. 5.34 % and after 240 
min, i.e. 6.64 % (Table 1). The same was the case for a tryptic hydrolysis of a heat- 
treated fraction o f p-lg which resulted in a DH value of 7.15 %.
In general, the native (i.e. unheated) form of the enriched fraction of P~lg, had 
lower DH values after 240 min than the heat treated forms, with the exception o f the 
hydrolysis of native Sigma p-lg  by trypsin which gave a DH value of 9.03 % after 240 
min hydrolysis at 37 °C.
The initial rate o f reaction for the hydrolysis of the enriched native P-lg fraction 
was slower using pepsin than for trypsin (Table 1). For example, at 50 °C the 
ADH/min value for pepsin was 0.12 versus 0.26 for trypsin. When heat-treated (3-lg 
was used, smaller differences in the ADH/min were observed i.e. values of 0.13 for 
pepsin and 0.22 for trypsin (Table 1). There was a difference, however, in the final DH 
values obtained for peptic or tryptic hydrolysis after 240 min with heat-treated P-lg, i.e. 
6.64 and 7.15 % respectively. No major differences in the DH in the first 120 min of 
the reaction was evident where pepsin (DH = 5.34 %) and trypsin (DH = 5.26 %) were 
used in different combinations for the heat-treated p-lg (Table 1, Figure 2 and 3).
The sequence of addition of pepsin and trypsin gave a small difference, i.e. 0.2 
% in the total DH values (i.e. after 240 min) obtained for the hydrolysis of native P-lg 
at 50 °C (Table 1). It was noted that when pepsin was used to hydrolyse the protein for 
only 120 min, that low degrees o f hydrolysis were obtained (i.e. ~  2.4 %) for the
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hydrolysis of native (3—lg, regardless of the sequence in which this enzyme was used. 
However trypsin hydrolysis during the same time period gave a DH value of ~ 7.6 %. 
The total degree of hydrolysis (i.e. after 240 min) was higher when pepsin was used 
before trypsin in the hydrolysis of heat-treated (3—lg (Table 1). The DH curves 
generated using pepsin followed by trypsin in the hydrolysis of native and heat-treated 
(3-lg can be seen in Figure 2. It is clearly seen that the final DH values for the heat- 
treated (3-lg were much higher than the corresponding values for the native [3-lg. In 
general, the initial rate o f reaction with trypsin was higher than for pepsin (Figure 2 and 
3) and Table 1.
Figure 3 shows the DH curves for the hydrolysis of native and heat-treated p-lg 
when the trypsin was used before pepsin in the hydrolysis reaction. It is surprising to 
note that the final DH value was higher for the native as opposed to the heat-treated [3- 
lg. The native and heat-treated P-lg gave similar types of hydrolysis curves on 
digestion with trypsin followed by pepsin (Figure 3).
The commercial pancreatic proteinases, which contain combinations of trypsin, 
chymotrypsin and elastase in differing ratios gave the highest DH values when 
presented to the native P-lg substrate. Corolase PP and PTN 3.OS, when used in the 
hydrolysis of the native p-lg  gave higher DH values of 16.72 and 11.23 % 
respectively, than the individual proteinases, trypsin, chymotrypsin or elastase (6.52, 
7.64, and 5.50 % respectively) after 240 min hydrolysis in all cases (Table 1).
It was seen that the higher temperature of 50 °C versus 37 °C increased the 
initial rate of reaction. For example, the initial rate (ADH/min) of hydrolysis of p-lg by 
trypsin at 37 °C was 0.14 versus 0.26 at 50 °C. In addition, the rate of hydrolysis of 
native p-lg using pepsin was higher at 50 °C than at 37 °C as seen in Figure 1 for the 
peptic hydrolysis of p-lg at these temperatures. The initial rate of P-lg hydrolysis was 
highest when using Corolase PP and PTN 3.OS, with ADI I/min values of 0.50 and 0.38 
respectively (Table 1).
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Table 1: Native and heat treated (3-Iactogloublin, temperature of enzymatic hydrolysis, proteinases used, degrees of
hydrolysis (DH%) obtained after 240 min (in case of one enzyme), after 120 min (in the case of two enzymes).
P-Lactoglobulin treatment Hydrolysis Temperature
(°C)
Proteinase %  D H
(first enzyme)
%  D H
(second enzyme)
A D H / m i n
Native ß-lactoglobulina
37 Pepsin 2.69 c 0.06
50 Pepsin 4.03 - 0.12
37 Trypsin 5.69 - 0.14
50 Trypsin 6.52 - 0.26
50 Chymotrypsin 7.64 - 0.12
50 Elastase 5.50 - 0.08
50 PTN 3.OS 11.23 - 0.38
50 Corolase PP 16.72 - 0.50
50 Trypsin+pepsin 7.66 2.48 0.30 + 0.03
50 Pepsin+trypsin 2.36 7.58 0.06 + 0.27
Heat treated C-lactoglobulin b
50 Pepsin 6.64 - 0.13
50 Trypsin 7.15 - 0.22
50 Trypsin+pepsin 5.26 4.06 0.15 + 0.06
50 Pepsin+trypsin 5.34 5.96 0.13 + 0.18
a P-lactoglobulin which was not pretreated prior to hydrolysis;b p-lactoglobulin which was heat - treated prior to hydrolysis (80 °C for 20 min);c - not 
applicable
De
gr
ee
 
of 
hy
dr
ol
ys
is,
 %
Figure 1: Plot of the degree of hydrolysis (% DH) versus time (min) for the hydrolysis of native P
Lactoglobulin at 37 °C and 50 °C with pepsin
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heat-treated P-Iactoglobulin at 50 °C with pepsin and trypsin. T h e  arrow marks the point of addition 
of the second enzyme.
Figure 2: Plot of the degree of hydrolysis (% DH) versus time (min) for the hydrolysis of native and
Time (min)
Figure 3: Plot of the degree of hydrolysis (% DH) versus time (min) for the hydrolysis of native and heat-treated p-lactoglobulin
at 50°C with trypsin and pepsin. The arrow marks the point of addition of the second enzyme.
Time (min)
5.4.2 Peptide profiles o f  hydrolysates analysed by RP-HPLC
In general, a complex profile containing a large number of peptides was 
obtained for those preparations which contained more than one endoproteinase activity, 
i.e. Corolase PP and PTN 3.OS (Figure 4 (a) and (b) respectively). The P-lg 
hydrolysates produced using Corolase PP (Figure 4 (a)) displayed a complex mixture 
o f peptides, the majority of which eluted at a lower acetonitrile concentration than the 
peptides derived from fi-lg using PTN 3.OS (Figure 4 (b). It appeared that PTN 3.OS 
produces hydrolysates which are more hydrophobic than the peptides produced by 
Corolase PP.
The peptic hydrolysis o f P-lg resulted in low degrees of hydrolysis for the 
native protein, which corresponded to a large amount of more hydrophobic peptides in 
the elution profile (Figure 5 (a)). Figure 5 (b) shows the RP-HPLC profile for a peptic 
hydrolysis o f the heat-treated P-lg and shows lower amounts of hydrophobic peptides 
eluting at the higher ACN concentrations. A large number of peptides were obtained 
for the hydrolysates produced using a combination of two individual proteinases, such 
as pepsin and trypsin (Figure 6).
In general, RP-HPLC profiles show that for the hydrolysis of the native p-lg, a 
greater number of hydrophobic peptides were generated than for heat-treated P-lg. At 
low DH values and where only one proteinase activity was used to hydrolysis P-lg, the 
majority o f peptides were eluted at higher ACN concentrations. Where combinations 
o f pepsin and trypsin, or commercial preparations, were used, peptides were eluted 
over a broader range of ACN concentrations.
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Figure 4 : R P - H P L C  chromatograms showing peptide profiles of hydrolysates 
of native p-lg enriched fractions produced using (a) Corolase P P  and (b) P T N
3.0S
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Figure 5 : R P - H P L C  chromatograms showing peptide profiles over 85 min 
gradient elution assayed at 280 n m  of peptic hydrolysate of (a) native (b) and 
heat treated p-lg enriched fraction
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Figure 6 : R P - H P L C  chromatograms showing peptide profiles over 85 min 
gradient elution assayed at 280 n m  of peptic followed by a tryptic hydrolysate of
(a) native and (b) heat-treated P-lg enriched fraction.
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Two sources of (3-lg, both AB variants, were used for DSC studies, i.e. an 
enriched fraction and a Sigma purified protein. The (3-lg enriched fraction has other 
whey proteins and ions in low concentrations (given in Materials Chapter 4) and this 
may have had a bearing on the results. The gel permeation chromatograms of the (3-lg 
enriched fraction and the Sigma (3-lg proteins were given in Figure 2, Chapter 4. 
Sigma P-lg has been used by other researchers for DSC studies (Table 2).
It was noted in this study that there was a visible difference in colour for the 
unhydrolysed p -lg  solution (8 % protein) at the three different pH values examined,
i.e. pH 3.00, 7.00 and 8.00. At pH 7.00 and 8.00, the p -lg  (enriched fraction) solution 
had a milky appearance. However, at pH 3.00 this solution was less turbid. Sigma p- 
lg gave clear solutions at the 3 pH values tested. All the protein solutions were at 8 % 
(w/v).
The transition temperature was dependent on the solution pH. The higher pH 
values resulted in lower transition temperatures. Typical thermograms (i.e. heat flow 
versus temperature) obtained for DSC analysis of the enriched fraction P-lg at pH 3.00 
and at pH 8.00 are given in Figure 7 (a) and Figure 7 (b) respectively. It was observed 
that the enriched fraction of p-lg  had a transition temperature which was quite similar 
to the Sigma protein at pH 3.00. The enriched fraction of p -lg  had a transition 
temperature of 82.98 ± 0.62 °C at pH 3.00 and 69.15 ± 7.59 °C at pH 8.00. Sigma 
purified p -lg  was found to have a transition temperature of 83.48 °C ± 0.32 °C at pH
3.00 (Table 2). The enriched fraction of p -lg  had a transition temperature of 71.9 °C ± 
1.12 °C at pH 7.00 (Table 2).
The shape o f the dénaturation curves obtained also gave information with 
regard to the stability of the protein. It appeared at lower pH values, i.e. pH 3.00, 
(Figure 7 (a)), that the dénaturation curve was more symmetrical and more defined 
than the curve obtained at pH 8.00 (Figure 7 (b)). In addition, for the pH 3.00 
thermograms, it was easier to select a position, at which to draw a baseline, for the 
determination of enthalpy values. The principle reason for the lack of reproducibility 
between enthalpy values at higher pH values was due to difficulties in selecting a 
suitable position for the baseline. In this study, higher standard deviations were
5.4.3 Differential Scanning Calorimetry (DSC)
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observed for the Tm values at higher pH. Transition temperature and enthalpy values 
were reproducible at pH 3.00. The average enthalpy value obtained for the p-lg 
enriched fraction at pH 3.00 was 0.9825 J/g. This value was obtained using the 
program recommended by the instrument manufacturers. Because of problems with 
reproducibility with respect to enthalpy values at pH 7.00 and 8.00, these values were 
not reported in this study.
There was no major difference in the Tm at pH 3.00 for the p-lg substrate 
which was held (i) at 50 °C for 5 min or, (ii) at 50 °C for 125 min, followed by heating 
at a rate of 5 °C to 100 °C (Figure 7 (a) versus Figure 8 (a)). However, the 
thermograms obtained at pH 3.00 and pH 8.00 were more diffuse and broad when p-lg 
samples were held for 125 min at 50 °C. This effect was more pronounced at pH 8.00 
(Figure 8 (b)) than at pH 3.00 (Figure 8 (a)). For pH 8.00 incubation at 50 °C for 125 
min, a transition temperature 67.30 °C was obtained. Heat treatment o f P-lg at 80 °C 
for 20 min prior to analysis by DSC resulted in the removal of the structure of the 
protein as indicated by the absence of differential heat flow and a flat line thermogram 
(data not shown). Figure 8 (b) shows a thermogram which is tending towards a flat 
line thermogram.
Table 2 summarises the transition temperatures obtained in this study and in 
those of other workers for p-lg at a range of pH values.
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Table 2 : Transition temperatures and p H  of solutions of (3- 
lactoglobulin A B  from this study in comparison with values 
from the literature.
Transition Analysis Reference
T em perature  (Tm) pH
(°C) ± SD a
83.48 ± 0.32 3.00 This study b
82.98 ± 0.62 3.00 This study c
81.10 ± d 3.00 Chen e ta l. , 1993 c
78.50 ± 0.50 6.50 Puyol et al. ,1994
70.50 ± 0.50 6.50 Puyol et al. ,1994 h
84.0f ± 0.08 6.50 Imafidon et al., 1991 6
79.6e ± 0.10 6.50 Imafidon et al., 1991 6
72.00 ± 0.40 6.60 Gotham et al., 1992 b
70.40 ± 0.50 6.70 deWit and Swinkels, 1980 1
76.70 ± 0.31 6.80 Imafidon e ta l., 1991 g
71.90 ± 1.12 7.00 This study0
75.30 ± * 7.00 Foegeding et al., 1992 b
77.00 ± 0 .5-1.0 7.00 Paulsson and Elofsson, 1994 b
78.50 ± - 7.00 Chen e/a/.,1994b
69.15 ± 7.59 8.00 This studyc
“ SD - Standard deviation obtained from 3 different experiments in the present 
study
b Sigma (3-lg
c Enriched fraction of (3-lg
d value not available
e using sodium phosphate buffer
f using Piperazine-N, N'-bis (enthanesulfonic acid)
g P-lg AB isolated according to Imafidon (1990).
h delipidated P-lg AB
i P-lg isolated according to Fox et al. (1967). 
j P-lg with bound palmitic acid
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Tem perature (°C)
Figure 7: Thermogram of P-lg showing dénaturation of the enriched fraction of P-
Ig at (a) pH 3.00 and (b) pH 8.00 Equilibration was at 50°C, followed by a heating
rate of 5°C /min to 100°C.
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Tem perature (°C)
Figure 8 T h e r m o g r a m  of (Mg showing dénaturation after equilibration at 50°C, 
holding at this temperature for 120 min, followed by a heating rate of 5°C /min to 
100°C at (a) p H  3.00 and (b) p H  8.00.
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5.5 Discussion
The transition temperature (Tm) is an indicator of the thermal denaturation 
process of a protein. At the Tm it is thought that protein aggregation begins to 
dominate and the unfolding reaction become irreversible. It has been shown 
previously, in the case of P-lg, that thermostability was affected by the source and 
purity of (3-lg, initial degrees o f denaturation of p-lg, phenotypes of p-lg, composition 
and pH of buffers (Imafidon et al, 1991), in addition to the protein concentration used 
during DSC analysis (Relkin and Launay, 1990; Paulsson and Dejmek, 1990). In this 
study, therefore, the pH and purity of the p-lg  sources used would be expected to exert 
the greatest influence on the thermal stability of the protein, and thus on their 
susceptibility to enzymatic hydrolysis, particularly at 50 °C. It should be noted that 
eventhough the same P-lg variants, i.e. AB was used by all groups in Table 2 that 
differences may arise between Tm values obtained because of the above mentioned 
factors, in addition to differences in the heating rates used during DSC analysis.
Our overall findings in this study with respect to transition temperature values 
for p-lg at pH 3.00 and pH 8.00 correlate with those in the literature (Table 2). In this 
study, the enriched fraction of p -lg  had a higher transition temperature, i.e. 82.98 ±
0.62 °C, at pH 3.00 than at pH 8.00, i.e. Tm value was 69.15 °C. The low DH values 
obtained in this study when native p -lg  was hydrolysed using pepsin at pH 3.00 may 
be correlated to the thermal stability of the protein at this pH (Table 2 and Figure 7).
The purity of the P-lg source is also known to have an influence on thermal 
stability of the protein. However unexpectedly, the enriched fraction of p-lg (which 
contains small amounts of contaminants) had a Tm value of 82.98 ± 0.62 °C at pH 3.00 
which was very similar to the value obtained for Sigma P-lg, which had a value of 
83.48 ± 0.32 °C (Table 2). Sigma p-lg  has been previously shown to have an 
transition temperature of 77 °C at pH 7.00. (Paulsson and Elofsson, 1994). The 
enriched fraction of p-lg  had a Tm value o f 71.9 ± 1.12°C at the same pH in this study.
This lower value might reflect the effect of trace impurities in the enriched fraction of 
P-lg, at higher pH values, as suggested by other groups (Imafidon et al., 1991; Gotham 
et al., 1992). Discrepancies in Tm of p-lg  have been attributed previously to the
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presence of other ‘contaminating’ proteins e.g. oc-lactalbumin and lactoferrin (Imafidon 
et al., 1991). Irregularities in the shape of the dénaturation curves at pH 8.00 may also 
indicate the involvement of contaminating proteins or ions in the unfolding/ 
aggregation processes. Two individual processes are known to occur during heating 
(deWit and Klarenbeek, 1984; Gotham et al., 1992), the unfolding step (endothermie) 
and the aggregation step (exothermic), the combination of which in this study may 
have become an interfering factor (Gotham et al., 1992) in the production of uniform 
and symmetrical thermograms. The complexities involved in this unfolding / 
aggregation process have already been argued by a number of groups (Gotham et al., 
1992; Lin Qi et al., 1995). It is obvious, however, from this study that p -lg  is 
thermally less stable at pH 8.00 than at pH 3.00. (Table 2 and Figure 5). When a 
complex is formed between proteins (depending on pH and other factors such as Ca 
ions), changes in thermostability are known to occur (Imafidon et al., 1991). An 
indication of the influence of ions such as calcium was seen in the difference in colour 
of the enriched (3—lg fraction at pH 3.00 and pH 8.00. The cloudy colour of the 
unhydrolysed enriched fraction at pH 8.00 may be due to calcium ions which are 
tightly bound to p—lg at high pH and may be involved in the aggregation process. The 
interference by calcium ions may have given the ‘broad’ and ‘diffuse’ peak as the 
unfolding and aggregation steps were combined (Figure 5 (b) and Figure 6 (a) and (b)).
In addition, in this study, the standard deviation of the temperature of transition 
was higher at high pH values (Table 2). This may also be indicative of the unstable 
nature o f the protein at higher pH values. Observations in this study at pH 8.00 
concluded that the enthalpy values at this pH were not reproducible and the values 
therefore were not reported. The position of the baseline could be changed slightly 
between samples, without affecting the transition temperature, but such changes had an 
effect on the calculation o f the enthalpy value at pH 8.00. This was seen in particular 
when samples of p-lg were held for 120 min at 50 °C. The thermograms obtained were 
more shallow, irregular and diffuse in comparison to those found for the protein which 
was not held for 120 min at 50 °C (Figure 7 (a) and (b) respectively). It is known that 
the absolute enthalpy value is very sensitive to the position of the base line (deWit and 
Swinkels, 1980; Gotham et al., 1992; Puyol et al., 1994). This phenomena was found
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during this study. However, at pH 3.00, P-lg was more thermally stable and an 
enthalpy value of 0.9825 J/g was obtained. This value was about ten fold lower than 
previously reported by Chen et al. (1993) who found a value of 50.5 kcal/mol, i.e. 11.4 
J/g. It might be suggested that the difference in values obtained was due to the 
different concentration of sample (60 |al of 7 mg/ml) used by this group, in addition to 
a different heating rate (10 °C/min) in comparison to this study which used a heating 
rate o f 5 °C/min. (Note: a monomer molecular weight value of 18,400 was used in the 
calculation of the enthalpy value in this study).
The DSC results obtained give insight into the thermal stability of P-lg, and 
thus stability o f this protein during the hydrolysis reaction. Our study showed that the 
pancreatic proteinases, trypsin and chymotrypsin showed high activity against p-lg 
with final DH values of 6.52 and 7.63 % respectively (Table 1). Hydrolysis by all 
pancreatic proteinases was at pH 8.00, which was seen from DSC analysis to be the pH 
value which correlated to a lower thermal stability (Figure 5 (b) and Figure 6 (b)). It is 
known that p -lg  dissociates to monomer and undergoes reversible conformational 
change above pH 7.5, causing the exposure of tryptophan and tyrosyl residues to 
solvent (Townend et al., 1969; Zimmermann et al., 1970). Therefore, p -lg  would be 
less resistant to tryptic and chymotryptic hydrolysis at pH 8.00 due to the increased 
number of exposed cleavage points for these enzymes (Chobert et al., 1991), 
particularly at 50 °C.
Several literature reports show that p-lg  is resistant to tryptic, chymotryptic in 
addition to peptic digestion (Otani, 1981; Reddy et a l, 1988; Porter el al., 1984). 
However in these studies hydrolysis reactions were carried out at lower temperatures
i.e. 20 °C or 37 °C and pH values i.e. < pH 2.00, whereas hydrolysis reactions in this 
study were carried out at 50 °C and pH 3.00. The resistance of P-lg to hydrolytic 
attack appears therefore to be only under conditions of low pH and temperature. Kella 
and Kinsella (1988) suggested that acid stability (pH 2.00) of p-lg  could result from 
increased internal hydrogen bonding that arises between either two titrated carboxyl 
groups or one amide and one carbonyl group. It has been shown, for instance, that p -  
lg is resistant to gastric digestion and remains intact after passage through the stomach 
(Miranda and Pelisser, 1983). These conditions would correspond to approximately
203
pH 2.00, a physiological temperature of 37 °C, and a transit time o f ~ 240 min. Peptic 
hydrolysis of the native enriched fraction of p-lg  was evident in this study at pH 3.00 
at both 37 and 50 °C, giving DH values of 2.69 and 4.43 % respectively (Table 1). It 
was evident from this study that at temperatures > 37 °C, and at pH values > pH 2.00, a 
certain degree of hydrolysis by pepsin could be expected.
It may be that holding at 50 °C for 120 or 240 min may make the protein more 
susceptible to enzymatic hydrolysis by pepsin, as indicated by DH of 2.36 and 4.03 % 
respectively. DSC analysis showed that holding p-lg at 50 °C for 120 min at both pH
3.00 and pH 8.00 resulted in more diffuse and broad thermograms (Figure 8 (a) and
(b)). These thermograms suggest that the protein is perhaps slowly unfolding and 
becoming more unstable over time. In general broad diffuse thermograms reflect 
thermal instability of proteins due to protein-protein interaction/unfolding (Gotham et 
ah, 1992). The specificity of pepsin is for tyrosine, phenyalanine, leucine, isoleucine 
and tryptophan residues (Fruton, 1971). \\-Lg  contains four tryptophan groups per 
dimer (McKenzie, 1971). Therefore, in the course of the holding time at 50 °C, P-lg 
become less stable and has a more ‘open’ structure, allowing hydrolysis by proteinases 
such as pepsin of susceptible bonds which become exposed.
The conformational resistance of P~lg to peptic hydrolysis at low pH values 
was removed by heat treatment of the substrate (80 °C for 20 min) as indicated by DH 
values of 5.34 and 6.64 % for 120 and 240 min hydrolysis times, respectively (Table 
1). This was opposed to DH values of 2.36 and 4.03 % for 120 and 240 min peptic 
hydrolysis of the native p-lg. Heat treatment o f p -lg  results in denaturation of the 
protein, reduction of the disulphide groups at high pH values, and thus exposure of 
mainly hydrophobic amino acid residues which are usually buried within the internal 
structure of the native molecule (Mihalyi, 1978; Puyol et al., 1994). DSC analysis of 
heat-treated p-lg samples indicated no differential heat flow and a flat line thermogram 
was observed (data not shown). Heat treatment, as expected also resulted in the 
exposure of additional amino acid residues for the action of trypsin. The final % DH of 
a tryptic hydrolysis of heat treated p-lg (DH = 7.15 %) was higher then that for tryptic 
hydrolysis of native P-lg (DH = 6.52 %). The native forms of the enriched fraction of 
P-lg, had a lower % DH after 240 min than the heat treated form (Table 1). This was
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not the case however, for the hydrolysis o f Sigma purified p-lg  by trypsin at 37 °C. 
The degree of hydrolysis obtained was highly unusual, as DSC analysis indicated that 
there was little difference between the structural stability o f this sample, indicated by 
the transition temperature, 83.48 ± 0.32, and those values obtained in the literature, 
81.10 (Chen et al., 1993) as seen in Table 2. It could be that an overestimated E:S ratio 
was employed in the hydrolysis reaction, giving higher degrees of hydrolysis.
Higher total DH values (i.e. after 240 min) were obtained, when pepsin was 
followed by trypsin hydrolysis of heat-treated P-lg (DH = 11.30 %) in comparison to 
trypsin followed by pepsin hydrolysis of the same protein (DH = 9.32 %) as seen in 
Table 1. Pepsin is important in the provision of substrates for the action of trypsin 
during hydrolysis of native P-lg at 50 °C. This is reflected in the DH values obtained 
during sequential hydrolysis of native p-lg with pepsin and trypsin. (Table 1). It has 
been established previously that pepsin makes the molecular structure of native p-lg 
more susceptible to proteolytic attack by other proteinases (Porter et al., 1984; Antila et 
al., 1991). RP-HPLC chromatograms for the reaction on both native and heat treated 
P-lg indicated the production of a larger number of peptides, with a broad range of 
hydrophobicities when both endoproteinases are used in this sequence (Figure 5).
In general, the peptides generated appeared to be more hydrophobic for the 
native than the heat-treated P-lg hydrolysates. The heat-treated, p-lg had no structural 
resistance to hydrolysis (as seen using DSC) by either pepsin or trypsin, and therefore, 
more peptides o f lower hydrophobicity are seen to elute on RP-HPLC, i.e. at lower 
concentrations o f acetonitrile.
The commercial proteinase preparations Corolase PP and PTN 3.OS produced 
complex RP-HPLC peptide profiles (Figures 2 (a) and (b)) which may be indicative of 
more than one proteinase activity (Chapter 1 and 2). The importance of the specificity 
and ratio o f proteinases within a proteinases preparation in the production of peptides 
with specific molecular characteristics was discussed previously (Chapter 1 and 2). It 
was evident that fewer peptides evolved from a hydrolysis reaction in which only one 
proteinase activity was used, such as the case with pepsin (Figure 6). In addition, 
higher initial hydrolysis rates, in addition to higher final DH values after 240 min, were 
obtained for the commercial preparations (Table 1),
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This preliminary study showed the utility o f DSC analysis in elucidating the 
thermal stability and as a consequence the susceptibility o f P-lg to enzymatic 
hydrolysis by gastric and pancreatic proteinases. The accessibility o f P-lg to enzymatic 
digestion is dependent not only on the purity and the initial level of denaturation of the 
substrate, but more specifically on the temperature and pH of the hydrolysis reaction.
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CHAPTER 6
Evaluation of an ultrafiltration system for the fractionation 
of whey protein hydrolysates1
1 This chapter was submitted as a final report for an EU Co-Responsibility funded project- 
contract no. 1116-92
6.1 Summary
A laboratory scale tangential crossflow plate and frame ultrafiltration (UF) 
membrane system was evaluated for the processing of a whey protein hydrolysate. 
Several problems were encountered during the optimisation of the above system. 
These problems were mainly due to incompatibility of the membrane with the pumps
and/ or with the feed solution. Two membranes (10 kDa cut-off) of different surface
2  2areas, i.e. 0.093 m and 0.46 m , were investigated. It was initially observed that a
peristaltic pumping system was unsuitable for processing of WPC hydrolysates using
2 , 
the 0.093 m membrane. The feed channels in the membrane frame holder were
narrow, causing high backpressures and resulted in bursting of the peristaltic tubing.
Therefore, a centrifugal pump with reinforced tubing was installed to the system
containing the 0.093 m surface area membrane. It was found, however, that this
assembly was very sensitive to the torque applied during membrane installation.
♦ 2Therefore, a membrane of larger surface area, i.e. 0.46 m , was used which was not as 
sensitive to torque and did not show compressibility problems during operation. It was 
also observed that the centrifugal pump was sensitive to high total solids content in the 
feed and to low crossflow. A strategy was thus adopted to control mean membrane 
pressure for the 0.46 m membrane operated with the centrifugal pump, by adjustment 
o f pump speed setting, whilst leaving both inlet and outlet valves open. For detailed 
characterisation of the 0.46 m surface area membrane mean membrane pressures of 
0.52 and 1.38 bar were used.
WPC hydrolysates were produced using the commercially available pancreatic 
proteinase preparation, PTN 3.OS. It was shown that the main proteolytic activities in 
PTN 3.OS are stable over 28 h in the presence of whey protein. For the membrane 
optimisation procedures, a hydrolysate with a degree of hydrolysis of 8 % and a total 
solids content of 10 or 5 % (i.e. from 8% to 4% total protein) was used. The lower 
total solids content in the feed was used to reduce the likelihood o f membrane fouling.
The ultrafiltration o f whey protein hydrolysates was subject to severe fouling by 
protein and mineral deposits. The membrane in our study permitted the use of alkaline 
detergents and sodium hypochlorite to remove deposited proteins and amino acids.
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However, it was found that the pump seals were not compatible with various cleaning 
reagents suitable for efficient membrane cleaning. A cleaning procedure which 
differed to that recommended by the manufacturers was thus developed.
Overall, the system studied was acceptable for the batch membrane processing of 
hydrolysates. The membrane allowed for retention of the active enzyme, PTN 3.OS, in 
addition to fractionation o f the WPC hydrolysate to peptides <10 kDa. This UF system 
would thus have the potential to enrich for hydrolysate peptides of a certain molecular 
mass distribution. Furthermore, active enzyme could be retained by the membrane 
allowing for enzyme re-use and thus eliminate the requirement o f a heat inactivation 
step, as in conventional hydrolysate production protocols. The system investigated, 
however, proved very difficult to efficiently operate due to problems with fouling by 
the feed. Much work remains to be carried out in order to develop an efficient 
ultrafiltration system for continuous/ semi-continuous hydrolysis of milk proteins.
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6.2 Introduction
Milk protein hydrolysates find application in a wide range of product areas, e.g. 
in infant formulae, dietetics, sports nutrition (Driessen and Van den Breg, 1988), 
functional food ingredients (Jost and Monti, 1977; Ennis and Harper, 1986; Chobert el 
al., 1988), cosmetics (Hidalgo and Jost, 1980), bacteriological growth media 
(Bouhallab el al., 1993), and as bioactive peptides (Bouhallab and Touze, 1995).
Traditionally, hydrolysates have been generated enzymatically in batch-type 
processes (Adler-Nissen, 1986). This involves holding the substrate, such as whey 
protein, and enzyme in a reaction vessel at a defined temperature and pH for a specified 
time interval. When a desired degree o f hydrolysis (DH, %) has been attained the 
enzyme is inactivated generally using a high heat treatment step. Significant costs are 
associated with batch processes due to the requirement for large quantities of enzyme 
and the high energy inputs, i.e. during enzyme inactivation.
Heat treatment as a means o f enzyme inactivation may induce formation of 
peptide aggregates, the amount and size of which may depend on the degree of 
hydrolysis and the heating temperature and pH of the solution (deWit and Swinkels, 
1980). Solubility is one characteristic which is changed, among others, as a result of 
this enzyme inactivation heat treatment step (Britten el al., 1994). In addition, heating 
may destroy some of the functional, or nutritive properties (Erbersdobler, 1983) 
associated with hydrolysates (especially those at low DH), where some tertiary protein 
structure may still be associated with stable domains, as in the case of partially 
hydrolysed p-lactoglobulin (Chen el al., 1994). Heat treatment may also lead to the 
generation of undesirable off-flavours. Furthermore, re-use of expensive enzyme 
systems is not possible with batch enzymatic hydrolysate production due to the 
irreversible inactivation o f the enzyme during heat treatment. The output from a batch 
process, defined as the mass of product produced per unit time, therefore, decreases as 
the reaction proceeds. This decrease is due to the disappearance of substrates and to 
the lowering of the concentration of active enzyme either due to inactivation or 
reversible adsorption to reaction products. Iacobucci et al. (1974), showed that there
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was a 2 % per hour loss of active enzyme during the hydrolysis o f soybean protein 
isolate using a thermostable fungal acid protease preparation.
The advent of ultrafiltration systems capable of being fitted with membranes 
having different molecular sieving capabilities eliminates the requirement for heat 
inactivation of the enzyme in the hydrolysis product after hydrolysis is complete, as the 
enzyme can be retained by the membrane. Substrates with relatively large molecular 
masses are enzymatically broken down during batch, semi-continuous or continuous 
enzymatic hydrolysis to smaller peptide products which are permeable to the 
membrane.
The application of membrane technology in the food industry has been reviewed 
(Hallstrom et al., 1989; Tragardh, 1988). Ultrafiltration has been used by many groups 
in the production of specialised protein hydrolysates (Turgeon et al., 1991; Gauthier el 
al., 1993), such as those having reduced allergenicity (Van Bersteijn et al., 1994) or 
hydrolysates which contain bioactive peptides (Bouhallab and Touze, 1995).
Further to the advances in membrane technology, the development of continuous 
hydrolysis systems offers the advantage of enzyme re-use. This alternative to the batch 
process often employs the use of enzyme immobilisation on solid supports and/or 
enzyme entrapment in membrane reactors (Turgeon and Gauthier, 1990; Haque, 1993). 
The system configurations and kinetics of enzymatic hydrolysis differ between batch 
and continuous hydrolysis of milk proteins (Sejr Olsen and Adler-Nissen, 1981). 
Given that enzymes can be re-used in continuous membrane systems, it becomes 
economically feasible to incorporate a high enzyme concentration in the reactor 
system. Quantitative and rapid removal of enzyme can also be achieved, a capability 
o f major importance, particularly during the development o f products with low degrees 
o f hydrolysis. By choosing suitable membrane pore sizes it is also possible to exercise 
some control over the molecular size of the product. Continuous/semi-continuous 
enzyme systems combined with membrane processing allow for high product outputs 
by (a) keeping the enzyme and substrate concentrations constant and (b) by using large 
enzyme to substrate ratios taking advantage of the enzyme retention capability of the 
membrane. In using high enzyme concentrations it is possible to achieve very fast 
reaction rates giving short residence times for the conversion of substrate into
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diffusible products. It is theoretically possible to achieve a steady state at constant flux 
in turn giving quantitative conversion of substrate for extended periods of time. There 
have been several reports in the literature describing laboratory-scale continuous and 
semi-continuous enzyme systems (Table 5.1 in Literature review). Such systems have 
been described for a variety of hydrolysable protein substrates, e.g. caseins, soybean 
protein isolate, blood proteins, fish proteins, alfalfa, leaf protein, etc. (Table 5.1).
The general principles o f ultrafiltration (UF), UF membranes and UF systems of
importance to dairy industry applications have been reviewed (Glover, 1985). Three
factors are of utmost importance in the optimisation of any membrane processing
system. These are: the membrane type, membrane configuration and permeate flux
through the membrane. Flux is usually given in units of permeation of the product
2 1over time per unit membrane area, i.e. 1 m ' h' . The membrane type is defined by the 
material the membrane is made of (organic, inorganic, metallic), the configuration by 
the geometry of the membrane (plate and frame, tubular, spirally wound, hollow fibre), 
and the permeate flux which is partly controlled by the fouling characteristics of the 
feed. Interaction of these factors must be carefully considered, especially the influence 
of feed characteristics on the membrane flux, and feed component retention on 
permeation characteristics. The performance of a membrane during a processing 
operation is usually represented by permeate flux curves, i.e. a plot o f flux against the 
mean membrane pressure or against the concentration of a given component such as 
protein/peptide under stated conditions. Optimisation of permeation (i.e. permeate 
flux) requires that concentration polarisation, (defined as the build up o f feed 
components on the surface of the membrane leading to reduced flux), be minimised.
Other interrelated factors that influence flux and feed component permeability 
(Koch Membrane Systems, 1986) are as follows:
6.2.1 Mean membrane pressure
The driving force o f an ultrafiltration process is a hydraulic pressure gradient 
between the feed and permeate sides o f the membrane. This pressure gradient is 
termed the mean membrane pressure. The permeate flux of an ultrafiltrate is dependent 
on the mean membrane pressure, defined as (Pressure in|et + Pressure outlet) -^ As the
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mean membrane pressure increases, the flux increases to a point where the hydraulic 
flow is limited by other membrane phenomena. At low pressure, the membrane 
usually responds to small changes in mean membrane pressure. As the pressure 
increases, the flux response to pressure decreases until the flux becomes pressure- 
independent. At this point, a gel layer or concentration polarisation layer restricts flux. 
Concentration polarisation and the formation o f the ‘gel’ polarisation layer of 
resistance at the membrane surface is inherent in each membrane process. This can 
never be eliminated but should be minimised during optimisation of a membrane 
process (Glover, 1985). The degree of concentration polarisation in turn is dependant 
on the type of membrane used, the feed composition, flow velocity and mean 
membrane pressure. When the pressure increases the gel layer is compressed which in 
turn provides a greater resistance to the passage of permeate through the membrane. In 
some cases, the compression of the gel layer under increasing pressure more than 
offsets the pressure gradient, and fluxes will then decline with added pressure.
6.2.2 Feed crossflow (I h'1)  over the membrane
Flow of feed over the membrane or flow through the module is a concept of 
filtration known as cross-flow or tangential flow. The crossflow technique allows for 
long term processing with little decline in permeate flux over the course of the process 
run. With conventional filtration, the retained particles on the filter material 
accumulate to a point where no liquid will pass through the filter. As the feed cross 
flow (1 h’1) is increased, concentration polarisation effects are alleviated due to the 
‘sweeping’ action of the feed across the membrane. Cross-flow filtration, therefore, 
creates a turbulent environment on the membrane surface that prevents accumulation of 
retained particles. A high flow velocity at the membrane surface sweeps particles back 
into the bulk stream and minimises formation of the protein gel layer. For some 
process streams, the permeate flux is highly dependent on the flow across the 
membrane. When flux is flow-dependant, flux is limited by the gel concentration 
layer. An increase in flow rate will increase the permeate flux. At very high flow 
rates, a flow-independent stream may become flow-dependent, where other controlling 
factors such as membrane fouling may take over.
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6.2.3 Process temperature
All ultrafiltration processes are temperature-dependent. Several membrane and 
enzyme systems can be operated at elevated temperatures, e.g., 50 °C. This is 
advantageous in that higher temperatures can result in faster rates of substrate 
conversion, lower viscosities o f the feed and retarded growth of (mesophilic) 
microorganisms. In general, the permeate flux will increase with higher temperature 
due to decreases in viscosity of the feed solution. When processing dairy streams, the 
relationship of increasing flux with increasing temperature holds only within a certain 
range. Below 35-39 °C, the fat components of dairy products undergo a phase change 
and solidify causing membrane fouling. Similarly at high temperatures (50-65 °C), 
over extended time periods whey proteins denature and this may result in membrane 
fouling.
6.2.4 Concentration o f  retained species
The objective of using the selective membrane, e.g. with defined molecular 
weight cut-offs, is to concentrate some components of the feed stream relative to 
others. When the concentration of retained species becomes sufficiently high, the 
process flux is limited. In dairy streams, the protein and fat fraction are flux- 
controlling species. This concentration dependent flux phenomenon is found in all UF 
systems operating at high concentration levels. In a batch process, as the total solids 
concentration is increased on the feed side of the membrane during ultrafiltration, this 
leads to a decrease in flux and fouling of the membrane occurs. This is accompanied 
by pressure build-up in the system.
6.2.5 Membrane cleanliness andfouling characteristics o f  the feed
All ultrafiltration membranes are subject to fouling by components in the feed 
stream. Membrane fouling can be defined as the accumulation of thin molecular layers 
on the surface of the membrane that cannot be removed by increasing the flow rate 
across the membrane. Fouling may be reversible where periodic cleanings remove this 
layer and restore performance of the membrane to original levels (i.e. > 90 % of the 
original Normal Water Permeability (NWP)). Irreversible fouling is caused by
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unwanted components in the process stream or cleaning water that cannot be removed 
by normal cleaning cycles. Reversible foulants include protein, fats, calcium salts, 
polysaccharides and polyphenols. Irreversible foulants include silicone, some 
surfactants, colouring agents in certain chemicals. The response of a membrane system 
to fouling is usually manifested as a productivity decline during the first hour of the 
process followed by a more gradual decline to the end o f the run. For some highly 
fouling streams the flux loss will be more pronounced causing large productivity losses 
in a short process time. Normal membrane fouling can be compensated for by 
increasing the mean membrane pressure or by adding membrane area, i.e increasing 
area to volume ratio. By increasing the mean membrane pressure, the fouling 
phenomena is counteracted by the increase in hydraulic pressure on the membrane. By 
adding an additional stage/membrane on line, the new clean membrane offsets the 
portion o f the system lost due to normal membrane fouling.
6.2.6 Pre-treatment conditions o f  the feed
Pre-treatment of the feed can potentially affect membrane performance by 
changing the fouling characteristics of the feed. The pre-treatment effect may be due to 
direct changes in the quality (molecular stability/thermal stability) of protein, fats or 
calcium in the feed stream or may be due to indirect changes related to e.g. 
microbiological contamination of the feed. As already stated, an upstream process can 
affect the performance of the ultrafiltration step. Such upstream process may include 
the following: product heating and holding at a high temperature for a certain time; fat 
removal or standardisation of the feed stream; pasteurisation temperature and holding 
times; chemical treatment of the feed; pH adjustment; prefiltration of the feed (fines 
removal or suspended solids removal); preconcentration o f the feed by evaporation or 
by osmosis and micro-organism contamination (e.g. lactic acid bacteria and their 
influence on feed pH; nonlactic acid bacteria; moulds and yeasts).
Commonly used treatments in the processing of WPC are heat treatments which 
can result in feed component unfolding and aggregation (Britten et al., 1994). The 
composition of the feed solution has an influence on the flux and susceptibility towards 
fouling. Whey protein concentrate may have a high content of calcium, which may
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result in precipitate formation in the feed and thus expedite fouling during 
ultrafiltration. Addition of chelators such as EDTA, pH adjustment and prefiltration 
steps (Haque, 1993) are also used in certain cases, to pretreat the feed prior to 
ultrafiltration (Pouliot and Jelen, 1995).
6.2.7 p H  o f  the feed
The pH value at which a membrane system is operated can effect the permeate 
flux. This may be due, for instance, to pH effects on the feed material leading to 
increased concentration polarisation. In addition, the operating pH may have a 
contributory affect to the deposition of salts on the membrane surface.
The effect of pH on the permeation o f casein hydrolysates and amino acids has 
been shown previously (Pouliot and Gauthier, 1990; Gourley et al., 1995). It was 
found that if  the pH was increased from 6.0 to 10.0, the rejection characteristics of a 
polysulphonal membrane increased and permeation was improved (Gourley et al.,
1995). The effects of pH on hydrolysate aggregation, especially in the presence of 
calcium, have been discussed (Brûlé et al., 1980; Britten et al., 1994). The solubility 
of a heated WPC hydrolysate at neutral pH was high, but below pH 7.0 heat induced 
aggregates were formed (Britten et al., 1994). These aggregates would contribute to 
rapid formation of the ‘gel’ layer during membrane processing.
6.2.8 Membrane fouling
While theoretically ultrafiltration/ membrane/ enzyme systems offer many 
advantages over batch processes there are still several technical/engineering difficulties 
to be solved for optimal operation. These relate mainly to control of concentration 
polarisation/fouling. Several approaches have previously been taken to try to 
overcome problems of concentration polarisation and fouling. By using dead-end 
ultrafiltration cells, Bhumiratana et al. (1977) and Payne et al. (1978) showed that 
periodic pressurisation and depressurisation was required to depolarise the membrane 
o f deposited matter. Iacobucci et al. (1974) employed a ‘bleeding’ facility in their 
continuous system for soybean protein hydrolysis with acid protease to remove 
insoluble, non-permeable and non-hydrolysable material building up at the feed side of
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their ultrafiltration membrane. These steps may result in a more controlled 
transmembrane pressure and thus concentration polarisation is minimised. 
Macromolecular adsorption and fouling problems during ultrafiltration and their 
relationship to concentration polarisation has been studied (Matthiasson, 1984; 
Nilsson, 1989; Van der Horst, 1995). A mechanism of whey deposit removal has been 
proposed for the cleaning of heat-exchangers (Jeumink and Brinkman, 1994) and 
deposition models for UF membrane fouling by milk proteins have been reported 
(Hallstrôm el a l,  1989; Jeumink and Brinkman, 1994). Fouling by whey protein 
solutions has also been studied by other groups (Belmar-Beiny and Fryer, 1993; 
Ramachandra Rao et al., 1995). The fouling layer on the membrane surface dominates 
membrane behaviour. It is made up of both absorbed protein and protein deposited in a 
multilayer (Marshall and Daufin, 1995). The properties of a membrane fouling layer 
are known to depend on the degrees of protein adsorption, hydrophobic interactions 
between the proteins and the membrane, and membrane ionic interactions, resulting in 
a multi-fouling layer formation. The composition of the feed solution is of particular 
importance (i.e. pH, ionic strength, calcium content and degree of protein aggregation, 
presence o f lipids and other particulates) in the formation of the fouling layer (Marshall 
and Daufin, 1995). A comprehensive discussion of the physico-chemical aspects of 
fouling, strategies to minimise fouling and the cleaning of membrane systems has been 
published recently (IDF Bulletin, 1995).
This study reports on initial attempts at characterising a tangential flow plate and 
frame membrane system for subsequent use in continuous/semi-continuous enzymatic 
hydrolysis of whey protein concentrate.
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6.3 Materials and methods
6.3.1. Materials
6.3.1.1 Reagents
The commercial pancreatic protease, PTN 3.OS (porcine), was supplied by Novo 
Nordisk A/S, Bagsvaerd, Denmark. Amino-Methyl-Coumarin (AMC) and the 
fluorogenic substrates, N-suc-leu-leu-val-tyr-AMC and N-benzoyl-L-arg-AMC, were 
obtained from Bachem, Bubendorf, Switzerland. All other reagents were of analytical 
grade unless otherwise specified.
6.3.1.2 Substrate
Whey protein concentrate Lactalbumin-80 (Soluble UF-WPC) was from Milei 
GmbH., Leutkinch, Germany and had the following composition: protein (80 %), 
lactose (4.7 %), minerals (2.8 %), fat (6 %) and moisture (5 %).
6.3.1.3 Ultrafiltration equipment
— (R) «A Pellicon stainless steel plate and frame system was obtained from Millipore
Corp (Millipore, U.K.). Two different systems were used, employing membranes with
2 2surfaces areas o f (a) 0.093 m and (b) 0.46 m . The membranes used had a molecular 
weight cut-off o f 10 kDa and were a low protein binding durapore microporus type 
(Biomax® 10K polyethersulphone). Two pumping systems were also investigated: (i) 
a peristaltic pump (Model XX80 2G2 30, Millipore, U.K.) and (ii) a centrifugal pump 
(Model 260 TXLE) which was from Procon® pumping systems (Munfreesboro, TN, 
U.S.A). Thermoplastic tubing with polyester braid reinforcement capable of 
withstanding pressures up to 6.9 bar, fitted with 316SS Triclover sanitary compression 
swaged terminations was obtained from H+H Equipment Co., Ltd. (Dungoumey, Co. 
Cork.).
6.3.1.4 Membrane cleaning agents
Henkel P3-53 (enzymatic preparation, containing organic and inorganic 
complexing agents, in addition to emulsifying agents) was from Henkel Chemicals
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(Ireland) Ltd., and Esperase (an enzymatic preparation) was from Novo Nordisk A/S, 
Bagsvaerd, Denmark.
6.3.2 Methods
6.3.2.1 Quantification of enzyme activity.
Enzyme activities were assayed using a modification o f the fluorogenic (AMC) 
assay as described in Chapter 1 and 2.
6.3. 2.2 Preparation of hydrolysates.
Whey protein concentrate (WPC) was reconstituted using a Silverson® mixer 
(Machines Ltd., Waterside, Chesham, Bucks, U.K.). Generally, a 5 L solution of WPC 
at 4 % or 8 % (w/v) protein, was hydrolysed with PTN 3.OS at 50 °C in a jacketed 
vessel, until a defined degree of hydrolysis was reached (i.e. 8 %). The pH was 
maintained at pH 8.0 by continuous addition of 4 N NaOH using a pH-stat (Metrohm 
Ltd, Herisau, Switzerland.). The degree of hydrolysis (DH, %), defined as the 
percentage of peptide bonds cleaved, was calculated from the volume and normality of 
NaOH used to maintain constant pH (Adler-Nissen, 1986). Details for the calculation 
of DH were given previously (Chapter 1 and 2). Following hydrolysis to a DH of 8 %, 
the protease was inactivated by heating the hydrolysate to 80 °C and holding for 30 
min. Samples were taken and stored at -20 °C until analysed. The enzyme (E) to 
substrate (S) ratio used (0.003) was calculated on the basis of total protein content in 
the enzyme preparation and WPC. The above hydrolysate was used to characterise the 
performance of the plate and frame tangential flow membrane system.
6.3.2. 3 Process optimisation using the Millipore tangential flow membrane 
filtration system
All optimisation experiments were carried out with feed temperature at 50 °C. In 
accordance with manufacturer specifications, the mean membrane pressure was 
maintained at less than 2.07 bar for the 0.093 m membrane and at less than 3.45 bar
9 2for the 0.46 m membrane. The recommended feed crossflow for the 0.093 m
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membrane was that value (1 h "’) which was obtained when the mean membrane 
pressure was adjusted to 1.3 bar. The recommended crossflow for the 0.46 m 
membrane was 360 1 h' 1 ± 50 %.
It should be noted that initial trials for the optimisation of permeate flux were
carried out using semi-soft tap water at 50 °C for both membranes (surface areas 0.093
2 2 • m (System no 1) and 0.46 m (System no. 2)) in batch recycle mode, i.e. where
2 1retentate and permeate lines were returned to the feed reservoir. Flux rates (1 m’ h") 
were recorded.
6.3.2.3.1 Calculation of Normal Water Permeability iNWP)
The first parameter which is measured with respect to any new membrane system 
is the normal water permeability (NWP). The normal water permeability (NWP) o f a 
membrane is a good indicator of cleanliness of a membrane following a processing 
operation and subsequent cleaning steps. The inlet valve was adjusted to give an inlet 
pressure o f 1.38 bar and the outlet valve was adjusted to give an outlet pressure of 0.69 
bar, giving a mean membrane pressure of 1.03 bar (using System no. 2 and the 0.46 m 
surface area membrane). A NWP value of 1.38 1 /m /h/bar was obtained for the new 
unused membrane (0.46 m surface area) with tap water at 50 °C. The water 
permeability value (NWP) for the membrane following each processing and 
subsequent cleaning was determined and compared to the above initial NWP value. 
The following equation was used to determine NWP:
NWP = R*F / (A* (Pin + Pout)/2)-Pp)
where R= Permeate flowrate (1); Pin = Feed inlet pressure (bar); Pout = Feed 
outlet pressure (bar); Pp = Permeate pressure (which in this case is zero); A = Total 
membrane surface area (m2); F= Correction factor used for temperature of water (See 
appendix no. 1).
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63.2.3.2 Optimisation experiments with hvdrolvsate in batch recycle mode
The whey hydrolysate (DH of 8 %, total solids o f 5 or 10 % at 50 °C) was
• 2 2 processed with membranes with surface areas of 0.093 m and 0.46 m , and where the
system was driven by either the peristaltic or centrifugal pump. These experiments
were carried out in batch recycle mode, i.e. where the permeate and retentate streams
were returned to the feed reservoir.
4 • 2During initial experiments with the 0.093 m surface area membrane, the inlet 
and outlet valves were adjusted to give the desired inlet and outlet pressures, and thus 
obtain a specific mean membrane pressure (bar) while keeping feed velocity constant. 
Later, using the 0.46 m surface area membrane, the membrane system was operated at 
variable inlet feed pressures by adjusting the velocity setting on the pump. Both inlet 
and outlet valves remained open throughout this process.
6.3.2.3.3 Optimisation experiments with hvdrolysate in concentration mode
The hydrolysate (DH of 8 %, total solids of 5 or 10 % at 50 °C) was fractionated
2 2using the tangential flow membrane system using the 0.093 m and 0.46 m surface 
area membranes, while driven by the centrifugal pump. These experiments were 
carried out in ultrafiltration mode where retentate was returned to the hydrolysate feed 
reservoir and permeate was continually removed.
During initial experiments with the membrane of 0.093 m surface area the inlet 
and outlet valves were adjusted to obtain a specific mean membrane pressure (bar), 
while the feed velocity was maintained constant. Later, using the 0.46 m surface area 
membrane, the system was operated at variable inlet feed pressures by adjusting the 
velocity setting on the pump. Both inlet and outlet valves remained open throughout 
the process.
6.3.2.4 Membrane cleaning procedures
As recommended by the manufacturers, the Pellicon® membranes were cleaned 
by recirculating 0.1 N NaOH at 50 °C through the system for 30 min. This was 
followed by rinsing with water at 50 °C before determining the NWP.
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6.3.2.5 Analysis of peptide molecular mass distributions using gel permeation HPLC 
Whey protein hydrolysate peptides, i.e. retentate and permeate from the UF 
system were analysed by gel permeation (GP) HPLC on a Beckman Spherogel-TSK 
2000 SW column (600 mm x 7.5 mm), equilibrated and run with 30 % (v/v) 
acetonitrile containing 0.1 % (v/v) trifluoroacetic acid (TFA) in water.
Chromatography was conducted using a Waters™ HPLC detector, autosampler and 
pumping systems (Millipore, U.K.), at room temperature, the flowrate was 1 ml min '1 
and the absorbance at 214 nm was recorded. The injection volume was 20 The 
column was calibrated with the following standard proteins and peptides: Bovine 
serum albumin (66,000 Da); Carbonic anhydrase (29,000 Da); Ribonuclease A 
(13,700 Da); Cytochrome C (13,000 Da); Aprotinin (6,500 Da); Insulin (5,700 Da); 
Bacitracin (1,400 Da); Tryptophan (204 Da); Phenyalanine (165 Da) and Glycine (75 
Da). A Minichrom® data handling package (V.G. Data Systems, Manchester, 
England) was used to record and integrate chromatograms (Mullally et al., 1994). The 
proportion of peptides corresponding to a particular molecular weight, e.g., < 1 0  kDa 
was calculated as a percentage o f the total area of the profile obtained at 214 nm.
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6.4 Results and Discussion
-2 -1The flux rate (1 m ' h" ) o f the permeate was the main factor requiring 
optimisation, since a higher flux results in shorter processing time. However, lower 
flux rates with minimum membrane fouling may be more desirable in some instances 
for the development of a semi/continuous mode for hydrolysate processing.
The factors considered during the optimisation of flux in our study were as 
follows: (a) temperature which was maintained at 50 °C. This temperature was the 
maximum allowable for the membranes used. Furthermore, at this temperature 
microbial growth was minimised; (b) mean membrane pressure (c) total % solids 
concentration of the feed and (d) the torque applied to membrane during installation in
the membrane holder. Optimisation trials were carried out using membranes of
2 2 different surface area, i.e. 0.093 m (System no. 1) and 0.46 m (System no. 2).
2
6.4.1 System no 1: Using membrane with a surface area o f 0. 093 m .
6.4.1.1 Optimisation of flux using water in batch recycle mode
The initial NWP using this membrane was 1.167 1 /m /h/bar obtained using a 
peristaltic pumping system. However, attempts to characterise this membrane in detail 
with respect to optimum flux proved impossible. Problems were encountered with 
increasing backpressure exerted by the feed, causing the connecting tubing to burst. It 
was concluded that the peristaltic pump was unsuitable for the operation of this 
membrane system. Therefore, the system was subsequently run with the centrifugal 
pump and reinforced tubing (capable of withstanding pressures up to 6.90 bar) 
allowing maximal crossflow across the membrane.
6.4.1.2 Optimisation of flux using whey protein concentrate
The objective was to characterise the system (system no. 1) using the 
unhydrolysed WPC substrate and a centrifugal pump. The pump speed setting was 
adjusted to 0.5, and the mean membrane pressure was adjusted to 1.3 bar (i.e. to obtain 
the recommended feed crossflow (1 h '1)).
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The feed substrate was unhydrolysed whey protein concentrate at 10 % (w/v) 
total solids. This substrate was presented to the membrane at 50 °C. Attempts at 
establishing the flux of the unhydrolysed material using a centrifugal pump resulted in 
immediate pressure build-up (within 1 min of start up) in the system and fouling of the 
membrane. The pressure attained was the maximal allowable for the system (i.e. mean 
membrane pressure of 2.07 bar), and therefore, this experiment was terminated.
It was concluded that the unhydrolysed WPC substrate could not be processed 
through the membrane as this resulted in immediate concentration polarisation and 
fouling. It was concluded that a limited degree of hydrolysis is required before the 
WPC substrate can be processed through the membrane. It is known that whey protein 
substrate viscosities can be reduced following hydrolysis (O’Keefe and Kelly, 1981; 
Hooker et ah, 1982).
In subsequent experiments, therefore, attempts at characterising the optimum 
flux for this system were performed with WPC which had been hydrolysed with PTN 
3.OS to DH of 8 %. It was still found, however, that there was a lack of reproducibility 
in the flux values when a WPC hydrolysate was used in attempts to characterise system 
no. 1. It was found that the NWP changed for this system on disassembly and re­
assembly of the membrane. This led to the conclusion that the system was sensitive to 
differences in the applied torque during membrane installation.
6.4.1.3 Establishment of an optimum torque for UF system assembly
The objective was to establish the optimum torque level which could be applied 
to the membrane during installation which in turn would result in reproducible NWP 
values following membrane use, cleaning and reassembly. Both water at 50 °C and a 
whey protein hydrolysate (5 % total solids, DH of 8 %, at 50 °C) were presented to the 
membrane. The pump speed setting was 0.5 and the mean membrane pressure was 
adjusted to give 1.3 bar. The membrane was installed into the membrane holder using 
different torques, as shown in Table 1. The permeate flux was recorded (Table 1).
There appeared to be no correlation between the torque applied to the membrane 
during installation and the resultant flux value. For example, it was seen following
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three different installations of the membrane at a torque of 200 in lbs that the permeate 
flux for water at 50 °C varied from 12.34 to 29.03 1 m"2 h’1.
Table 1: Effect of torque applied on the m e m b r a n e  (surface area 0.093 m 2)
2 1during installation, on permeate flux (1 m  h~ ).
Torque (in lbs) Permeate flux (1 m ’2 h"1)
Water a t 50°C
1 st installation
200 12.3
2 nd installation
150 33.55
200 21.29
160 37.60
3rd installation
200 29.03
200 27.35
Hydrolysate at 50°C
100 23.23
200 28.39
It was concluded that the membrane with a surface area of 0.093 m was very
sensitive to the torque applied during installation in the holder. During consultation
with the membrane manufacturers, it was disclosed that this type of membrane was
also shown by other research workers to be susceptible to deformation due to applied
torque/pressure, in particular if  this pressure was applied in an uneven manner.
Compressibility was a further problem as the membrane had the ability to ‘recover’
after each installation. For example, the first installation with an applied torque of 200
2 -1in lbs gave a permeate flux value of 12.34 1 m" h' . However, after the second
_2
installation when the torque was adjusted to 200 in lbs, a permeate flux of 21.29 1 m' 
h"1 was attained using water at 50 °C in both cases. It was conceded by the membrane 
manufacturers that ‘wafer-thin’ membranes may display this problem. Following 
recommendations by the manufacturer and distributor of the Pellicon system, a
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membrane with larger surface area, i.e. 0.46 m was purchased. This cassette proved to 
be most robust and was not as sensitive to applied torque and did not show 
compressibility problems during further experiments.
6.4. 2 System no 2: Using membrane with a surface area o f  0.46 in
6.4.2.1 Optimisation of flux using water in the batch recycle mode
The NWP using this system was initially determined to be 1.410 ± 0.006 
l/m /h/bar, using a torque of 300 in lbs during installation of the membrane. The value 
obtained for this system was the average of four separate determinations. This 
membrane, in general gave more reliable results as compared with the 0.093 m surface 
area membrane, as it was not subject to compressibility.
6.4.2.2 Optimisation of flux using whey protein hydrolysate (10 % total solids, at 
50°C, DH of 8 %) in the concentration(UF) mode.
The objective was to characterise the permeation properties o f 0.46 m 
membrane with a hydrolysed feed at a particular pump speed setting (i.e. velocity). 
The initial mean membrane pressure was ~ 0.28 bar (i.e. 4 psi) which was obtained by 
adjustment of inlet (Pin ) and outlet (Pout) valves. The initial feed crossflow was ~ 26 
1 h ’1 at a pump speed setting no. 1. The final objective was to repeat this 
characterisation using higher speed settings.
According to the recommended operating conditions, membrane pressure and 
feed crossflow rate are normally controlled by adjustment of inlet and retentate valves 
in order to generate standard performance curves of permeate flux versus mean 
membrane pressure for the ultrafiltration system. From these curves the optimum 
mean membrane pressure to be used in order to provide maximal permeate flux over a 
long processing time can be ascertained. Therefore, using a hydrolysate and a constant 
pump speed setting, i.e. speed setting no. 1, a performance curve for the membrane 
system was generated (Figure 1).
From Figure 1 it was seen that it is possible to generate a performance curve for 
the membrane system when it was operated in the concentration mode. Figure 1 shows 
that permeate flux initially increased with increasing mean membrane pressure.
2
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However, a situation was reached where the permeate flux was independent of mean 
membrane pressure, i.e. at a mean membrane pressure of approximately 1 bar.
It should be noted, during this experiment, that fluctuations were observed in the 
pressure values which was due to an unusual ‘pulsing’ action by the pump. Therefore, 
the curve generated in Figure 1 was generated from the average pressure obtained at 
the inlet and outlet pressure gauges (i.e. the highest and the lowest pressure value on 
each pressure dial divided by 2). This fluctuation was ± 0.70-0.14 bar above and 
below the each average reading initially, however, the fluctuation increased to ± 0.35 
bar for each of the higher readings. It appeared, therefore, that the concentration of the 
feed/substrate used was too high. The pump appeared to malfunction due possibly to 
the development of high backpressures exerted by the feed as the inlet and outlet 
pressure valves/gauges were adjusted, for each mean pressure value, during the 
generation of the standard performance curve.
It was concluded that problems associated with concentration polarisation, 
membrane fouling and increasing back pressures were found using a whey protein 
hydrolysate at 10 % total solids during membrane characterisation in the concentration 
mode. Although the objective would be to increase system productivity by using a 
high substrate total solids concentration, the results indicated that a lower total solids 
concentration would be required for optimisation of this membrane system.
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Figure 1: Performance curve showing permeate flux (1 m‘ h‘ ) as a function of mean membrane
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pressure (bar), using a whey protein hydrolysate feed.
6.4.2.3 Optimisation of flux using whey protein hydrolysate (5 % total solids, at 50 °C, 
DH of 8 %) in batch recycle mode.
The objective was to characterise permeation properties of the membrane using a 
whey protein hydrolysate with a lower total solids concentration. The procedure was 
as in as in previous experiment (6.4.2.2) except using 5 % total solids concentration in 
the feed.
It was observed that at low feed crossflow (pump setting no. 1), the centrifugal 
pump behaved in an irregular manner. This was characterised as a ‘pulsing’ of 
pressure over the membrane resulting in irreproducible results. This problem persisted 
even when using water at 50 °C. The observed crossflow values in this experiment 
were lower than the manufacturer recommendations, particularly at low mean 
membrane pressures. The manufacturer recommended crossflow values were 240-480 
1 h '1. The values obtained in this experiment were between 60 and 288 1 h The 
higher crossflow value obtained corresponds to a mean membrane pressure of 2.06 bar 
(this pressure is approximately 60 % of the maximal allowable pressure for the 
system). At this time the pump had to be switched off due to the severe ‘pulsing’ of 
the pressure across the membrane.
It was concluded that the system could not be operated when the mean 
membrane pressure and feed crossflow rate were regulated by adjustment of the feed 
inlet and outlet valves. The strategy subsequently adopted, was to control mean 
membrane pressure by adjustment of pump speed setting, whilst leaving both inlet and 
outlet valves open.
6.4.2.4 Generation of flux performance curves in a batch recycle mode with mean 
membrane pressure set with variable pump speed control
The objective was to find the relationship between mean membrane pressure, 
feed crossflow and permeate flux over a broad range of inlet pressures. The procedure 
was as for the previous experiment (6.4.2.3), except that mean membrane pressure was 
regulated solely by the velocity setting on the pump, while the inlet and outlet valves 
remained fully open.
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It was shown that as inlet pressure was increased by adjustment o f pump speed 
setting that both permeate flux (1 m-2 h*1) and feed crossflow (1 h '1) increased in a linear 
fashion (Figure 2).
It was concluded that this new approach for characterisation of the membrane 
was satisfactory. For further studies feed inlet pressures of 1.03 bar and 2.76 bar were 
selected. These inlet pressures correspond to mean membrane pressures of 0.52 and 
1.38 bar at pump speed settings of 0.1 and 0.8 respectively.
230
Cr
os
sfl
ow
 
(I
h
')
i
Figure 2: Effect of mean membrane pressure on crossflow (1 h"1) and permeate flux (1 m'2 h'1)
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concentration mode at two selected mean membrane pressures
•  * * 2 The objective was to characterise the permeation properties of the 0.46 m
membrane using two different mean membrane pressures.
Both the inlet and outlet valves remained open. Two separate trials were carried
out, the first using a mean membrane pressure of 0.52 bar and the second using a mean
membrane pressure of 1.38 bar. The mean membrane pressure was regulated by the
velocity speed setting on the pump. The feed (10 litres) used was a whey protein
hydrolysate at DH of 8 %, with a total solids concentration of 5 %. The initial flux and
crossflow values were recorded after ten minutes o f operation. The initial feed
crossflow was 37.5 1 h"1 for the mean membrane pressure of 0.52 bar. The initial feed
crossflow for the mean membrane pressure of 1.38 bar was 218 1 h' .
It was seen that for a mean membrane pressure of 0.52 bar, the permeate flux
remained relatively constant for the first 90 min of operation. However, after this time
_2
as the total solids concentration increased in the retentate, the flux decreased to 3 1 m"
h _1 after 120 min (Figure 3). Figure 3 also shows slight increases in mean membrane
pressure over time. After 90 min the mean membrane pressure was readjusted (to the
initial value, i.e. 0.52 bar), however, this reduced the flux rate. The drop in flux was
not proportional to the drop in pressure. This would indicate that concentration
polarisation was beginning to dominate and fouling of the membrane was occurring,
thus reducing the flux.
For the higher mean membrane pressure of 1.38 bar the time of processing was
-2 - 1shorter. Over a 25 min period the flux decreased from approximately 42.5 1 m' h" to 
321 m '2 h '1. At this stage, a large volume of the hydrolysate (i.e. 8.21) had been 
processed (Figure 4). For the lower mean membrane pressure, 1.12 1 of the feed was 
processed in the same time.
It was concluded that the higher the mean membrane pressure the shorter the 
processing time. For the development of a semi-continuous/ continuous operation, 
however, this may not be desirable, as a certain reaction time must be allowed for the 
enzyme and substrate in the reactor. This experiment showed that it is possible to 
characterise the membrane system while keeping the inlet and outlet valves open.
6.4.2.5 Characterisation o f  permeate flux with whey protein hydrolysate in the
232
Pe
rm
ea
te
 
flu
x 
(1 
m
2 1Figure 3: A performance curve showing permeate flux (1 m' h ' ) over time using an inlet pressure of
1.03 bar.
Time (min)
M
ean 
m
em
brane 
pressure 
(bar)
2 1 ♦Figure 4: A  performance curve showing permeate flux (1 m' h " ) over time using an inlet pressure of 
2.76 bar
T i m e  (min)
However, there is less control of the mean membrane pressure over time as seen in 
Figure 3. It appears that the lower mean membrane pressure value chosen (i.e. 0.52 
bar) would favour an extended processing time, in particular for the potential 
continuous processing of a hydrolysate.
6.4.2.6 Evaluation of suitable cleaning agents for cleaning Millipore membranes
Whey is a well known membrane foulant. Whey protein concentrates such as 
that used in our study have a high mineral content, in particular calcium and phosphate, 
which may contribute to protein aggregation and fouling. For optimal productivity an 
efficient membrane cleaning procedure is required. Periodic cleaning o f the membrane 
removes deposited protein and salts from the membrane pores and should return the 
membrane to those conditions favouring optimal productivity. The objective was to 
evaluate an efficient cleaning procedure for the Millipore ultrafiltration membrane.
Cleaning agents/ procedures were evaluated for their ability to restore the NWP
value o f the membrane to its initial value, i.e. for the new unused membrane. The
2NWP value established for the 0.46 m surface area Pellicon cassette, using an applied 
torque of 300 in lbs, was 1.410 l/m2/h/bar.
According to the manufacturers instructions, the membrane should be efficiently 
cleaned by recirculating 0.1 N NaOH at 50 °C through the system. This procedure 
alone, however, was not capable o f restoring NWP values following ultrafiltration 
trials with the whey protein hydrolysate. A number of alternative cleaning agents, such 
as sodium hypochlorite or nitric acid were then recommended by the cassette 
manufacturers. However, some of the recommended cleaning procedures were not 
compatible with the stability of the membrane and /or the seals within the pumping 
system. The differential compatibility o f certain cleaning agents with the pumping 
system had to be taken into consideration when developing an efficient cleaning 
procedure. Sodium hydroxide (0.1 N) in combination with sodium hypochlorite (200 
ppm) was recommended as an efficient cleaning agent for the removal of whey protein 
foulants. However, sodium hypochlorite is not compatible with the seals in the 
centrifugal pump and therefore a peristaltic pump was linked to membrane for this 
cleaning step. In cases of severe fouling, a 1-2 % (v/v) solution of a commercially
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available enzymatic membrane cleaning agent, Henkel P3-53, was run through the 
system at alkaline pH values and at temperatures up to 50 °C. This reagent restored the 
NWP to between 80-90 % of the original value. Cleaning trials with a second 
enzymatic cleaning agent, Esperase at 1-2 % (v/v) concentration was used but lead to 
immediate severe fouling of the membrane within minutes of start up and the NWP 
value was reduced to less than 20 % of the original NWP.
It was also observed that over time a grey deposit was formed on the membrane 
at the feed inlet channels. This suggested the formation of a mineral precipitate. A 
cationic chelator ethylenediaminetetracetic acid (EDTA) tetrasodium salt, was then 
used in 0.1 N NaOH at a concentration of 0.5-1 % (w/v) in an attempt to clean the 
membrane. However, this cleaning step appeared to have only minimal effect on the 
recovery of NWP. When mineral fouling is a problem in other membrane systems, 
usually an acid wash is included. Phosphoric acid, at a concentration o f 6.6 % (v/v), 
therefore became the reagent of choice to remove mineral foulants. This acid wash 
restored the NWP to >90 % of the original value. However, acids including nitric acid, 
which are usually used in this situation were not compatible with the seals o f the 
centrifugal pumping system. Table 2 summarises the cleaning agents considered and 
shows their compatibility with the system.
236
Table 2: Compatibility of various cleaning agents with the centrifugal p u m p  
and m e m b r a n e  system
Cleaning agent at 50 °C Pump Membrane
0.1 N  NaOH V V
Henkel P3-53 1 % (w/v) V V
Esperase® 1 -2 % (w/v) X X
EDTA, tetrasodium salt 0.5 % (w/v) V V
Sodium hypochlorite 
(200 ppm in 0.1 N NaOH) X V
0.1 N Nitric acid X V
6 % (v/v) Phosphoric acid V V
where X = not compatible; and where V = compatible.
During cleaning, the flowrate o f the cleaning solution was found to be important, 
it has been shown that with decreasing flowrate, the rate of cleaning decreases (Bird 
and Fryer, 1991). However, it appears that low mean pressures are favoured during the 
rinsing step, because at higher pressures, the permeate stream may exert high 
compressional forces on the deposited particles, not allowing them to be removed as 
efficiently as in the case of lower pressures (Kulozik, 1995). In our study, it was 
difficult to reduce mean pressures, without lowering velocities. Therefore, the 
maximum allowable flowrate within the pressure limits of the system was used during 
the cleaning procedure. A number of cleaning steps with NaOH (0.4 % w/v) as used in 
our study may lead to the build-up of a sodium layer on the membrane from this 
reagent as seen by others (Timperley and Smeulders, 1988; Bird and Fryer, 1991), thus 
reducing NWP values. It appeared that the acid washing step was the most efficient, in 
terms o f cleaning the membrane, in particular, immediately after the alkaline cleaning 
step.
The whey deposit is represented as a complex of protein together with calcium 
salts, containing mainly calcium phosphate. In the case of concentrated whey, calcium
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nitrate deposits have also been found (Jeumink and Brinkman, 1994). Whey deposit is 
known to contain considerably more mineral compounds than other milk based 
deposits (Delsing and Hiddink, 1983), therefore it has been recommended to start the 
cleaning procedure with an acid cleaning step followed by an alkaline step after 
processing of whey (Jeumink and Brinkman, 1994). Fouling by whey protein 
solutions and deposition models for UF membrane fouling have been studied 
(Hallstrom et al., 1989; Belmar-Beiny and Fryer, 1993). A more specific study of an 
individual whey protein, (3-lactoglobulin, by differential scanning calorimetry, showed 
that the rate of fouling decreased as the pH of the feed solution was increased. 
However, the thermal stability of (3-lactoglobulin as expected decreased as the pH 
increased, (Gotham et al., 1992).
It was concluded that the following cleaning steps for the 0.46 m surface area 
membrane, were thus adopted: In all cases an inlet pressure of 1.38 bar and an outlet 
pressure of 0.35 bar was used, (a) the system was flushed with water at 50 °C (b) 0.1N 
NaOH was recirculated for 30 min at 50 °C (c) the membrane system was then 
connected to a peristaltic pump system and a solution of sodium hypochlorite(200 ppm 
in 0.1N NaOH) was pumped through the system at 50 °C. Step (a) was then repeated. 
If the NWP was not restored at this point, a 6.6 % (v/v) phosphoric acid solution was 
recirculated through the system for 30 min at 50 °C. Step (a) was than repeated, 
followed by (b), before rinsing with water and recording the NWP.
6.4. 3 Gel permeation HPLC o f  the ultrafiltered whey protein hydrolysate
The objective was to monitor the effect of membrane processing on the 
fractionation of peptides produced by enzymatic hydrolysis of WPC. The molecular 
weight distribution of peptides produced during hydrolysis was monitored using gel 
permeation HPLC to assess the fractionation effectiveness of the membrane, in 
addition to ascertaining the peptide profile in the permeate. The molecular size 
distribution o f a whey protein hydrolysate can dictate its use as a functional food 
(Turgeon et al., 1991,1992), as a fraction rich in bioactive peptides (Bouhallab and 
Touze, 1995) or for inclusion in hypoallergenic infant foods (Jost et al., 1988).
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The procedure was as outlined in methods (section 3.2.5) using hydrolysate of 
DH = 8 % and the 0.46 m membrane (i.e. System no. 2). Samples were taken during 
the course of the hydrolysis experiment as outlined in section 3.2.2. (Figure 1).
The gel permeation HPLC peptide profiles of the permeate and retentate 
following ultrafiltration o f the whey protein hydrolysate through the 10 kDa molecular 
weight cut-off membrane are shown in Figure 5 (a) and (b). Samples permeate and 
retentate were taken after 30 min and when the system was operated in the 
concentration mode. The HPLC profiles of the permeate, as expected, revealed that a 
large proportion of the peptides are <10 kDa. The permeate peptide profile revealed 
that after processing o f the hydrolysate, only 3.9% of the peptides had a molecular 
weight distribution >10 kDa (Figure 5 (b)). In the retentate (unfractionated 
hydrolysate) 10.5 % of the peptides were > 1 0  kDa (Figure 5 (a)). The peptide profile 
of the retentate therefore gives an indication of the molecular size distribution of the 
fraction of hydrolysate peptides retained by the membrane, which were produced by 
hydrolysis of WPC by the pancreatic preparation, PTN 3.OS to DH of 8 % (Figure 5 
(a))-
It is well known that peptides of certain size have certain functional properties, or 
specific properties such as hypoallergenicity and bioactivity. It was concluded that 
these properties may be enriched within hydrolysates if  peptides can be fractionated 
using membrane processing.
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Figure 5: Gel permeation chromatograms from the Spherogel - TSK 2000 SW 
HPLC column showing millivolt response, assayed by absorbance at 214 nm 
and elution times of (a) retentate and (b) permeate peptides following 
ultrafiltration using a 10 kDa cut-off membrane. The arrow marks the elution 
of peptides at an elution time corresponding to 10 kDa.
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6.4.4 Enzyme stability in the presence o f  whey protein substrate
The objective was to establish the rate of decay for trypsin and chymotrypsin, 
enzymes present in the commercial protease preparation, PTN 3.OS which were used in 
the development of whey protein hydrolysates in this study. The hydrolysis reaction 
(as outlined in method 3.2.2 ) was extended for 28 h, during which subsamples of the 
hydrolysate were taken, frozen at -20 °C, and later assayed for trypsin and 
chymotrypsin activity.
It was shown that trypsin and chymotrypsin (^moles AMC/min/mg protein) 
remained active for extended processing times in the presence of the whey protein 
substrate/hydrolysate (Figure 6).
It was concluded that the fact that trypsin and chymotrypsin are completely 
active for 28 h even at 50 °C argues well for their application in a continuous enzyme 
hydrolysis system. It has previously been shown that whey protein/ hydrolysates 
appears to stabilise trypsin activity (Jost and Monti, 1977).
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6.5 Conclusions
This study attempted to characterise a tangential crossflow plate and frame 
membrane system with a view to its use in batch, semi- and continuous processing of
milk protein hydrolysates. Two membranes of different surface areas were
2 2investigated, i.e. 0.093 m and 0.46 m . A number of conclusions were drawn:
It was initially observed that a peristaltic pumping system was unsuitable for 
processing o f WPC hydrolysates using the above membrane system. This was due to 
the fact that the tubing which linked the pump to the plate and frame membrane unit 
was not sufficiently reinforced to withstand high backpressures. A centrifugal pump 
was selected for further experiments to allow maximal crossflow over the membrane. 
This pump could be equipped with high pressure tubing capable of withstanding high 
backpressures.
It was found that the unhydrolysed WPC (10 % total solids) substrate could not 
be processed by the membrane as this resulted in rapid membrane fouling. A certain 
degree of hydrolysis was required before the WPC substrate could be processed 
through the membrane. Hydrolysis of the WPC should bring about a reduction in the 
viscosity of the feed (Hooker el al., 1982). The hydrolysate used therefore for 
characterisation of the system had a degree of hydrolysis of 8 % (DH = 8 %). 
Furthermore, the total solids concentration of the hydrolysate was decreased during 
membrane optimisation experiments from 10 to 5 % (i.e. from 8 % to 4 % total 
protein). The feed solution was maintained at 50 °C during membrane processing, this 
temperature would result in a further reduction in the viscosity of the feed, in addition 
to controlling possible microbial contamination during the course of a membrane
processing experiment.
___ 2
The membrane with a surface area of 0.093 m was very sensitive to the torque 
applied during installation in the holder. Following recommendations by the 
manufacturers and distributors of the Pellicon®, a membrane of larger surface area, i.e. 
0.46 m2 was used. This cassette proved to be most robust and was not as sensitive to 
torque and did not show compressibility problems in further experiments.
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Another important consideration during our study was the efficacy of the 
cleaning and sanitation procedures for the membrane. Membranes are fouled by 
proteins, and to different extents depending on the concentration of the product reached 
during processing. The membrane in our study permitted the use of alkaline detergents 
and sodium hypochlorite to break down proteins and amino acids. Acids could also be 
used to remove mineral deposits. However, it was found that the pump seals were not 
compatible with various cleaning reagents suitable for efficient membrane cleaning. A 
cleaning procedure which differed to that recommended by the manufacturers was thus 
developed.
The centrifugal pump was sensitive to high feed solids concentrations and low 
crossflow. Because this system was unsuitable for the use at low cross flow, the 
strategy adapted was to control mean membrane pressure by adjustment of pump speed 
setting, whilst leaving both inlet and outlet valves open.
For characterisation of permeation of the 0.46 m membrane, 1.03 bar and 2.76 
bar, were selected as the feed inlet pressures, corresponding to mean membrane 
pressures of 0.52 and 1.38 bar respectively. It was found that the 1.38 bar mean 
membrane pressure resulted in a shorter processing time.
The stability of the PTN 3.OS enzyme preparation over time in the presence of a 
whey protein substrate suggests that this preparation is ideally suited to continuous 
enzymatic hydrolysis over extended periods, even at temperatures up to 50 °C.
It is well known that fractionated peptides, produced using membrane 
ultrafiltration, of a specific size have certain functional properties (Gauthier et al.,
1993), or may have specific properties such as hypoallergenicity (Van Bersteijn et al.,
1994) and bioactivity (Bouhallab and Touzé, 1995). These properties are enriched 
within hydrolysates if  peptides can be fractionated using membrane processing. 
Fractionation of peptides <10 kDa was achieved by membrane processing of the WPC 
hydrolysate in this study. In addition, if  membrane processing was adopted as a 
method of fractionation of specific peptides, heat inactivation could be eliminated 
during processing of hydrolysates, as the proteolytic activities could be retained by the 
membrane. The enzymatic preparation could, potentially be reused. Elimination of the
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heating step would also alter the permeation characteristics and solubility of the 
hydrolysate (Turgeon and Gauthier, 1990; Britten et al., 1994).
However, the Millipore membrane system has not been specifically designed or 
developed for use in the daily industry. The primary market to date has been in the 
pharmaceutical industry, where these membrane systems are used mainly in 
clarification steps involving low feed protein concentration. Future developments in 
the processing of milk proteins in the food industry should involve ceramic 
membranes, as suggested by others (Hallstrom et al., 1989). Ceramic membranes are 
in general more robust towards the stringent cleaning required to remove protein and 
mineral foulants and in general are more suitable for highly viscous feed solutions 
(Daufin and Merin, 1995). The system investigated proved very difficult to efficiently 
operate due to problems with fouling by the feed and due to a lack o f compatibility of 
conventional cleaning agents with the pumping systems. Much work remains to be 
carried out in order to develop an efficient pilot scale ultrafiltration system for 
continuous/ semi-continuous hydrolysis of milk proteins.
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6.8  Appendices
Appendix B
NORMALIZED WATER PERMEABILITY TEMPERATURE CORRECTION FACTOR (F)*
T|*F] T(°C] F T(°F| T(°C) F T(°FJ T(°C| F
125.6 52 0.595 96.8 36 0.793 68.0 20 1.125
123.8 51 0.605 95.0 35 0.808 66.2 19 1.152
122.0 5Q 4L&L5 93.2 34 0.825 64.4 18 1.18!
120.2 49 0.625 91.4 33 0.842 62.6 17 1.212
118.4 48 0.636 89.6 32 0.859 60.8 16 Q4J
II6 .Ó 47 0.647 87.8 31 0.877 59.0 15 1.276
114.8 46 0.658 86.0 30 0.896 57.2 14 1.310
1 13.0 45 0.670 84.2 29 0.915 55.4 13 1.346
111.2 44 0.682 82.4 28 0.935 53.6 12 1.383
109.4 43 0.694 80.6 27 0.956 51.8 1 1 1.422
107.6 42 0.707 78.8 26 0.978 50.0 10 1.463
105.8 41 0.720 77.0 25 1.000 48.2 9 1.506
104.0 40 0.734 75.2 24 1.023 46.4 8 1.551
102.2 39 0.748 73.4 23 1.047 44.6 7 1.598
100.4 38 0.762 71.6 22 1.072 42.8 6 1.648
98.6 37 0.777 69.8 21 1.098 4 1 .0 5 1.699
* Bosed on Woter Fluidify Relolive to 25°C (77°F) Fluidify Vclus
P = *mT0C/',250C* ° r W aF '^7V«f'
i
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